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SUMMARY 
The primary aim of this work was the construction ofa multianalyte amperometric 
immunosensor. In the course of this work a new technique was developed for the selective 
immobilisation of organic molecules at defined areas on a variety of surfaces, including 
silica, glass, gold and carbon. The immobilisation technique comprised of binding avidin to 
the surface, and addition of photo biotin (a photactivatable biotin analogue) which bound to 
the avidin. This resulted in surfaces that were resistant to non-specific binding, and that 
allowed site specific immobilisation of biological molecules by exposure of selected areas 
of the surface to light, in the presence of the species to be immobilised. The application of 
this patterning technique was demonstrated for the immobilisation of antibodies, antig~I1s, 
enzymes, lectins and nucleic acids. 
In order to further demonstrate the application of this technology, a simultaneous 
quantitative electrochemical immunoassay was developed for the measurement of follicle 
stimulating hormone and luteinising hormone in human plasma. The assay showed good 
specificity and sensitivity, and values obtained for clinical samples correlated well with 
results obtained from an established commercial assay. This was the first report of an 
electrochemical multianalyte immunosensor for high molecular weight analytes. 
Further work demonstrated the applicability of the selective immobilisation method to the 
construction ofmultianalyte enzymic biosensors and immunosensors, using 
ultramicroelectrodes 10 ~m in diameter. It was shown that previously reported advantages 
of using microspot immunoassays were not applicable to these amperometric assays, as 
non-planar diffusion of species to ultramicroelectrodes effectively greatly increased the 
instruments "field of view". Investigations into "cross-talk" between ultramicroelcctrodes 
showed that it would be possible to fit over 350 sensors into a 1 mm" area. 
Finally, the applicability of the immobilisation method in the detection of mUltiple nuckic 
acid sequences was also demonstrated, and an assay was developed for the detection of the 
Factor Vlciden genetic polymorphism. 
The model systems described above, demonstrated both the efficiency of the protein 
patterning techniques developed, and its application to multianalyte sensing systems. The 
technology that has been developed is applicable to a generic range of sensors, and 
fabrication methods are compatible with the requirements of larger scale production and 
miniaturisation, utilising processes common in the microelectronics industry. 
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CHAPTER 1 
The Road goes ever on and on 
Down from the door where it began. 
Now far ahead the road has gone, 
And I must follow if I can, 
Pursuing it with eager feet, 
Until it joins some larger way 
where many paths and errands meet. 
And whither then? I can not say. 
1 
J. R. R. Tolkien 
Lord of the Rings 
1 Study Aims 
The primary aim of this work was the construction of a multianalyte amperometric 
immunosensor, capable of quantitatively measuring two or more high molecular weight 
analytes simultaneously. An integrated electrochemical multianalyte immunosensor had not 
previously been reported in the literature, although electrochemical multianalyte 
immunosensing systems have been reported where more than one sensor or parts of sensors 
have been fabricated separately and later integrated to make an array.l.2 In general, in the 
miniaturisation of sensors, it is preferable that the sensor should be constructed in such a 
manner that facilitates fabrication, namely from a single piece of material and employing 
techniques suitable for mass production. 
Miniaturisation is desirable for a number of reasons including the ability to perform the 
analyses with a very small sample, faster response times, high throughput and reduced cost 
as well as the potential for implanting sensors into biological tissues.3•4 In this study two 
glycoproteins, follicle stimulating hormone (FSH) and luteinising hormone (LH) were 
chosen as the model analytes, the measurement of FSH and LH being selected as, in clinical 
analysis, the determination of these hormones is usually requested simultaneously. 
Additionally, FSH and LH are normally assayed by heterogeneous immunoassay, the 
approach to be used in this work. 
1.1 Biosensors:- General Principles. 
Biosensors are analytical devices that use biological material to detect chemical or 
biological species directly, without the need for complex sample processing. Biosensors 
consist of a biological 'receptor' element that has the ability to bind to a very narrow range 
of analytes (conferring specificity) and a 'transducing' element that provides a quantitative 
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indication that the analyte and the biological receptor have combined. Measurement of the 
target analyte is achieved by selective transduction of an aspect of the biomolecule-analyte 
reaction into a signal. Generally, biosensors are distinguished from other biologically based 
analytical devices, in that the biological element is immobilised so that it is in intimate 
contact with, or incorporated within the transducer element. As analytical devices, they may 
also possess several other attractive features such as compact size, low cost, fast response 
time, specificity of response, simplicity in use and absence ofradioactivityY 
A variety of materials have been used as the biological receptor element including 
enzymes,6,7 antibodies,8 antigens,9 organelles,to cell membrane receptors, 1 1 complete cells '2 
and slices oftissue. 13•14 Of these biological materials, enzymes and antibodies are the most 
frequently employed, which is a reflection of their widespread use in conventional 
analytical techniques. One great advantage of the use of biological molecules is that they 
possess discriminatory powers equal to or better than the most powerful of the 
non-biological analytical techniques. '5 For example, both enzymes and antibodies are able 
to distinguish between such closely related molecules as optical and geometrical isomers. 
An additional advantage ofthe use of biological molecules in analyses, is that it may be 
possible to incorporate a functional amplification system, which can allow improvement of 
both detection limits and sensitivity by several orders of magnitude. 16 
The transducer element of a biosensor detects a change in physiochemical properties upon 
binding ofthe analyte to its biological receptor. This interaction may result in a change of 
pH, electron transfer, refractive index, heat transfer, or uptake or release of specific ions or 
gases. Transducer mechanisms include electrochemical,6.'7 optoelectronic,18 piezoelectric '9 
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and thennometric20•21 devices. Changes in physiochemical properties and possible detection 
methods used in biosensors are summarised in Table 1.1 
Physicochemical Possible Detection Methods 
Change 
Heat Calorimetric 
Optical Absorbance, luminescence, fluorescence, reflective, 
ellipsometric, Surface Plasmon Resonance, optoelectronic 
Electrons Amperometric 
Ions Potentiometric, conductimetric 
Gases Amperometric, potentiometric, piezoelectric, 
conductimetric 
Mass Piezoelectric 
Table 1.1. Physicochemical changes and possible detection methods in biosensors. 
1.1.1 Electrochemical transducers 
Electrochemical biosensors combine the analytical power of electrochemical techniques 
with the selectivity and specificity of biological molecules. Clark and Lyons22 first 
introduced the concept of the "soluble enzyme" electrode, but the earliest incorporation of 
an enzyme into an electrode was by Updike and Hicks/' who immobilised glucose oxidase 
in a gel over an oxygen electrode to measure the glucose concentration of biological fluids. 
The majority of electrochemical biosensors can be classified into one of two groups; 
amperometric or potententiometric devices. In amperometric devices5 an electrical potential 
is applied to an electrode system, which facilitates reduction or oxidation of electroactive 
species at the electrode surface. This "redox" reaction involves the transfer of electrons 
between the electrode and an electroactive species, with a current being produced which is 
proportional to the concentration of the electrochemical species at the electrode surface. 
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Amperometric transducers have been very widely used in biosensing, particularly systems 
based upon the detection of oxygen or hydrogen peroxide. The amperometric approach has 
high sensitivity and a linear concentration dependence (compared with a logarithmic 
relationship in potentiometric systems), and improved selectivity can be obtained by careful 
selection ofthe electrode potential. Many molecules (such as proteins) are not intrinsically 
electroactive, therefore it is frequently necessary to introduce enzymic labels that can 
catalyse redox reactions and produce electroactive species. For example, amperometric 
sensing of immunological reactions can be performed by using an immobilised antibody to 
bind the analyte, and then adding a second enzyme labelled antibody which is also directed 
against the analyte.23-3o 
The first potentiometric enzyme electrode was reported by Guilbault and Montalv07 for the 
determination of urea. In this technique, the fact that the Nemst potential across a 
membrane was dependent upon the concentration of electro active species on either side of 
the membrane was exploited; thus if the concentration on one side was kept constant then 
the potential generated across the membrane (measured against a reference electrode 
maintained at zero current flow) was proportional to the concentration on the other side (the 
concentration - potential relationship being logarithmic). The use of ion-selective 
membranes introduced specificity into the system. Examples of potentiometric sensors are 
ion-selective electrodes (ISEs) including the pH electrode31 and ion-sensitive field effect 
transistors (ISFETs).32 Potentiometric electrodes have been used as the transducer in 
biosensors employing immunological reactions, employing a number of approaches,33-3b one 
of which, is to measure the change in potential caused by the alteration in the ionophoric 
properties of an immobilised antigen (either ionophoric in its own right, or conjugated to an 
ionophore) when selectively bound by antibodies.37•38 Due to their small size, their generic 
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technology and ease of manufacture ISFETs are very attractive in biosensor technology, one 
example of their usage is in detecting changes in charge densities and isoelectric points that 
take place upon the formation of an antibody-antigen complex.39 
A third electrochemical transduction system that has been used in biosensors is the 
measurement of conductance. An example is the measurement of urea using urease which 
results in the production ofNH/ causing an increase in the conductance of the solution. 17 
Conductimetric biosensors utilising immunological reactions for the measurement of 
pesticides40 and drugs of abuse41 have also been developed. The use of conductance has not 
been widely used in biosensors, partially because conductimetric techniques tends to suffer 
from poor specificity of measurement as the resistance of a solution is dependent upon all 
of the ions present, and there are variations in ionic strength and buffering capacity between 
samples. 
1.1.2 Optical Transducers 
The measurement of absorbance or emission of electromagnetic radiation, by either 
reactants or products of a biological system has been widely used in biosensors. Optical 
transducers are able to respond to changes in absorbance, fluorescence, luminescence, 
reflectance, resonance, interference or refractive index. Early optical sensing techniques 
generally required the use of labels, and these indirect optical sensing techniques are still 
very widely used in biosensor technology. In some of the earliest optical systems, reactants 
were immobilised in columns or on tubing and optical readings (such as absorbances) were 
taken downstream in a flow through system.42 Fibre-optic technology enables the 
fabrication of "optrodes", where the reagent phase is immobilised on a single optical fibre, 
so that changes in optical properties of the reagent phase attributable to the analyte can be 
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measured. Antibodies can be labelled with a number of materials in order to allow optical 
measurement. Enzymes can be used as a label to eliminate substrates or generate products 
that absorb light,43-47 fluoresce48 or luminesce,49-51 and these have been widely used in 
biosensor technology. Antibodies can also be directly labelled with fluorescent 
compounds52 or coloured material such as red blood cells53 or colloidal gold.54 
Optical techniques for the direct monitoring of changes in adsorption, fluorescence, 
refractive index or light scattering have been used in biosensors. These direct optical 
sensing techniques (those that do not require a label) include attenuated total internal 
reflection,s5 ellipsometry,56 surface plasmon resonance57 and waveguides. 58 In most of these 
systems, light entering the device is directed towards the sensing surface and then reflected 
back, with the light emerging from the device revealing information regarding the events 
occurring at the sensor surface. These direct sensing techniques are particularly useful for 
real time applications such as investigating reaction kinetics, although they tend to be 
affected to a greater extent by non-specific interference than do indirect sensing techniques. 
Attenuated total internal reflection,59 ellipsometry,60 surface plasmon resonance61 and 
waveguides62 have all been used to monitor immunochemical reactions. 
1.1.3 Mass Detecting transducers 
In 1880 Jacques and Pierre Curie discovered that a mechanical stress applied to the surface 
of quartz (and a number of other crystals) resulted in an electrical potential across the 
crystal; the piezoelectric effect, the magnitude of which was proportional to the mechanical 
stress applied.63 The piezoelectric effect only exists in materials that crystallise in 
noncentrosymmetric space groups. The quartz crystal microbalance (QCM) makes use of 
this phenomenon, and comprises a thin quartz crystal sandwiched between two electrodes. 
An alternating current (a.c.) field is established across the crystal causing vibrational motion 
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of the crystal at its resonant frequency. One of the parameters that the resonant frequency is 
sensitive to, is a change in the mass of absorbate on the crystal. In piezoelectric biosensors, 
crystals are coated with an adsorbent that selectively interacts with the analyte of interest, 
subsequent binding increases the mass of the coated crystal and alters its frequency of 
oscillation. Monitoring the change in oscillation frequency enables determination of the 
change in mass, which is proportional to analyte concentration. However, in thick films of 
adsorbed layer (as is generally the case in biosensing), the change in resonant frequency is 
not only caused by the addition of mass, but by change in the viscoelastic response of the 
sensor system.64 Thus, crystals employing thick elastic layers which "couple" into the 
supporting fluid medium (e.g. multilayer sensors containing organic molecules), which 
makes interpretation of data difficult. 
Notwithstanding this, the QCM has excellent sensitivity, being capable of measuring mass 
changes corresponding to submonolayer adsorption and desorption. Consequently it has 
been employed in the analysis of gaseous environmental pollutants,65-67 herbicides,QK,6<J 
medical diagnostic assays70.71 and in monitoring antibody-antigen interactions. 19 
Surface Acoustic Wave (SAW) devices have also been used as transducers in biosensors. In 
these devices, an acoustic wave is generated by the application of an alternating voltage 
across an interdigital transducer (a pattern of interlaced metal electrodes). The acoustic 
signal produced is detected by a second interdigital transducer located a few millimetres 
away. The adsorption of analyte to the crystals slows the acoustic wave, and the change in 
velocity (which is proportional to the analyte concentration) is recorded. Again SAW 
devices have seen application in the analysis of gaseous environmental pollutants,72 and in 
monitoring antibody-antigen interactions.73 
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Surface plasmon resonance (SPR) is a quantum optical-electrical phenomenon arriving 
from the interaction of light with a suitable metal or semiconductor surface, where under 
certain conditions the photon's energy is transferred to packets of electrons called 
plasmons.57 In SPR the angle of incident monochromatic light is varied. At most angles the 
light is reflected but at a particular angle the plasmons are excited and the incident light is 
almost completely absorbed. The angle of incidence that causes resonance is dependent 
upon the refractive index of the metal, the nature of the metal's surface (i.e. roughness) and 
the refractive index of the medium in contact with the metal surface, therefore changes in 
mass at the surface result in a change to the resonance characteristics. 
A disadvantage of direct immunosensing techniques (e.g. QCM, SAW and SPR) is that any 
protein that is adsorbed will interfere with the assay, whilst for indirect immunosensing 
techniques, only proteins that contribute to the signal as generated by the label will interfere 
with the assay (unless the non-specific binding interferes with the molecular recognition 
between immobilised molecule and analyte). 
1.1.4 Calorimetric Transducers 
Calorimetric biosensors are constructed by attaching the biological component to a 
thermistor, which detects the heat generated by enzymatic reactions. 74,75 These devices have 
been used for enzymatic measurements76 and have also been used for immunological 
analysis by labelling antibodies with enzymes.77•78 
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1.2 Immunosensors 
The primary aim of this work was the construction ofa multianalyte amperometric 
immunosensor. Immunosensors are biosensors where the biological receptor component 
immobilised at the transducer is an antigen or an antibody. Immunosensors set out to 
perform an immunoassay without the requirement for the multiple, time-consuming, 
procedures that are usually associated with this technique. Immunoassay may be defined as 
a technique based on the reaction between an antigen and an antibody for measuring the 
concentration of either reactant in solution. In solid phase immunoassay, the antibody or the 
antigen is immobilised on a solid insoluble matrix.79 An indirect immunosensor uses a 
separate labelled species that is detected after binding, e.g. enzyme linked immunosorbent 
assay (i.e. a heterogeneous immunoassay), whilst direct immunosensors can monitor 
binding in real time, by measuring parameters such as changes in mass or optical properties 
such as refractive index. Immunosensors have been used for a number of applications in 
medical, environmental and biotechnology measurements, some of which are summarised 
in Table 1.2. 
1.3 Principles of immunoassay 
1.3.1 Solid Phase Immunoassay 
Antigens and antibodies can be coupled to an insoluble matrix with the retention of 
immunological activity,79 which facilitates the separation and washing steps required to 
differentiate bound and free fractions of the label in heterogeneous assays. The chemical 
composition and the form of the solid phase of the immunoadsorbent can be varied in many 
different ways, solid phases that have been used include fine powder particles,82 thin discs/3 
magnetic particles,84.85 microtitre wells86 and coated tubes. s7 
10 
Transduction technique Medical Applications Environmental applications 
Amperometric hCG,23,29 LDH5,30 theophylline,24 Herbicides28 
von Willebrand Factor,25 
apolipoprotein E,26 a I-acid 
glycoprotein27 
Potentiometric Penicillin,33 Insulin,34 hCG,35 
HBsAg36 
Conductometric Methamphetamine4! Pesticides40 
Absorbance hCG,44 C-reactive protein,45 
theophylline,46 insulin47 
Fluorescence P2 microglobulin48 
Luminescence Oestradiol,49,50 a-interferon, 49,50 Mercury5! 
hCG,8! IgG49,5o 
Ellipsometric y interferon6O 
SPR hCG6! 
Waveguides Microbial toxin62 
Interferometric HBs Ag80 
Piezoelectric Drugs of abuse,70 HIV Gaseous pollutants 65, bb herbicides66,bQ 
antibodies 7! 
SAW IgG73 Gaseous pollutants72 
Calorimetric Pro insulin, 77 albumin,78 
gentamicin 78 
Table 1.2 Examples ofapplications of immunosensors for medical and environmental monitoring, 
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1.3.2 Antibody-antigen binding. 
Antibody-antigen binding is due to the summation of a number of relatively weak non -
covalent forces including Coulombic interactions, van der Waals forces and hydrophobic 
and hydrogen bonding.88 The binding of an antigen (Ag) to the antibody (Ab) is reversible 
and the strength of the interaction is dependent upon the affinity of the antibody and the 
number of binding sites on the antigen. Antibody-antigen binding can be expressed as an 
equilibrium as shown in Equation 1.1 
Ab +Ag <:> AbAg (1.1) 
The equilibrium point is dependent upon the concentration of the antibody and antigen 
([Ab] and [Ag]) respectively and upon the strength of their interaction. This strength of 
interaction can be expressed as an affinity (or association) constant, Ka (Equation 1.2). 
Values for this constant range between 50 and 109 M-1•89 
[AgAb] 
Kn = [Ab][Ag] (1.2) 
The affinity is independent of the number of binding sites on the antigen. Avidity is the 
term used to express the total binding strength of the antibody to all of the binding sites on 
the antigen. A typical IgO molecule binds at least four orders of magnitude more strongly to 
a multivalent antigen ifboth binding sites are engaged, than if only a single site is bound. 89 
Antibody-antigen reactions at surfaces are discussed more fully in Chapter 4. 
1.3.3 Labels in Immunoassay 
Early immunoassay techniques used radioactive labels to quantify the degree of binding. 
The first of these techniques to incorporate radiolabels was radioimmunoassay (RIA) which 
was developed and applied to measurement of substances in humans by Berson and 
Yalow.90•91 In recent years there has been a move away from the use of radioactive labels, 
and they have largely been replaced by amongst others luminescent,92 fluorescent,93 and 
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enzymatic labels.94,95 These non-isotopic labels possess a number of advantages such as 
longer shelf life, shorter assay time, easier automation and improved detection limits. They 
also introduce the possibility of developing disposable devices that can be used to perfonn 
near-patient testing.96•97 The main objective ofthis study was to establish a multianalyte 
immunosensor based upon the electrochemical detection of the fonnation of products 
catalysed by enzymic labels. Immunoassays utilising enzyme labels are generally classified 
into one of two classes, heterogeneous and homogeneous assays. 
1.3.4 Enzyme Immunoassay 
In heterogeneous enzyme immunoassay, after the antibody and antigen have been incubated 
together, a step is required to separate the free antigen and antibody from the 
antibody-antigen complexes. The enzymic activity of one or both of these fractions is then 
assessed. The most common heterogeneous enzyme immunoassay is Enzyme-Linked 
Immuno-Sorbent Assay (ELISA), in this technique either the antigen or the antibody can be 
labelled with the enzyme. In the so called 'Sandwich' ELISA assay (Figure 1.1), an excess 
of immobilised antibody is incubated with the sample (Figure l.1 a), and the antigen binds 
with the immobilised antibody. After washing away the unbound sample constituents 
(Figure 1.1 b), the immobilised antibody-antigen complex is incubated with excess 
enzyme-labelled antibody. This enzyme labelled antibody binds to a second antigenic site 
(Figure I.Ic). Excess enzyme-labelled antibody is washed away. Therefore, the remaining 
enzyme activity is directly proportional to the antigen concentration (Figure 1.1 d). 
In homogeneous enzyme immunoassays (enzyme multiplied immunoassay technique 
(EMIT)), a separation process is not required. In this technique antigen-coupled enzyme 
activity changes when bound to an antibody. Upon the addition of a sample, less 
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antigen-enzyme conjugate will bind to the antibody, as it is in competition for the limited 
numbed of antibody binding sites with free antigen from the sample. Therefore, when 
antigen from the sample is added to the reaction mixture, the change in enzymic activity is 
inhibited, and the degree of change is inversely proportional to concentration of the analyte 
in the sample. ELISA is generally applicable to the measurement of almost any antigen, and 
can detect substances at much lower concentrations than can EMIT. EMIT is mainly used 
for the analysis for substances of relatively low molecular weight, including many drugs. 
1.4 Applications of Biosensors 
Biosensors have applications in a wide variety of fields including defence,'n safety,'l'l 
agricultural and industrial analysis,100 process monitoring,101 environmental monitoring,102.103 
food monitoring,I04 drug screeninglOS and medical diagnosis and monitoring. 106 
Commercially, biosensors have not as yet achieved as significant percentage of sales in the 
diagnostics market as in some predictions, but there is the potential of hugely increased 
sales. 107 Specific examples of the applications of immunosensors are shown in table 1.2. 
1.4.1 Biosensors in Clinical Chemistry 
The use ofbiosensors in medical diagnosis and assessment introduces an increased capacity 
for decentralised testing, i.e. performing the analyses outside of the central laboratory. 
Dependent upon the analyte this can be important in special care units such as intensive 
therapy (lTV), cardiac care (CCV) and special care baby units (SCBU), on hospital wards, 
outpatient clinics, General Practitioner's surgeries or even for patient self-monitoring at 
home. The main criterion for determining if decentralised testing is effective, is whether 
obtaining the result immediately will aid in the treatment of the patient, other factors are 
whether a reduction in cost or inconvenience will result. Sensors have a greater potential for 
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Fi~ure 1.1. Schematic re,presentation of the ELISA 'Sandwich' assay. An excess of immobilised antibody is 
incubated with the sample (a), and binds the antigen therein. After washing away the unbound sample 
constituents (b), the immobilised antibody-antigen complex is incubated with excess enzyme-labelled 
antibody. This enzyme labelled antibody binds to a second antigenic site (c). Excess enzyme-labelled 
antibody is subsequently washed off, and the remaining enzyme activity is directly proportional to the antigen 
concentration (d). 
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the de-skilling of analysis than of any previous technology. lOS Table 1.3 shows frequently 
requested tests from various sources. Whilst this list is clearly not definitive, it illustrates 
potential applications ofbiosensors for near patient testing. 
It can be seen from Table 1.3, that only a small proportion of the frequently performed 
assays on units where the patient is critically ill (i.e. lTV and SCBV) are amenable to assay 
using biosensors. By contrast, biosensors can playa much more important role in accident 
and emergency (A&E) departments, where their ease of use and rapid response time can be 
invaluable in diagnosis, particularly in the case of poisonings. However, the speed of 
obtaining a result is not only important in life or death situations. In tests performed on 
outpatients (in clinics, GP's surgery and patient self-testing), a rapidly obtained result may 
assist in the treatment of the disorder. Examples of this are self-monitoring of blood glucose 
by diabetics, who can then adjust insulin dosage and/or diet accordingly, and therapeutic 
drug monitoring where circulating levels ofthe drug are determined, such that if necessary 
the dosage ofthe drug can be changed so as to bring the circulating levels within the 
effective range. In addition, obtaining a result rapidly, can obviate the need for extra visits, 
saving time and money for both the patient and the health service. 
Near-patient testing (NPT) is not without problems, as errors can occur in the operation of 
even the most user-friendly tests and unskilled or semi-skilled staff are often unaware of 
these and thus they may go unnoticed. The risk of this occurring can be reduced by skilled 
laboratory staff providing proper training and support and the introduction of a Quality 
Control System. 109 
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--...l 
ITU 
pH 
p02 
pC02 
Na+ 
K+ 
CI-
HC03-
Urea· 
Creatinine • 
Glucose • 
Total Protein 
Albumin 
Calcium 
Out-patient clinics 
Glucose • 
Urea· 
Creatinine • 
Cholesterol • 
Triglyceride • 
LIT· 
TIT • 
Infertility Tests • 
Uric acid· 
TOM· 
SCBU CCU 
asITU K+ 
plus LDH· 
Bilirubin CK· 
Intralipid AST· 
GP.s surgery 
as Outpatient clin ics 
plus 
hCG· 
LDH· 
CK· 
AST· 
A&E General Wards 
asITU Na+ 
plus K+ 
Paracetamol • Urea· 
Salicylate * Creatinine • 
Ethanol· Glucose • 
Amylase· Uric acid· 
Uric acid· 
Drugs of abuse • 
Patient Self monitoring Screening Tests 
Glucose· 
TDM* 
alpha-foeto protein • 
Phenylalanine • 
TSH· 
LIT = Liver function tests (mainly enzyme assays) 
TFT = Thyroid function tests (honnone assays) 
Infertility Tests are mainly hormone assays 
TOM = Therapeutic drug monitoring 
Table 1.3. Some of the most frequently requested clinical chemistry investigations from different sources. Assay marked • are those frequently performed 
utilising functionality of biological molecule. 
At present most biosensors employ the biological functionality of enzymes or antibodies to 
impart specificity to the analytical system. The greatest market in biosensors for medical 
applications is in devices for the self-monitoring of glucose by sufferers of diabetes 
mellitus. Self-monitoring allows diabetics to better control glucose levels by adjusting their 
diet and/or insulin dosage in response to the results. It has been demonstrated that at least 
in some diabetic groups improved control of glucose concentration results in a better 
prognosis, with a reduced risk ofthe disease's complications such as peripheral neuropathy 
and retinopathy.IIO 
The measurement of glucose provides a good example of the varying degrees of 
complexity that are possible in biosensor technology. These biosensors are based upon the 
concentration of glucose being the rate limiting parameter in an enzyme catalysed reaction, 
the enzyme employed usually being glucose oxidase (GOD), which can be obtained as large 
amounts ofa pure preparation relatively cheaply. The simplest of these sensors are the so 
called "stick tests." In these glucose acts as the substrate for GOD resulting in the fonnation 
of hydrogen peroxide, which oxidises a chromaphore resulting in a colour change. The 
resultant colour intensity is proportional to the glucose concentration which can be 
determined by comparison of the colour with a chart or by the use of a simple reflectance 
spectrophotometer.111.112 
A successful commercial product for the determination of glucose is the Exactech device 
marketed by Abbott (Chicago, IL, USA). In this device GOD oxidises glucose to 
gluconolactone and in the process is itself reduced. GOD is reoxidised by means of a 
mediator, which in the process of being reoxidised at an electrode surface results in the 
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production of a current, proportional to the glucose concentration. This process is illustrated 
in Figure 1.2. 
Mediator 
red 
Mediator 
ox 
Glucose 
luconolactone 
+HP2 
Figure 1.2. Scheme for amperometric measurement of glucose using glucose oxidase and a mediator. Glucose 
oxidase (GOD) oxidises glucose to gluconolactone and in the process is itself reduced. GOD is reoxidised by 
means of a mediator, which in the process of being reoxidised at an electrode surface results in the production 
of a current, proportional to the glucose concentration. 
A glucose biosensor can be incorporated into more complex instruments which are capable 
of measuring several analytes simultaneously. \13 Work is in progress to incorporate 
biosensors into implantable artificial organs to provide feedback loops, for example an in 
vivo glucose biosensor connected to an insulin pump has the potential of acting as an 
artificial pancreas, maintaining glucose homeostasis in diabetics. 1 14 
For sensors employing antibodies as the biological element providing analytical specificity, 
a number of qualitative assays based upon the visual observation of agglutination reactions 
are on the market. Most common are tests for human chorionic gonadotrophin in urine 
which is an indicator of pregnancy. 1 15 These types of tests are discussed more fully in 
Chapter 3. 
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1.5 Multianalyte Biosensors 
As already mentioned individual biosensors can be incorporated into more complex 
instruments which are capable of measuring several parameters simultaneously. 113 A major 
problem in the construction of a multianalyte biosensor fabricated as a single element, is the 
selective deposition of different biological molecules at predetermined sites (discussed in 
detail later in this chapter). A number of enzyme based multianalyte biosensors have been 
reported, using a variety of protein immobilisation methods. 116-119 These multianalyte 
sensors have been employed for the simultaneous determination of small organic molecules 
of biological importance such as glucose, urea and galactose. A single electrochemical 
multianalyte immunosensor had not previously been reported, although electrochemical 
multianalyte immunosensing systems have been reported where several sensors or parts of 
sensors have been fabricated separately and joined to make an array.1.2 
Existing multianalyte immunosensors tend to be qualitative assays, examples of such 
systems are the Triage™ test for qualitative determination of drugs of abuse, 120 and the 
Spectral Diagnostics assay for markers of myocardial infarction. 121 These assays are based 
upon immunochromatography reactions, which are observed visually and are generally 
unsuitable for quantitative assay. Multianalyte immunosensors using optical transduction 
have also been reported,122.123 based upon glass optical waveguides or fibre-optics, where a 
change in absorbance or fluorescent intensity is related to the concentration of a labelled 
antibody close to the transducer surface, and therefore to the presence of antigen at the 
surface. 
Simultaneous multianalyte immunoassays, where several analytes are measured by a simple 
procedure, are required in a number of clinical situations, such as the measurement of 
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honnones related with thyroid function and the measurement of gonadotrophins for the 
investigation of infertility. 
1.6 Protein Patternin2 on Sensor Surfaces 
An important requirement for the success of this study was the development of a method for 
the specific immobilisation of biochemical species at individual electrodes within an array. 
A problem in trying to specifically immobilise species on one electrode in an array, is in 
preventing non-specific adsorption of the protein to the other electrodes and the surrounding 
area, as the majority of proteins will adsorb very strongly to a variety of surfaces. 124,125 
Prevention of non-specific adsorption to the area surrounding the electrode is particularly 
important when using microelectrodes, as there is an increased diffusion to the electrode 
from the surrounding area with these very small electrodes when compared to 
macroelectrodes (see Chapter 4). 
Most proteins are highly surface active, that is they have a strong tendency to accumulate at 
interfaces. Proteins usually have a hydrophilic surface with a hydrophobic inner, thus they 
tend to "unfold" on hydrophobic surfaces or stick to hydrophilic surfaces. A number of 
factors playa role in the adsorption process; hydrophobic interactions with non-polar 
surfaces, electrostatic interactions between the protein and the surface, surface 
heterogeneity, the solvent used, other species present in solution and the structure and 
possible denaturation of the protein. 126 
Protein adsorption is frequently irreversible (often due to denaturation as a result of the 
protein unfolding), but an adsorbed protein, may be displaced by another (usually larger) 
protein even if the adsorbed protein does not desorb in pure solvent. Protein adsorption 
tends to the fonnation of a monolayer (although its structure may be complex) as the 
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process involves the loss of some of the molecules conformational and hydration energy 
(which is thermodynamically favourable) when it encounters an interface. 125 The result is 
that at the interface, the protein tends to undergo a conformational change from their 
globular conformation to an extended chain conformation. Protein multi layers tend not to 
form because, as protein is deposited on the surface, the interface becomes less distinct and 
it becomes less thermodynamically favourable for subsequent molecules to undergo 
changes in conformation and hydration. Relatively simple thermodynamic descriptions such 
as the Langmuir Isotherml27 can not readily be applied to protein adsorption, as it is a 
complex phenomenon involving a number of processes that occur simultaneously.124,12~ 
These processes include structural alterations of molecules at the interface and interactions 
with other adsorbed molecules. A number of more complex descriptions of protein 
adsorption kinetics have been suggested.124.126,128 
1.7 Non-specific Bindine 
Non-specific binding (NSB) is an inherent property of proteins (including antibodies) and is 
considered the major obstacle to the development of immunosensors.l29 In solid-phase 
enzyme immunoassays for single analytes, non-specific binding can be caused by three 
mechanisms. In the first of these mechanisms, which will be referred to as "direct reagent 
binding," the second antibody-enzyme conjugate binds to the surface of the solid support. 
This type of binding results in elevated signals that are usually relatively unaffected by the 
sample composition. Direct reagent non-specific binding results in a diminished ability of 
the assay to distinguish the "true" analyte derived signal from the elevated background 
signal, resulting in a poorer assay sensitivity. 
The second mechanism which will be referred to as "sample mediated binding," is where 
the antibody-enzyme conjugate binds to the solid support via a sample derived species other 
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than the analyte. Ifthis "cross-linking" species is present in equal quantities in all samples 
(including standards), then the effect will be similar to that observed for direct reagent 
binding, i.e. there is a diminished ability of the assay to distinguish the "true" analyte 
derived signal from the elevated background signal. If, however, the "cross-linking" species 
is present in differing quantities in any samples, variation of the observed signal will occur 
unrelated to the analyte concentration, resulting in a reduced assay specificity. 
The third mechanism is "direct sample binding." This is where enzymes catalysing the same 
reactions as those catalysed by the enzymes conjugated to the antibodies, bind to the surface 
of the solid support. Direct sample binding results in poorer assay sensitivity and 
specificity. In multianalyte sensing systems there is a fourth type of non-specific binding; 
"capture antibody non-specific binding." This occurs where a capture antibody binds 
non-specifically to a sensor element designed for the analysis of a different antigen. This 
"inappropriately" bound antibody is then able to bind its antigen, and subsequent binding of 
a labelled second antibody can occur. This results in poorer assay specificity, and can easily 
lead to the production of incorrect results. 
Prevention of non-specific binding is of great importance in developing a technique for 
immobilising organic molecules (including biomolecules) in a predetermined pattern on a 
surface. Non-specific adsorption of reagents or of sample components, may lead to 
interference and incorrect results in the assay. The techniques for reduction of non-specific 
adsorption are generally based upon either, coating the surface with a substance that will 
decrease the tendency of proteins in solution to bind to the surface, or to mask areas of the 
surface with a substance that can be stripped off along with any protein, leaving the bare 
surface exposed. A number of approaches that have the potential to solve this problem have 
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been reported in the literature including, pre-coating the electrode surface with protein or 
amino acids,125 and using electrochemical adsorption and desorption ofthioalkanes and 
thioalcohols. 130 These techniques are discussed in greater detail later in this chapter. 
1.8 Immobilisation 
A large number of techniques have been employed to immobilise the biologically active 
moiety of electrochemical biosensors on or in close proximity to the electrode. These can be 
categorised as encapsulation, entrapment, adsorption, cross-linked adsorption, electrostatic 
attraction, covalent attachment and affinity binding as illustrated in Figure 1.3. 
1.8.1 Desirable properties of immobilisation method. 
An immobilisation technique should not adversely modulate activity of the biological 
molecule, and should not limit access of non immobilised reactants to the immobilised 
molecule. This is particularly important where reactants of relatively high molecular 
weights (e.g. antigens) are involved. In addition, there is a requirement for an efficient 
sensing surface i.e.; a high surface density of functional molecules, the absence of 
non-specific binding, stability and durability. Several parameters such as pH. ionic strength 
and the surface chemistry of the solid surface influence the amount ofimmobilised protein 
at a solid surface. These parameters can be expected to influence the orientation and 
conformation and thereby the biological activity of the protein. 131 ,132 
In immunosensors with high molecular mass analytes, those methods that immobilise the 
antibody by trapping it by virtue of its size (i.e. entrapment and encapsulation) will also 
effectively exclude the analyte from the majority, ifnot all, of the binding sites. Therefore, 
for such devices it is preferable, if not essential, to immobilise the antibody at the sensor/ 
sample interface. 
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Figure 1.3 Classification of techniques for immobilisation of biomolecules. Encapsulation involves retaining 
molecules that are in solution or a gel, by the use of a semipermeable membrane. Entrapment involves the 
trapping of the biological molecule in a porous insoluble polymeric matrix. In adsorption the biological 
molecule sticks to the surface by a number of physical processes such as hydrophobic interactions with 
non-polar surfaces, this can be further stabilised by covalent cross-linking of the adsorbed molecules. 
Immobilisation can also by achieved by electrostatic interactions between the charge on the biological 
molecule and a charged surface. In covalent attachment the molecule is tethered to the surface via covalent 
chemical bonds, whilst affinity binding makes use of specific interactions between biological molecules to 
attach the desired molecule to the surface. 
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1.9 Review of possible immobilisation strateeies 
1.9.1 Physical deposition techniques 
Some workers have tried to overcome the problem of specific immobilisation by casting 
different membranes (e.g. cellulose acetate), each containing a specific antibody. These 
membranes were then placed on the electrodes. l This is a labour intensive technique, and 
would be very difficult to apply to microelectrodes. Alternatively, one can construct the 
electrodes separately and place them together in an array2 but again, this technique is labour 
intensive and difficult to apply to microelectrodes. 
Micropositioning has been used to deposit biological materials on specific areas of a 
surface. In one of its simplest forms this simply involved the micropipetting of the species 
into etched wells in a glass substrate. l22 Constructing micron-scale patterns on a planar 
surface using this technique is difficult as it is hard to accurately and reproducibly control 
the spread of a liquid on surfaces particularly if the surface is hydrophilic. Other 
micropositioning methods include screen-printing and ink-jet printing techniques. 
Screen-printing has been widely used for the selective deposition of biological molecules in 
the fabrication ofbiosensors.l33.l36 Site specific immobilisation is achieved using screen 
printing by placing a stencil on top of the surface to be patterned. An ink which contains the 
species to be immobilised is coated over the stencil, and passes through holes onto the 
surface below. The resolution of the technique is limited to approximately 50 J.lm by a 
number of factors, particularly the nature of the surface and the rheology of the ink. This 
technique is generally used for immobilisation of proteins in relatively large patterns, but is 
not suitable for micron-scale patterning. The molecules tend not to be deposited as a 
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monolayer, which means that a considerable proportion may be inaccessible to the analytc, 
particularly in the case of antibody/antigen reactions. 
Ink-jet printing technology has been used to specifically deposit biological molecules 
(principally enzymes) on surfaces. 137-139 In this technique an inlet from a reservoir allows an 
enzyme containing solution access into a pressure chamber, which is surrounded by a 
piezoelectric element. The application of an electrical pulse to the piezoelectric element 
induces contraction of the pressure chamber, thus forcing the solution through a small 
nozzle ( typically 50 ~m diameter) onto the surface. A 50 ~m diameter hole results in a 
surface patterned area with a diameter of between 150 and 200 ~m, and the distribution of 
the enzyme within this area tends to be uneven (typically much greater at the periphery of 
the patterned area). The use of smaller nozzles coupled with treatment of surfaces so that 
they are hydrophobic and thus resistant to spreading of solutions, has enabled an 
improvement by an order of magnitude for the minimum area to be patterned. 139 Air-jet 
printing is a similar technique, where an aerosol produced by mixing a solution stream with 
an air-jet and passing though a nozzle, is directed at the sensor surface. 14o 
1.9.2 Photolithographic "lift-off' techniques 
Molecular patterning has been achieved on planar surface using photolithographic 
processes. 141 ,142 This can be achieved in two ways as shown in Figure 104. In the first 
technique, the surface is coated with photoresist, which is patterned and developed. The 
surface is then coated with a hydrophobic silane, and "lift-off' is performed leaving a 
hydrophobic pattern on the surface. The remainder of the surface is coated with a 
hydrophilic silane to which proteins may subsequently be attached. 
27 
In the second technique, the surface is coated with aminosilane and then photoresist which 
is patterned and developed. A protein species is added and "lift-off" is performed leaving 
the patterned protein. A second protein species can be added to complete a 2 protein pattern. 
Details of creating photoresist patterns and the use of lift off techniques are given in 
Chapter 3. There are two major problems with this technology: firstly that a maximum of 
two proteins can be immobilised; and secondly that of these, only one is likely to be 
functional as the first patterned is exposed to organic solvent during lift-off, which can 
cause denaturation of the protein:43•144 
A modified lift-off technique has been described for the patterning of enzymes in a 
multianalyte biosensor.145 An enzyme solution containing glutaraldehyde was spin-coated 
onto a wafer covered with patterned photoresist. The resultant immobilised enzyme layer 
was removed by ultrasonic vibration in acetone, except in areas where there was no resist. 
Photoresist was again coated over the entire surface and repatterned. A second enzyme 
solution containing glutaraldehyde was spin coated onto the wafer, and again lift-off was 
used. A disadvantage of this process was that most of the enzyme solution was consumed 
without contributing to membrane fabrication, therefore the application was limited to usc 
in sensors which utilise relatively inexpensive enzymes.137 
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Figure 1.4 Techniques for molecular patterning using photoresist lift-off. In the first technique, the surface is 
coated with photoresist, which is patterned and developed. The urface is then coated with a hydrophobic 
silane, and "lift-off' is performed leaving a hydrophobic pattern on the surface. The remainder of the surface 
is coated with a hydrophilic silane to which proteins may subsequently be attached. In the second technique 
the surface is coated with aminosilane and then with photoresist which is patterned and developed. A protein 
species is added and "lift-off" is performed leaving the patterned protein. A second protein species can be 
added to complete a 2 protein pattern. 
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1.9.3 Entrapment in Polymers 
A successful method of specifically immobilising enzymes at electrodes is to entrap them in 
an electropolymerised matrix,12,llb,14b-155 a technique which offers the possibility of the 
entrapment matrix reducing the effect of interfering compounds by limiting access of 
potential interferents to the electrode surface. 146,153-155 These matrices allow access of low 
molecular weight substrates to the protein, but unless the films were very thin (thinner than 
the dimensions of the protein molecule) they would prevent high molecular weight antigen 
reaching the antibody's active site, and therefore would not be a suitable immobilisation 
procedure for immunosensors. 
Polymerisation can also be achieved by exposure of certain electrodes to electromagnetic 
radiation. X-rays, y-rays and UV and visible light have all been used.150-15s This method of 
entrapping protein suffers from the same disadvantages as the electropolymerised matrix, 
but additionally the protein can be severely damaged by the radiation rendering it 
non-functional. 
A third approach is to form a polymer film on the electrode (by electro- or photo-
polymerisation) and then to adsorb or covalently link the antibody to the polymer. 159,loo 
Polymers have been used to influence the orientation of molecules and can provide direct 
electronic communication between a redox protein and an electrode. 161 A major problem 
with polymerisation techniques for patterning biological molecules for use in multianalyte 
immunosensors, is in preventing non-specific binding to the polymer or the uncoated 
electrodes. 
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1.9.4 Electrodeposition followed by covalent cross-linking. 
The migration of proteins to electrically charged electrodes, followed by cross-linking with 
glutaraldehyde has been used, as a means of selectively depositing enzymes on electrode 
surfaces.I44.162 The migration of proteins in an electric field is dependent upon the isoelectric 
point (PI) of the protein and the pH of the supporting buffer. At pH values greater than the 
pI the protein molecule possesses a net negative charge, and will migrate towards a 
positively charged electrode. Once the protein has been deposited at the electrode, it can be 
secured by forming covalent linkages using glutaraldehyde as a crosslinker. The technique 
results in the formation of protein multi layers at the electrode, the thickness of which can be 
controlled by variation of the immobilisation conditions. It is generally considered that the 
protein layer that is in direct contact with the electrode surface is denatured and that protein 
functionality resides in ensuing layers. 163 A multianalyte sensor for the simultaneous 
determination of glucose and lactate has been fabricated using this technique, but it has not 
been applied to immunoassays due to a number of problems; firstly the technique is rather 
wasteful of the molecule to be immobilised as it is in a relatively thick layer, part of which 
has been denatured;163 secondly with high molecular weight analytes, many of the antibody 
binding sites within the deposited layer will be unavailable to the antigen. 
1.9.5 Technigues using deep ultraviolet light 
The coating of the entire surface with protein followed by selective removal using deep 
ultraviolet (DUV) irradiation (A. = 193 nm) has been used to pattern IgG onto a surface. 143 
The exact mechanism was not elucidated, but the irradiation caused either protein cleavage 
or denaturation in exposed areas. It was found, however, that the functionality of the 
remaining IgG was variable, and non-specific binding remained a major problem. 
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1.9.6 Langmuir-Blodgett 
Orientation of immunoglobulins has been demonstrated using Langmuir-Blodgett (LB) 
films, thus maximising the immunoglobulin's efficacy.164,165 Electrostatic interaction 
between proteins and Langmuir-Blodgett films has also been used as an immobilisation 
technique. 166 However, LB technology has not been successfully extended to patterning 
surfaces in a predefined manner, and the problems of specific immobilisation remain. 
1.9.7 Self assembled monolayers 
Patterns of hydrophilic and hydrophobic SAMs (each element 20~m in size) have been 
constructed on gold by using a stamp to attach an alkanethiol to selected areas of a gold 
surface (sulphur readily binds to gold),167 a mercaptoa1cohol is then attached to the 
remainder of the surface. SAMs have also been used to pattern a protein on a surface. In 
particular SAMs fonned by the chemisorption ofthiol alcohols, especially oligo(ethylene 
glycol)-terminated alkanethiols (HS(CH2)m(OCH2CH2)nOH), have been shown to resist the 
adsorption of a variety of proteins. 168 
Patterns of pyruvate kinase, with resolution ofa few ~m, have been formed on gold by 
stamping the surface with HS(CH2) 15CH3 and then derivatising the rest of the surface with 
HS(CH2)l1(OCH2CH2)60H, followed by protein adsorption as shown in Figure 1.5. A 
polydimethylsiloxane (PDMS) stamp was fabricated using a resist master pattern, this mask 
was peeled away and inked with an alkanethiol (hydrophobic) which was transferred as a 
pattern onto the gold surface by stamping. The surface was then exposed to a solution 
containing HS(CH2)Il(OCH2CH2)60H (hydrophilic), and upon subsequent exposure to 
protein, adsorption occurred at the hydrophobic but not the hydrophilic areas. 
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This technique has the potential of constructing very high resolution patterns, as resolution 
is not limited by the wavelength of light, however it is limited to the patterning of a single 
protein. Patterns of SAMs could be formed in a similar way using resist based lift-off 
techniques (lift-off described in Chapter 3). The use of electron beam lithography would 
allow patterns to be formed whose resolution is not limited by the wavelength of light. 
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Figure 1.5. Schematic diagram for the construction of a protein pattern by means of stamping SAM films. (a) 
A polydimethyl iloxane (PDMS) stamp was fabricated using a resi t master pattern, (b), this mask was peeled 
away and (c) inked with an alkanethiol (hydrophobic) which was (d) transferred as a pattern onto the gold 
surface by stamping. (e) The surface was then exposed to a solution containing HS(CH2)II(OCH2CH2)60H 
(hydrophilic), and (f) upon subsequent exposure to protein, adsorption occurred at the hydrophobic but not 
the hydrophilic areas. 
It has been suggested that self assembly combined with LB techniques could be used to 
pattern proteins on gold. 169 A mixture of palmitic acid and a sulphur containing lipid 
(thiolipid) was spread on the water/air interface of a Langmuir trough. On compression the 
components of the floating monolayer separated and domains were formed which 
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predominantly contained palmitic acid. The film was transferred to a gold substrate where 
the thiolipids covalently bound to the gold and the physisorbed palmitic acid was washed 
away to leave domains of bare gold to which other species such as proteins could be 
attached. This technique would have the advantage that resolution of patterning would not 
be limited by the wavelength oflight as in photoactivationldeactivation or 
photolithographic techniques. However, methods for precisely controlling the size, 
geometry and position of this pattern have not yet been reported, additionally this technique 
would only be of value for patterning a single protein. 
Protein patterning has been performed using DUV irradiation of SAM films of 
organosilanes.143.170 This procedure is represented diagramatically in Figure 1.6. DUV 
irradiation (A = 193 nm) of the thiol groups results in their oxidation to sulphonate groups. 
Protein is then attached to the remaining thiol groups (on areas of the surface that have not 
been irradiated) either directly or via a heterobifunctional cross-linker. This method 
achieved a resolution ofless than 10 /-lm, but it is limited to the patterning of a single 
species and at best non-specific binding was reduced to 15%. 
1.9.8 Masking using thioalkanes 
It has been suggested that it is possible to mask electrodes to prevent antibody adsorption, 
whilst leaving other electrodes exposed so that the antibody can be immobilised, by the use 
of species (for example thioalkanes) that are adsorbed or desorbed at particular electrode 
potentials. 130 The successful application of this technique to patterning proteins on surfaces 
has not been reported. A potential disadvantage of these techniques is that the use of 
organic solvents is required which may affect the structural integrity and therefore the 
function of proteins. 144 Additionally, these techniques would be wasteful of biomolecules. 
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Figure 1.6 Schematic diagram for the patterning of proteins by DUV irradiation of SAM films. DUV 
irradiation (A = 193 om) of the thiol groups results in their oxidation to sulphonate groups. Protein is then 
attached to the remaining thiol groups (on areas of the surface that have not been irradiated) either directly or 
via a heterobifunctional cross-linker. Protein does not attach to the sulphonate groups. 
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1.9.9 Photoactivation and photodeactivation techniques 
Fodor and co-workers have reported the light-directed spatially addressable parallel 
chemical synthesis of oligopeptides and oligonucleotides. 171 ,172 They have combined the use 
of solid phase chemistry, photolabile protecting groups and photolithography to synthesise 
a range of chemical products. The principle of the technique is illustrated in Figure 1.7. The 
substrate possesses amino groups that are blocked with a photolabile protecting group such 
as nitroveratryloxycarbonyl (Nvoc), illumination of specific regions through a lithographic 
mask results in photodeprotection. The exposed amino groups are thus available for 
coupling to another species (which has a photolabile protecting group attached) using 
conventional solid phase synthesis methods. 173 A different mask is used to photodeprotect 
different regions of the substrate, and a different photolabile protected group containing 
species is attached to the exposed amino groups. Additional cycles of photodeprotection 
and coupling are performed to obtain the desired set of products. 
This technology is capable of rapidly synthesising large numbers of oligopeptides and 
oligonucleotides. With a simple binary mask, 256 different species can be synthesised in 
only 8 steps, the use of more complex masks can increase the number of species 
synthesised. 174 Resolution of between 10 and 20!lm has been achieved within the arrays of 
synthesised oligopeptides. 17s 
The formation of a covalent linkage between the protein and the substrate by means of a 
photoactivatable link has previously been reported. 176 In some of these techniques, a 
photoactivatable function provided by an aryl azide (e.g. 3-nitro-4-aminophenyl azide) was 
attached directly to a silica surface. The modified surface was covered with an enzyme 
containing solution, and designated areas were exposed to light by using a mask. Assay of 
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Figure 1.7 Schematic diagram for light-directed spatially addre sable chemical synthesis. The substrate 
possesses amino groups that are blocked with a photolabile protecting group such as Nvoc. Illumination of 
specific regions through a lithographic mask results in photodeprotection. The exposed amino groups are thus 
available for coupling to another species; A (which has a photolabile protecting group (x) attached) using 
conventional solid phase synthe is methods. A different mask is used to photodeprotect different regions of 
the substrate, and a different photolabile protected group containing species is attached to the exposed amino 
groups. Additional cycles of photodeprotection and coupling are performed to obtain the desired set of 
products. 
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enzyme activity was perfonned by monitoring the fonnation of fluorescent products, the 
observed fluorescence reproduced the pattern of the mask. This procedure did not address 
the problem of preventing non-specific binding, and was only used to pattern one protein at 
a time. 
Benzophenone has been used as a photoactivated cross-linker to pattern fluorescently 
labelled proteins to glass (Figure 1.8),177 although this method suffered greatly from 
non-specific binding which at best was 20%. The method was not used to attach more than 
one species to the surface. 
1.9.10 Miscellaneous Techniques 
Another method of selective attachment is to immobilise the antigen, and then add a 
multivalent antibody. Some ofthe antibody binding sites will bind to the immobilised 
antigen, whilst others will be available to bind the antigen that is in solution. I n The 
problem of how to selectively inunobilise the antigen remains, and for high molecular 
mass antigens such as in this study, it is no easier than to immobilise the antibody itself. 
Finally, functional antibodies and enzymes have been patterned on to surfaces by laser 
induced plasma deposition. In this technique biomolecules are vapourised and ionised by 
the laser, the ionised proteins are guided by electric fields towards a substrate on which they 
are deposited. Patterning can be achieved by placing a mask (copper grid) on the substrate, 
or by using spatially well defined electric fields. This technique has only been used to 
pattern one protein with a resolution of approximately 100 /lm. The activity of the 
deposited protein over the surface tends to be non-unifonn possibly due to deposition of 
large clusters consisting of several molecules.179.18o 
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Figure 1.8 Use of benzophenone as a photoactivatable cross linker for protein imroobilisation. 
Benzophenone is attached to the surface via aminopropyltroethoxysilane (note that this is not 100% efficient). 
The benzophenone-derivatized surface is treated with a solution of the protein (Ig) and then irradiated through 
a lithographic mask. The protein molecules are bound covalently only in areas that are exposed to light. 
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CHAPTER 2 
Se vogliamo che tutto rimanga come e, 
bisogna che tutto cambi 
(If we want things to stay where they are, 
things will have to change) 
Guiseppe di Lampedusa 
II Gattopardo (The Leopard) 
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2 Introduction to Initial Experimental Work on Protein Patternine Techniques. 
Initial investigations were perfonned into the feasibility of using a variety of techniques for 
the site specific immobilisation of antibodies. Of the techniques studied, which included 
employing very thin polymer films and masking of electrodes using thioalkanes (data not 
shown), the use of a photoactivable binding agent appeared to be the most promising. 
Section 2.1 provides an introduction to the theory and principles, of the protein patterning 
methods, and of work carried out in investigating these techniques. Sections 2.2 to 2.12 
provide materials used and detailed experimental methods. The remainder of the chapter 
(sections 2.13 to 2.22) presents the results obtained along with discussion of their 
significance. 
2.1 The use of a Photoactivable Bindin&: A&:ent for Immobilisation of Biolo&:ical 
Molecules. 
The possibility of patterning proteins by the use ofphotoactivable binding agents was 
investigated, particularly the use of a photo active biotin analogue (photobiotin), in 
conjunction with avidin, a molecule with which biotin exhibits a specific affinity. Avidin is 
a protein with a molecular mass of approximately 60,000 found in egg whites (a microbial 
fonn streptavidin is obtained from Streptomyces avidinii) and possesses four binding sites 
for biotin (vitamin H) with which it forms a very stable complex, with an association 
constant Ka =101s M-I 181-183 corresponding to a free energy of association of about 330 KJ 
M-I of tetramer (81 Kcal M-I).184.185 The role of avidin - biotin bonding in nature, and the 
significance of the bond strength is unknown, although avidin and biotin exhibit the 
highest known affinity between a protein and ligand, with a binding energy which is 
comparable to that of a covalent linkage. 
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Both avidin and streptavidin consist of 4 subunits, each of which is an 8 stranded 
antiparallel P sheet forming a p-barrel. The biotin binding site is situated near the end of the 
barrel and involves a highly stabilised network of polar and hydrophobic interactions. IMI 
Biotin can be conjugated to proteins or other biologically active species, and this complex 
can be attached to immobilised avidin.186-189 The rationale in using the avidin - biotin system 
is based on the premise that if a biologically active species is modified with biotin through 
its side chain, the biological and physicochemical properties of the biotin modified 
molecule will not be significantly affected, and that the biotin is still available to bind to 
avidin or streptavidin. This system has been extensively used in immunoassay 
techniques.189.190 Avidin tends to show a high degree of non-specific binding to substances 
which is usually attributed to two inherent characteristics of the native molecule; a high pI 
and the presence of carbohydrate residues. Streptavidin, which has a lower carbohydrate 
content, and deglycosylated avidin, both exhibit reduced non-specific binding as compared 
to intact avidin.185.191 The high isoelectric point (PI 10.0 - 10.5) of avidin, as well as the 
presence of carbohydrate (which accounts for about 10% of avidin's total molecular weight) 
on the protein contribute to non-specific binding in applications involving avidin. Due to its 
more favourable isoelectric point and lack of carbohydrate, streptavidin has historically 
been the accepted substitute for applications where the non-specific binding characteristics 
of avidin can not be tolerated. More recently, modified forms of avidin have become 
available, with pI values closer to 7.0 and reduced carbohydrate content leading to 
improved non-specific binding characteristics.192.193 Streptavidin and deglycosylated avidin 
have been utilised as coatings on immunoassay microtitre plates to minimise non-specific 
binding. 194 
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Photobiotin is a photoactivable biotin analogue (N-(4-azido-2-nitrophenyl)-N'-
(N-d-biotinyl-3-aminopropyl)-N'-methyl-l ,3-propanediamine), which was developed as a 
nucleic acid hybridisation probe,195 and has also been used to label proteins. 196 Photobiotin 
contains an aryl azide group which is stable in the dark, but upon exposure to ultraviolet / 
blue light (340 - 375 nm) a highly reactive aryl nitrene group is generated which will react 
with proteins (and other species).19b The potential effects of steric hindrance preventing 
binding between an activated aryl nitrene group and a protein can be minimised by 
introducing a spacer arm into the photobiotin molecule. 195 Such a spacer arm contains basic 
tertiary amino groups, which are positively charged at neutral pH and give a high solubility 
in water. The structure of the long arm photobiotin used in this work is shown in Figure 2.1 
HOO~COOH 
CO2 
Figure 2.1 Chemical structure of long arm photobiotin. Photobiotin is a photoactivable biotin analogue, 
containing an aryl azide group which is stable in the dark, but upon exposure to ultraviolet / blue light (340 -
375 run) a highly reactive aryl nitrene group is generated which will bind non-specifically to organic 
molecules. The introduction of a spacer arm minimises steric hindrance, and this spacer arm contains basic 
tertiary amino groups, which are positively charged at neutral pH and give a high solubility in water. 
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A number of approaches to the use of photobiotin and avidin in the immobilisation of 
molecules were examined; 
a) Depositing a protein layer on the surface, adding photobiotin in the presence of light, 
followed by the attempted immobilisation of a second protein through avidin-biotin 
interactions. 
b) Depositing a protein layer on the surface, adding avidinated protein with photobiotin 
attached and exposing to light; 
c) Depositing an avidin layer on the surface, adding photobiotin followed by the addition 
of the species to be immobilised in the presence of light. 
2.1.1 Depositing a protein layer on the surface, adding photobiotin followed by the 
immobilisation of a protein through avidin-biotin interactions 
In this technique bovine serum albumin (BSA) was deposited on a surface which was 
subsequently exposed to light in the presence of photo biotin. This was followed by the 
sequential addition of avidin and a biotinylated protein, the rationale being that the avidin 
would bind to the immobilised biotin moiety and to the biotinylated protein resulting in the 
biotinylated protein's immobilisation. This is represented diagramatically in Figure 2.2. 
Initially, BSA was immobilised on to the surface (Figure 2.2a), photobiotin was added and 
exposure of selected areas of the surface to light through a mask resulted in activation of the 
photobiotin molecule (Figure 2.2b). Unbound photobiotin was removed by washing, and 
avidin was added which bound to the immobilised photobiotin groups (Figure 2.2c). A 
biotinylated protein was then added which bound to the immobilised avidin (Figure 2.2d). 
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Light 
_____ ~ __ -------------------- Mask 
, 
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d AM '" •• Q QQQQmQQQ 
D = avidin 
• = Protein to be patterned 
I = photobiotin o =BSA 
Figure 2.2 Scheme for depositing a protein layer on the surface adding photobiotin and immobilising proteins 
through avidin-biotin interactions. BSA was immobilised on to the surface (a), photobiotin was added and 
exposure of selected areas of the surface to light through a mask resulted in activation of the photobiotin 
molecule (b). Unbound photobiotin was removed by washing, and the surface was incubated with a solution 
of avidin which bound to the immobilised photobiotin groups (c). A biotinylated protein was then added 
which bound to the immobilised avidin (d). 
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2.1.2 Depositing a protein layer on the surface. and add avidinated protein with photobiotin 
attached 
In this technique BSA was deposited on a surface, followed by the addition, in the presence 
of light, of an avidinated protein which had been preincubated with photobiotin. The 
rationale behind this method was that the photobiotin (and as a consequence of the avidin 
biotin interaction, the avidinated species), would bind to the protein coated surface. This is 
depicted diagramatically in Figure 2.3. Initially a protein - avidin - photobiotin complex 
was fonned (Figure 2.3a), which was then placed in contact with a surface on which BSA 
had been immobilised (Figure 2.3b). Exposure of selected areas of the surface to light 
through a mask resulted in activation of the photobiotin molecule which attached to the 
surface BSA, thus immobilising the attached protein (Figure 2.3c). 
2.1.3. Depositing an avidin layer on the surface. adding photobiotin followed by the 
addition of the species to be immobilised. 
A third approach to protein patterning developed in this study was the use ofphotoactivable 
binding using photobiotin, which was bound to an avidin covered surface,197-199 the 
immobilisation procedure is shown in Figure 2.4. Initially, avidin was immobilised on the 
surface and photobiotin was added and bound to the avidin (Figure 2.4a). Exposure of 
selected areas to light through a mask resulted in activation of the photobiotin molecule and 
a protein in the solution was immobilised specifically (Figure 2.4b). Unbound material was 
removed by washing, and the procedure repeated with a second protein (Figure 2.4c), the 
entire surface was then exposed to light in the presence of an agent such as casein in order 
to block previously unreacted photobiotin (Figure 2.4d). 
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a 
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Light 
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- = Substrate 
o =BSA 
= Photobiotin 
o = avidin 
• = Species to be immobilised 
Figure 2.3 Scheme for irnmobilising an avidinated protein by depositing a protein layer on the surface and 
adding the avidinated protein with photobiotin attached. A protein - avidin - photobiotin complex was formed 
(a), which was then placed in contact with a surface on which BSA had been immobilised (b). Exposure of 
selected areas of the surface to light through a mask resulted in activation of the photobiotin molecule which 
attached to the surface BSA, thus immobilising the attached protein (c). 
47 
a, HHHHHHHHHHHHHH 
Light 
o 
• • • 
• • ••• • •••• 
HmOHHHHHHHHHU 
Mask 
b, 
Mask 
c, 
Light 
d, 
~o 
o 0 0 0 0 
wO:-ffi?C:OWW~~?~1~w ~~~~RR~RRrOR 
o o 
D = avidin .= 1st protein 
~= 2nd protein 
1= photobiotin 
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Figure 2.4. Scheme for immobilisation procedure coating the surface with avidin and photobiotin. followed 
by the addition of the protein to be patterned in the presence of light. Initially, avidin was immobilised on to 
the surface and photobiotin was added and bound to the avidin (a). Exposure of selected areas to light through 
a mask resulted in activation of the photobiotin molecule and a protein in the solution was immobilised 
specifically (b). Unbound material was removed by washing, and the procedure repeated with a second 
protein (c), the entire surface was then exposed to light in the presence of an agent such as casein in order to 
block previously unreacted photobiotin (d). 
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2.1.4 Investigation into resolution of avidin-photobiotin immobilisation procedure. 
Investigations were performed to determine the resolution of patterned proteins that were 
achievable using the patterning technique that was selected as being the best of the methods 
(the criteria being relative efficiency of the immobilisation process, and contrast between 
patterned and non-patterned areas, results shown later in this chapter). This was done by 
patterning of proteins using a photolithographic mask with equal mark:space ratio lines of 
different widths. The patterned proteins were visualised by the addition of fluorescently 
labelled antibodies, and resolution was examined by measurement of the relative 
fluorescent intensity across the pattern. 
2.1.5 Investigation into timescale of avidin-photo biotin immobilisation procedure. 
The aim of this work was to determine the time required to complete the patterning process, 
under defined conditions (photobiotin being activated by light from a a 100W HB-I 0 101 AF 
super high pressure mercury vapour lamp (Nikon, Tokyo, Japan) situated 185 mm from the 
substrate (irradiance - 9 mW cm·2». The distance of 185 mm was chosen, as this was the 
height of a chamber that was constructed to house samples being irradiated and providing 
protection to the user. Irradiance was directly measured by the use of a calibrated 
photovoltaic cell. 
2.1.5.1 Activation of Photohiotin 
The photoactivation of the photobiotin molecule (Figure 2.1) is due to the incorporation of 
an aryl azide. Aryl azides are derivatives of benzene and fused ring analogues, in which the 
azide (N3) function is attached to a carbon that is part of the aromatic ring, i.e. all aryl 
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azides contain the group shown in Figure 2.5. The bonds in aryl azides are in equilibrium, 
as shown in Figure 2.6. 
Figure 2.5 Structure of azidobenzene, the structure common to all aryl azides 
Q-N-- N+ N 
Q-N t N+ N-
t Q-N- N+ N 
Figure 2.6 EQuilibrium between bonds in aryl azide. 
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Aryl nitrenes are generated by thennolysis or photolysis of aryl azides which readily lose 2 
nitrogen atoms as N2 as shown in Equation 2.1 
L1 or 
ArN3 -----4ArN + N] (2.1) 
h 
Aryl nitrenes are extremely reactive and will undergo a large variety of reactions, some of 
which are shown in Figure 2.7. 200 Aryl nitrenes are very short lived species (halflives less 
than a second) but they may rearrange to give less reactive species, with longer half lives. 
Azidobenzene itself absorbs short - wavelength light (Amax = 250 nm E = 10,000) having a 
spectra with characteristic shoulders at 277 and 286-288 nm, but in aryl azides irradiation of 
the aromatic system allows transfer of energy to the azide function,z°I,202 Nitro substitution 
of the aromatic ring leads to the appearance of an absorbance band at longer wavelengths so 
that light with a A of around 350 nm will cause the production ofnitrenes from the nitro 
substituted aryl azide present in photobiotin. 
As the aryl nitrene group will bind to any organic molecules, the attachment of photobiotin 
to molecules should not be perfonned in buffers that contain organic material such as 
Tris(hydroxymethyl)methylamine (Tris).203 Additionally, azides are rapidly converted to 
amines by thiol groups, commonly used in biochemical buffers in order to produce a 
reducing environment. The presence of electron withdrawing groups on the aromatic ring 
may be used to increase the reactivity of aryl nitrenes. The inclusion of such groups also 
affects the specificity of the reaction, making reactions with nucleophiles much more rapid 
at the expense of insertion reactions. 204 
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Figure 2.7 Some of the reaction of aryl azides upon activation.2°O They can react with amine groups and 
saturated and unsaturated carbons. Alternatively they can react with oxygen or acids, dimerise or undergo 
spontaneous rearrangements. 200 
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2.1.6 Light activated patterning of multiple proteins on a silicon dioxide surface. 
Once a patterning method had been selected (criteria being relative efficiency of the 
immobilisation process, and contrast between patterned and non-patterned areas, results 
shown later in this chapter), further work was performed to ascertain the possibility of 
patterning multiple proteins using this technique. Initially this was using just two proteins, 
but further work was performed to demonstrate the application of the developed patterning 
technique to the site-specific attachment of six different proteins (including 5 functional 
antibodies) within an area of200 x 50 J.1m. 
2.1.7 Demonstration of light-dependent coupling of enzymes and antibodies to gold, glass 
and carbon surfaces 
Once a patterning method for the immobilisation of proteins on silicon dioxide had been 
selected, further work was performed to demonstrate the application of the immobilisation 
procedure to a range of surfaces, and to examine further characteristics of the technique. 
The aim of this section of work was to demonstrate the application of the patterning 
technique to the immobilisation of enzymes (GOD) and/or antibodies on to gold, glass and 
carbon surfaces. Successfully patterning enzymes and antibodies onto gold and/or carbon 
would allow the technique to be used for the fabrication of multianalyte amperometric 
enzymic biosensors and immunosensors. 
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2.1.8 Investigation into reducing non-specific binding on gold surfaces. 
For the protein patterning to work efficiently, and in order to use the technique to develop a 
multianalyte electrochemical immunosensor, it was necessary to minimise non-specific 
binding of proteins to the surface. The effect upon non-specific binding of using different 
forms of avidin. different avidin immobilisation methods and different blocking reagents 
were examined. The types of avidin used were streptavidin (Vector) and two deglycosylated 
forms of avidin; avidin D (Vector) and Neutravidin (Pierce). The avidin immobilisation 
methods employed were adsorption. using N-acetyl-I-cysteine (NAC) with 
l-ethyl-3-(3-dimethyl- aminopropyl)- carbodiimide (EDC). and using 
3.3'-dithiobis(sulfosuccinimidylpropionate) (DTSSP). The three potential blocking agents 
examined were BSA. casein and Superblock™. 
2.1.8.1 Immobilisation of avidin on gold using carbodiimide coupling to aN-acetyl-cysteine 
self assembled monolayer. 
In this procedure NAC was assembled onto a gold surface through chemisorption of the 
thiol group. Subsequent attachment of the avidin to the NAC was by means ofa 
carbodiimide. Carbodiimides comprise a group of compounds with the general formula 
R-N=C=N-R', where R and R' can be aliphatic or aromatic. This group of compounds has 
long been used for the synthesis of peptide bonds.205 The carbodiimide used in this work 
was l-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC). 
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The reaction of carbodiimides may be represented as a dehydration via an intermediary as 
shown in Figure 2.8. 205·207 (Temperatures of around oDe favours the formation of peptide 
bonds, at higher temperatures the reaction shifts towards the formation of acyl ureas 207 
(Figure 2.9)). 
R1 
I 
RNHCHCOOH 
(Protein 1) 
+ R4N=C=NRs --+ 
(carbodiimide) 
R2 
I 
+ H2NCHCOOR3 
(Protein 2) 
Rl R2 
I I 
R1 R4 
I NH+ 
RNHCHCOOC 
I 
N 
Rs 
(Intermediary) 
RNHCHCONHCHCOORJ + R4NHCONHRs 
(Protein 1 and Protein 2 
linked by peptide bond) 
Figure 2.8 Reaction scheme for the promotion of peptide bond formation between amino and carboxylic acid 
residues in two proteins by use of carbodiimides. 
Rl R4 
I NH 
RNHCHCOOC 
I 
N 
Rs 
(Intermediary) 
Rl 
I 
RNHCHCOONR4 
C 
N 
R5 
(acyl urea derivative) 
Figure 2.9 Reaction scheme for the formation of acyl ureas from carbodiimides attached to a carboxylic acid. 
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2.1.8.2 Immobilisation of avidin on gold using DrSSp 
The structure of the 3,3'-dithiobis(sulfosuccinimidylpropionate) (DTSSP) is shown in 
Figure 2.10. DTSSP possesses two N-hydroxysuccinimide (NHS) esters connected by a 
disulphide linkage. The sulphur atoms in the disulphide bond will chemisorb to gold 
surfaces with a stability greater than that given by covalent silane bonds with glass. NHS 
esters react with primary amine - containing species to from stable amide (peptide) bonds 
(Figure 2.11). NHS esters also react with thiols. 
Figure 2.10 Structure ofDTSSP C3.3'-dithiobisCsulfosuccinimidylpropionate». The molecule possesses two 
N-hydroxysuccinimde (NBS) esters connected by a disulphide linkage. 
Protein 
I 
NH2 
+ 
Gold substrate 
Protein 
I 
NH 
I 0=9 
CH
2 I 
CH 2 I 
S 
I 
Gold substrate 
+ 
Figure 2.11 Coupling of protein to a DTSSP activated gold surface. The sulphur atoms in the disulphide bond 
chemisorb to gold surfaces with great stability. NHS esters react with primary amine - containing species (e.g. 
proteins) to from stable amide (peptide) bonds. 
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2.1.9 Regeneration of avidinated surfaces 
Investigations were perfonned to elucidate if it was possible to break the avidin -
photo biotin bond, whilst the avidin remained immobilised on the surface. pH extremes and 
chemicals (urea and guanidine) which are known to disrupt non-covalent bonds,20~-2JO were 
examined. Being able to break the avidin-photobiotin bond, whilst leaving the immobilised 
avidin intact would introduce the possibility of regenerating and repatteming the surface, 
which could be advantageous if one wished to repattem and reuse the transducer element of 
an immunosensor (which is desirable if using expensive transducer elements). 
2.1.10 Characterisation of biomolecular patterns using atomic force microscopy and 
fluorescence microscopy. 
Atomic force microscopy was utilised to ascertain ifinfonnation on the avidin-photobiotin 
patterning technique could be obtained, and comparing this infonnation with data from 
fluorescent microscopy. Since its invention a little over a decade ag0211 scanning probe 
microscopy (SPM) has rapidly become a powerful technique for the imaging and analysis 
of surfaces. Scanning probe microscopy, (including atomic force microscopy (AFM) and 
scanning tunnelling microscopy (STM» has been used to study the structure of immobilised 
biological molecules.212-214 
The principle of scanning tunnelling microscopy (STM) is simple, when a bias voltage 
(0.1-1.0 V) is applied to a metallic tip, and advanced towards a conducting surface a 
tunnelling current is initiated at an appropriate distance from the surface (0.1-10 nm), due to 
electrons tunnelling from the tip through the gap to the surface. The size of the current is 
dependent upon on the work function of the tip and the bias voltage and is very sensitive to 
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the gap distance. Typically a change in distance of 0.1 nm results in an order of magnitude 
change in current. This critical relationship between distance and current gives rise to the 
vertical resolution of the technique. 
Typically, in an experiment the tip is rastered across the surface controlled by a 
piezoscanner and the height of the tip above the surface is kept constant by means of 
feedback control (constant current mode), thus providing an image of the surface 
topography. Alternatively the tip is kept at a constant absolute height and changes in the 
current are recorded (constant height mode). STM requires that both the tip and the surface 
to be conducting. The advantage of STM over scanning electron microscopy (SEM) is 
primarily that of resolution, STM being capable of atomic resolution for flat surface,215 and 
molecular resolution when imaging biomolecules.214 Additionally, STM unlike SEM does 
not require the use of a high vacuum and images can be obtained at ambient temperature 
and pressure. 
In AFM the elastic response of molecules to the force exerted by a scanning tip are 
measured. As the tip is rastered over the surface, changes in the surface cause small 
deflections in a spring mounted tip which can be measured and processed to give a 3 -
dimensional image of the surface. The great advantage of AFM as compared with STM is 
that it can be used to image non-conducting surfaces. The main problem in imaging "soft" 
organic and biological material with an AFM is that the relatively high force exerted by the 
cantilever tip onto the sample may cause distortion or it may even be destructive. 216•217 
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z Piezo 
Figure 2.12. Diagram showing principle of operation of scanning tunnelling microscope. The tip is rastered 
across the surface controlled by a piezoscanner and the height of the tip above the surface is kept constant by 
means of feedback control (constant current mode), thus providing an image of the surface topography 
(represented by the red line). Alternatively the tip is kept at a constant absolute height and changes in the 
current are recorded (constant height mode). 
Spring deflection sensor 
Spring 
Tip 
Figure 2.13 . Diagram showing principle of operation of atomic force microscope. The tip is rastered over the 
surface, changes in the surface cause small deflections in the spring mounted tip (represented by the red line) 
which can be measured and processed to give a 3 - dimensional image of the surface. 
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2. 2 Materials 
Photo biotin, avidin D and Streptavidin were obtained from Vector Laboratories, 
Peterborough, England. IgG from chicken, guinea pig, goat, mouse, rabbit and rat, all 
antibodies and their conjugates (fluorescent and enzymic), ferrocenemonocarboxylic acid, 
l-ethyl-3-(3-dimethylaminopropyl)carbodiimide, N -acetyl-I-cysteine, sodium 
cyanoborohydride, guanidine, urea, Sephadex G25 & G200, p-nitrophenol phosphate and 
glucose oxidase were obtained from Sigma, Fancy Road, Poole, Dorset, England. 
Neutravidin, bovine serum albumin, casein, N-succinimidyI4-(n-maleimido- methyl)-
cyclohexane-1-carboxylate and Superblock™ were obtained from Pierce Warriner, Chester, 
England. 1,3-trimethoxysilylpropyl-ethylene diamine, ethanol, sodium dihydrogen 
phosphate, disodium hydrogen phosphate, sodium chloride, glutaraldehyde, Tris, 
hydrochloric acid, dimethylformamide, zinc chloride and magnesium chloride were 
obtained from BDH, The Old Brickyard, Poole, Dorset, England. 
Positive S 1400-31 photoresist and Microposit developer were obtained from Shipley 
Europe, Coventry, England. Silicon wafers were obtained from Shin Etsu, Livingston, 
Scotland; NiChrome (80:20 Ni:Cr) and gold were obtained from Goodfellow Cambridge 
Ltd, Cambridge, England. 
Bioanalytical Systems (BAS) gold electrodes, glassy carbon electrodes (BAS) and BAS 
RE4 Ag/ AgCI reference electrodes were obtained from Biotech Instruments Ltd (Luton, 
England). 
Instrumentation used comprised a EG&G 273A potentiostat (EG & G, Sunninghill, 
England), a Cecil Series 5000 spectrophotometer, Cambridge, England and a 100W 
HB-I0101AF super high pressure mercury vapour lamp, Nikon, Tokyo, Japan. 
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2.3 Methods for Patternina: of Proteins usina: Avidin and Photobiotin. 
The use of photobiotin and avidin in the site specific immobilisation of molecules were 
examined using three different formats as outlined in sections 2.1.1 to 2.1.3. 
2.3.1 Method for patterning of an avidin-protein conjugate by depositing a protein layer on 
the surface. adding photobiotin followed by the addition of the avidinated protein. 
A Si02 wafer was immersed in 1 % 1,3-trimethoxysilylpropyl-ethylene diamine in 95:5 
(v/v) ethanol I distilled water for 120 seconds and briefly rinsed in 95:5 (v/v) ethanol I 
distilled water before heating at 1200e for 30 minutes. The wafer was immersed in 2% 
glutaraldehyde in 100 mM phosphate buffered saline pH 7.4 (PBS) for 15 minutes, and in 
40mM sodium cyanoborohydride, 0.2mg ml-1 BSA in PBS for 30 minutes. The Si02 
substrate was washed in PBS after this and all subsequent steps. The BSA-modified wafer 
was incubated in 5 ml of lO).lg ml- I long arm photobiotin in PBS whilst exposed to light 
from a 100 W high pressure mercury vapour lamp sited 185 mm from the wafer, for 15 
minutes through a 10 ).lm interval equal mark space ratio mask ( that had been fabricated 
photolithographically), following which the wafer was incubated in 20).lg ml- I avidin in 
PBS for 60 minutes. After washing in PBS, the wafer was incubated in 20).lg ml-1 
biotinylated rabbit IgG in PBS for 60 minutes. 
The wafer was then incubated in 10 ).lg ml- I tetramethylrhodamine isothiocyanate (TRITe) 
labelled goat anti-rabbit IgG in PBS, for 60 minutes. After washing in PBS and distilled 
water the sample was dried in a stream of nitrogen and examined using fluorescence 
microscopy. Results are shown in Section 2.13.1, a photomicrograph of the resultant surface 
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is shown in Figure 2.14 and a cross sectional profile showing fluorescent intensity is shown 
in Figure 2.15. 
Profiles of relative fluorescent intensity were obtained by digitising images by scanning 
into a computer using PhotoshopTM software. A plot of relative fluorescent intensity was 
then produced by assigning a value of 100 to the brightest point (i.e. greatest fluorescence) 
on a line across the pattern. A fluorescent intensity of 0 was set as a point that would show 
no fluorescence (i.e. totally black). It should be noted that this zero value was based upon 
the software definition of black, and that it was not obtained from the photographic image. 
This was done so that a more objective measure of contrast and non-specific binding could 
be obtained. 
2.3.1.1 Method for patterning avidin by depositing a protein layer on the surface. adding 
photobiotin followed by the addition of avidin 
BSA was coated on to a Si02 surface, and photobiotin was subsequently attached as 
described in Section 2.3.1, following which the wafer was incubated in 20 J.lg ml- I 
avidin-TRITe in PBS for 60 minutes. After washing in PBS and distilled water the sample 
was dried in a stream of nitrogen and examined using fluorescence microscopy. Results are 
shown in Section 2.13.1. 
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2.3.2 Method for patterning a protein by depositing a protein layer on the surface. and add 
avidinated protein with photobiotin attached 
Avidin D was conjugated to rabbit IgG by using a maleimide as the conjugation reagent. 
8 mg ml- I avidin D was dissolved in 50 mM sodium borate buffer, pH 7.6 containing ImM 
MgCh and 0.1 mM ZnCh. To 1.0 ml of this avidin solution was added I mg of 
N-succinimidyl 4-(n-maleimido- methyl)cyc1ohexane-l-carboxylate (dissolved in 50 III of 
N, N-dimethylformamide), and the mixture was incubated at room temperature for 1 hour. 
The reaction mixture was then applied to a Sephadex G-25 column (1.0 x 10 cm) 
equilibrated with 100 roM Tris-HCI buffer pH 7.0. Reaction products were eluted using the 
same buffer, and 1.0 ml fractions were collected. The protein content of these fractions was 
assessed by the measurement of absorbance at 280 nm using a Cecil Series 5000 
spectrophotometer, and protein containing fractions were pooled and concentrated to 1.0 
m!. Subsequently, 2.5 mg of rabbit IgG was dissolved in 0.5 ml of 50 mM sodium acetate 
buffer, pH 5.0 and this was added to the maleimide- avidin preparation and incubated at 4°C 
for 20 hours. 20 III of 100 roM 2-mercaptotoethylamine was added to the reaction mixture 
and incubated at room temperature for 30 minutes to block remaining maleimide groups. 
In order to separate the conjugated and unreacted material, the reaction mixture was applied 
to a Sephadex G-200 column (1.0 x 10 cm) equilibrated with 100 mM Tris-Hel buffer pH 
7.0. Elution of reaction products was undertaken using the same buffer, and 1.0 ml fractions 
were collected. The relative protein content of these fractions was assessed by the 
measurement of absorbance at 280 nm and those that were earliest eluting (therefore having 
the highest molecular weight) were used as the avidin-IgG conjugate. The integrity of the 
conjugate was validated by use of a colourimetric ELISA, where the capture antibody was 
directed against avidin and the conjugate was a goat anti-rabbit IgG-alkaline phosphatase. 
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BSA was immobilised on a Si02 wafer using the silanisation procedure described in Section 
2.3.1. 2.5 ml of 20 /lg ml-! avidinated rabbit IgG was incubated with 2.5 ml of 20 /lg ml-! 
long arm photobiotin in PBS for 20 minutes. This solution was then placed on the protein 
coated Si02 wafer and exposed to light as described in Section 2.3.1. The wafer was then 
incubated in 10 /lg ml-! TRITC labelled goat anti-rabbit IgG in PBS, for 60 minutes. After 
washing in PBS and distilled water the sample was dried in a stream of nitrogen and 
examined using fluorescent microscopy. Results are presented in Section 2.13.2. 
2.3.2.1 Spectrophotometric determination of alkaline phosphatase activity. 
Alkaline phosphatase (ALP) (E.C.3.1.3.1) activity was determined spectrophotometric ally 
using p-nitrophenol phosphate (pNPP) as a substrate. pNPP is essentially colourless in 
solution, but when the phosphate is removed by the action of ALP the resultant 
p-nitrophenol gives an intense yellow colour with an absorbance maxima at 404 nm. 
ALP was assayed by the addition to the sample of a 100 mM Tris-HCI buffer pH 9.8, 
containing ImM MgCh and 10 mM pNPP. Samples were incubated at room temperature 
for 15 minutes before reading the absorbance at 404 nm (proportional to ALP activity). 
2.3.2.2. Assessment of cross reaction between photobiotin conjugates in solution. 
To assess whether crosslinking occurred between the avidinated species-photobiotin 
complexes in solution, 2.5 ml of20 /lg ml-! avidinated rabbit IgG was incubated with 2.5 
ml of 20 Ilg ml-! long arm photobiotin in PBS for 20 minutes. This solution was then split 
into two equal portions and half was exposed to light as it would be in the immobilisation 
procedure, whilst the other portion was kept in the dark. Both portions were then analysed 
using size exclusion chromatography using a lOx 1 cm Sephadex G200 column, eluting 
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using 10 mM phosphate buffer pH 7.4.1.0 ml fractions were collected and their protein 
content was determined by measurement of absorbance at 280 nm. The resultant elution 
profiles are shown in Section 2.13.2. 
2.3.3 Method for light activated patterning of a protein on a silicon dioxide surface using an 
avidin / photobiotin / immunoglobulin construct 
Avidin was immobilised on a Si02 wafer using the method described in Section 2.3.1 but 
replacing the BSA with avidin D. The avidin-modified wafer was incubated in 5.0 ml of 
10 Jlg ml- I long ann photobiotin in PBS for 20 minutes, this and all subsequent stages were 
performed under dark room conditions. The wafer was covered with 10 Jlg ml-
' 
rabbit IgG 
in PBS and exposed to light as described in Section 2.3.1. The temperature of the wafer 
was monitored throughout the exposure period and did not increase by any more than 5°C. 
The wafer was covered with 10 mg ml- I casein in PBS and exposed to light for 15 
minutes in the absence of a mask. The wafer was then incubated in 10 Jlg ml- I TRITe 
labelled goat anti-rabbit JgG in PBS, for 60 minutes. After washing in PBS and distilled 
water the sample was dried in a stream of nitrogen and examined using fluorescent 
microscopy. Results are presented in Section 2.13.3. 
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2.4 Method for Investieation into Achievable Resolution of Protein Patternine usine 
Avidin-Photobiotin Technique. 
The methodology of this Section of work was identical to that in Section 2.3.3 apart from 
the lithographic mask used, which consisted of series of lines (equal mark:space ratio) 
ranging from 1 J.1m to 10J.1m in width. Results are presented in Section 2.14. 
2.5 Investieation into Timescale of Avidin-Photobiotin Immobilisation Procedure. 
2.5.1. Method for monitoring effect of exposure time on patterning process using 
fluorescence microscopy. 
Avidin D and photobiotin were immobilised onto wafers of Si02 as described in Section 
2.3.3. Wafers were then flood exposed to light from a mercury vapour lamp (irradiance - 9 
mW cm-2) in the presence of 10 mg ml- I casein in PBS for varying periods of time. After 
washing in PBS all samples were exposed to light for 15 minutes through a 
photolithographic mask in the presence of 10 mg ml-1 chicken IgG in PBS. Following 
washing in PBS, samples were incubated with TRITe labelled rabbit anti - chicken IgG for 
one hour, and examined using fluorescence microscopy. 
2.5.2. Method for monitoring effect of exposure time on patterning process using 
colourimetric enzyme assay. 
Avidin D and photobiotin were immobilised onto wafers ofSi02 as described in Section 
2.3.3. Wafers were then flood exposed to light from a mercury vapour lamp (irradiance - 9 
m W cm-2) in the presence of 100 Ilg ml-I ALP in PBS for varying periods of time. Other 
"control" samples were exposed to the enzyme for the same periods oftime but were not 
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exposed to light, in order to monitor any variation in non-specific binding as a function of 
exposure time. After washing in TBS, the ALP activity of all samples was assayed as 
described in Section 2.3.2.1. The Si02 wafers were weighed and the enzyme activity 
related per gram of Si02 was calculated in order to correct for any variation in wafer size. 
The results are presented in Section 2.15. 
2.6 Methods for Li2ht Activated Patternin2 of Multiple Proteins onto Silicon Dioxide 
Surfaces 
2.6.1 Method for light activated patterning of two immunoglobulins on a silicon dioxide 
surface using an avidin / photobiotin / immunoglobulin construct 
Avidin and photobiotin were irnmobilised on a Si02 wafer using the silanisation process 
described in Section 2.3.1. The wafer was covered with 1 0 ~g ml-] rabbit IgG in PBS and 
exposed to light through a mask with 10Jlm interval equal mark:space ratio lines as 
described in Section 2.3.1. The wafer was then covered with 10 Jlg ml-] rat IgG in PBS and 
exposed to light for 15 minutes through the same mask rotated through 90°. The wafer was 
covered with 10 mg ml-] casein in PBS and exposed to light for 15 minutes in the absence 
of a mask. The wafer was then incubated in 1 0 ~g ml-] TRITC labelled goat anti-rabbit IgG 
in PBS, for 60 minutes, washed and covered with 1 0 ~g mi-] fluorescein isothiocyanate 
(FIrC) labelled rabbit anti-rat IgG, for 60 minutes. After washing in PBS and distilled 
water the sample was dried in a stream of nitrogen and examined using fluorescent 
microscopy. A photomicrograph of this surface is shown in Section 2.16.1. 
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2.6.2 Method for patterning of five functional antibodies on a silicon dioxide surface using 
an avidin / photobiotin / immunoglobulin construct 
Avidin (Neutravidin™ in place of Avidin D (note that the manufacturers ofNeutravidin 
claim that it shows less non-specific binding than Avidin D, but Neutravidin was not 
available at the start ofthe study, hence the two type of avidin used» and photobiotin were 
immobilised on a Si02 wafer using the silanisation process described in Section 2.3.1. The 
Si02 wafer was attached to a microscope so that it was in a fixed position below the 
microscope's objective lens with the top of the wafer level with the microscope stage. The 
five different antibodies were sequentially bound to the surface by selective light activation 
of distinct areas using a 100W high pressure mercury vapour lamp and a series of five 
photolithographic masks, each with a common registration mark (+) and a different number 
between 1 and 5 (50J.lm x 25J.lm in size) as a pattern. Polyclonal rabbit antibodies (10 flg 
ml- I), raised against chicken, guinea pig, goat, mouse and rat were patterned in each case 
realigning the patterned substrate by means of the registration mark and a CCD camera 
attached to the microscope (the wafer was thoroughly washed in PBS between each 
exposure). The surface was then flood - exposed with light in the presence of 10 mg ml- I 
casein in PBS, so immobilising the "blocking" protein at any previously unreacted 
photobiotin sites. After thorough washing with PBS, the wafer was incubated in a mixture 
of complementary antigens (chicken IgG, guinea pig IgG, goat IgG, mouse IgG and rat 
IgG, 100 J.lg ml- I of each) in PBS at room temperature for one hour. 
Following thorough washing with PBS, the wafer was incubated for one hour in 100 flg ml- I 
rabbit anti - chicken IgG - TRITC in PBS and washed in PBS. Excess liquid was removed 
using a gentle stream of nitrogen, and the sample was examined using fluorescent 
68 
microscopy recording the image photographically (using a single lens reflex camera with 
automatic exposure times). This procedure was repeated sequentially, replacing the addition 
of rabbit anti - chicken IgG - TRITe with TRITe conjugates of anti - guinea pig IgG, rabbit 
anti - goat IgG, rabbit anti - mouse IgG or rabbit anti-rat IgG, on each occasion. Results are 
presented in Section 2.16.2. 
2.7 Demonstration of Lieht Dependent Coupline of Proteins to Gold Surface 
2.7.1 Method for demonstration of light dependent coupling of enzyme to gold surface 
Avidin D was adsorbed on to two identical2mm diameter gold electrodes (Bioanalytical 
systems (BAS)) by placing the electrodes in 5 ml of a 0.2mg ml- I solution of avidin 0 in 
PBS for one hour at room temperature. After extensive rinsing with PBS the electrodes 
were then incubated in 5 ml of 1 0 ~g ml- I solution of long arm photobiotin in PBS for 20 
minutes under dark room conditions. After extensive rinsing with PBS electrodes were 
incubated with 50 ~l of identical solutions of glucose oxidase (GOD) (SOU ml- I ) in PBS, 
one electrode was retained in dark room conditions whilst the other was exposed to light 
from a high pressure mercury vapour lamp for 15minutes. After extensively rinsing both 
electrodes with PBS under dark room conditions, 50 ~l of 10 mg ml- I BSA in PBS was 
added to each electrode and both were exposed to light from a high pressure mercury 
vapour lamp for 15 minutes. 
An amperometric enzyme based assay was performed using the modified gold surface as a 
working electrode, with an Ag/ Agel electrode as the reference and a bare platinum flag as a 
counter electrode. Chronoamperometry was performed in a working solution containing 
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10 mM sodium phosphate, 140 mM NaCl, 25 mM KCl, pH 7.4, or with the same solution 
but with the addition of 100 mM glucose. Initially, the working electrode was poised at a 
potential of OV for 300 seconds, after which the potential was "stepped" to 650m V for 120 
seconds during which time the current was monitored. Resultant traces and currents 
obtained 30 seconds after the application of the 650 mV potential are presented in Section 
2.17.1. 
2.7.2 Method for Demonstration of light dependent coupling of antibody to gold surface 
Avidin D and photobiotin were immobilised onto two gold electrodes as described in 
Section 2.7.1. After extensive rinsing with PBS each electrode was incubated with 
50 ~l of 1 00 ~g mI-! rabbit anti-rat IgG in PBS whilst being exposed to light from a high 
pressure mercury vapour lamp for 15 minutes. 
Electrodes were incubated in either 5 ml of 1 0 ~g ml-! rat IgG in PBS for 60 minutes, whilst 
the other was placed in 5 ml of 10 ~g ml- l rabbit IgG in PBS for 60 minutes. Following this 
both electrodes were extensively washed with PBS. Background currents were obtained by 
performing an amperometric measurement using the modified gold surface as a working 
electrode, with a Agi AgCI electrode as the reference and a bare platinum flag as a counter 
electrode. After thorough rinsing, the electrodes were placed in 15ml of 25 mM KCl, 10mM 
hydrogen peroxide, 1 mM ferrocenemonocarboxylic acid. The potential was stepped to 
+ 150 m V for 120 seconds, during which time the current was monitored. After extensive 
washing with PBS the electrodes were incubated in 5 ml of a solution of 20 ~g ml-! 
horseradish peroxidase labelled rabbit anti-rat IgG at room temperature for 60 minutes, and 
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following thorough rinsing, amperometric measurements were made as described above. 
Results are presented in Section 2.17.2. 
2.S. Method for Lia:ht Dependent Couplina: of a Protein to a Glass Surface 
A clean glass slide was immersed for 30 seconds in a 1 % solution of 1,3-trimethoxysilyl-
propylethylene diamine in 95% ethanol 5% distilled water, pH adjusted to 5.0 with glacial 
acetic acid. After removing the slide from this solution it was rinsed briefly in 95% ethanol 
5% distilled water before being heated at 120°C for 30 minutes. The slide was immersed in 
2% glutaraldehyde in PBS for 15 minutes, and then in a solution of 40mM sodium 
cyanoborohydride, 0.2mg ml- l avidin D in PBS for 30 minutes at room temperature. After 
extensive rinsing with PBS the wafer was incubated in 5 ml of 1 O~g ml- I long arm 
photobiotin in PBS for 20 minutes under dark room conditions. After extensive rinsing with 
PBS the wafer was covered with 1 O~g ml-\ rat IgG in PBS and exposed to light from a high 
pressure mercury vapour lamp for 15 minutes through a patterned chrome mask. Following 
further rinsing with PBS the wafer was covered with 10mg mI-\ BSA in PBS and the entire 
surface was exposed to light from the mercury vapour lamp for 15 minutes. The slide was 
incubated with 1 O~g mI-\ TRITC labelled rabbit anti-rat IgG in PBS, for 60 minutes at 
room temperature. After washing in PBS and distilled water the sample was dried in a 
stream of nitrogen and examined using a fluorescent microscope. A photomicrograph of 
the surface is shown in Section 2.18. 
71 
2.9. Method for Li2ht Dependent Couplin2 of a Protein to a Carbon Surface 
The carboxyl groups on two freshly polished glassy carbon electrodes (GCEs) were 
activated by the mixed anhydride method,188 which allows primary amines in the avidin 
molecule to bind directly to activated carboxyl groups on the GCE surface. This procedure 
involved incubation of the GCEs in 10% RN03 for 10 seconds at +2V vs. Ag/AgCl 
followed by incubation in dimethylformamide (DMF) containing 1 % N-methylmorpholine 
and 1.5% isobutylchloroformiate for 60 minutes (no electrical potential applied). The 
electrodes were then incubated in 50 mM sodium phosphate buffer pH 7.0 containing 
100J.1g ml- I avidin D for 2 hours. After extensive rinsing with PBS the electrodes were then 
incubated in 5 ml of a 10 J.1g ml- I solution of long arm photobiotin in PBS for 20 minutes 
under dark room conditions. 
After extensive rinsing with PBS each electrode had 50 J.11 of identical solutions of GOD in 
PBS aliquotted onto it. One electrode was subsequently retained in dark room conditions, 
whilst the other was exposed to light from a high pressure mercury vapour lamp for 15 
minutes. After extensively rinsing both electrodes with PBS under dark room conditions, 50 
J.11 of a 10 mg ml- I solution of BSA in PBS was added to each electrode and both were 
exposed to light from a high pressure mercury vapour lamp for 15 minutes. 
An amperometric enzyme based assay was performed using the modified carbon surface as 
a working electrode, with an Ag/ Agel electrode as the reference and a bare platinum flag as 
a counter electrode. Chronoamperometry was performed in a working solutions containing 
either 0 or 100 mM glucose solutions in 10 mM sodium phosphate, 140 mM NaCl, 25 mM 
KCI, pH 7.4. Initially, the working electrode was poised at a potential ofOV for 300 
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seconds, after which the potential was stepped to 650mV for 120 seconds during which 
time the current was monitored. Results are presented in Section 2.19 
2.10 Methods for Investi2ation into Reducin2 Non-Specific Biodio2 00 Gold Surfaces. 
2.10.1 Method for investigation into reducing non-specific binding on gold surfaces. 
Gold was evaporated onto a Si02 wafer as described in Section 3.5.1. The gold coated wafer 
was cut into portions of uniform size (10 x 4 mm), so that results obtained were directly 
comparable. 3 forms of avidin were examined, two deglycosylated preparations (Avidin D 
and Neutravidin) and the microbial type (streptavidin). 
2.10.1.1 Immobilisation of avidin on gold by adsorption 
The different forms of avidin were adsorbed onto gold by incubation of 100J.lg ml- t avidin 
in 10 mM phosphate buffer (PH 7.0) for 16 hours at 4°C, followed by extensive washing in 
PBS. 
2.10.1.2 Immobilisation of avidin on gold using NAC and EDe 
Gold surfaces were incubated in 2 mM NAC in 10 mM phosphate buffer (pH 7.0) for 120 
minutes at room temperature, followed by 120 minutes incubation in 1% (w/v) EDC in 10 
mM phosphate buffer (pH 7.0). The gold surfaces were then incubated in 100J.lg mI· t of the 
different forms of avidin in 10 mM phosphate buffer (PH 7.0) for 16 hours at 4°C 
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2.10.1.3 Immobilisation of avidin on gold using DTSSP 
Gold surfaces were incubated in 2 mM DTSSP in 10 mM phosphate buffer (pH 7.0) for 
120 minutes at room temperature. The gold surfaces were then incubated in 1 OO~g ml-' 
avidin in PBS for 16 hours at 4°C. As described in Section 2.1.8.2 the disulphide bond in 
DTSSP is thought to strongly chemisorb to the gold, and the NHS esters are available to 
react with primary amines in avidin to form a peptide bond. 
2.10.1.4 Treatment with blocking agent and testing for non-specific binding. 
Subsequent to the immobilisation of the avidin, the gold coated Si02 wafers were 
thoroughly washed in PBS and exposed to additional blocking proteins (BSA, casein and 
Superblock TM) by incubation in a lOOllg ml- I solution in PBS for 24 hours at 4°C. The gold 
coated Si02 wafers were then thoroughly washed in TBS (10 mM Tris, 140 mM NaCI, pH 
7.4) and incubated in 10 ~g ml-' rabbit IgG - ALP in TBS for 15 minutes at room 
temperature. The samples were washed extensively in TBS and ALP activity was 
determined colourimetrically using pNPP as the substrate as described in Section 2.3.2.1. 
The absorbance was measured at 404 nm, and results were normalised against the response 
obtained for bare gold, the higher the response, the greater the degree of non-specific 
binding (note that the results were corrected to take account of the relatively small amount 
of non-specific binding occurring on the reverse side of the Si02 wafer by running controls 
ofSi02 wafer that did not have gold attached). The results of these experiments are 
summarised in Section 2.20. 
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2.11 Methods to Investia:ate Rea:eneration of Avidinated Surfaces 
2.11.1 Methods to investigate regeneration of avidinated silicon dioxide surfaces 
Rabbit IgG and BSA were patterned (4~m equal mark:space ratio lines) onto Si02 surfaces 
as described in Section 2.3.3, and rabbit IgG was visualised by the addition of goat 
anti-rabbit IgG - TRITC conjugate. The surfaces were examined using fluorescence 
microscopy, and then underwent a number of treatments to ascertain if the avidinated 
surface could be regenerated. 
The treatments were; 
a, Incubation in NaOH solution pH 12 for 16 hours. 
b, Incubation in HCI solution pH 1.5 for 16 hours. 
c, Incubation in 6M guanidine in HCI solution pH 1.5 for 16 hours. 
d, Incubation in 10M urea for 16 hours. 
e, Incubation in PBS for 16 hours (control). 
The surfaces were subsequently washed in distilled water, dried under a gentle stream of 
nitrogen and examined using fluorescence microscopy. The treated Si02 was then 
re-incubated with photobiotin and was subjected to repatterning with rat IgG and BSA as 
using the mask with 4~m equal mark:space ratio lines rotated through 90°. The presence of 
rat IgG was visualised by the addition of rabbit anti-rat IgG - FITC conjugate, and the 
samples were examined using fluorescence microscopy. The results are summarised in 
Section 2.21.1. 
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2.11.2. Method to investigate regeneration of avidinated gold surfaces 
Four gold electrodes were incubated in 2 mM NAC in 10 mM phosphate buffer (pH 7.0) 
for 120 minutes at room temperature, followed by 120 minutes incubation in 1 % (w/v) 
EDC in 10 mM phosphate buffer (PH 7.0). The electrodes were then incubated in lOOflg 
ml-· Neutravidin™ in 10 mM phosphate buffer (pH 7.0) for 16 hours at 4°C. All 
subsequent stages of the immobilisation procedure were performed at room temperature. 
After washing in PBS, the electrodes were first incubated in 10 mg mI·) casein in PBS for 
60 minutes and then in 10 flg mI·· long arm photobiotin in PBS, for 20 minutes in the dark. 
All subsequent stages of the immobilisation procedure were performed in the dark. After 
extensive rinsing with PBS each electrode had 50 III of identical solutions of goat anti-rat 
IgG in PBS placed onto it and the electrodes were exposed to light from a high pressure 
mercury vapour lamp for 15 minutes. 
Two electrodes (#1 and #3) were incubated in 5 ml of 10 flg ml-· rat IgG in PBS for 60 
minutes, whilst the the others ( #2 and #4) were incubated in 5 ml of 10 flg ml-) rabbit IgG 
in PBS for 60 minutes. Following this electrodes were extensively washed with PBS. 
Background currents were obtained by performing an amperometric measurement using the 
modified gold surface as a working electrode, with a Agi AgCI electrode as the reference 
and a bare platinum flag as a counter electrode. After thorough rinsing, the electrodes were 
placed in 15ml of 25 mM KCI, 10mM hydrogen peroxide, 1 mM ferrocenemonocarboxylic 
acid and a potential 150 mV was applied for 120 seconds during which time the current was 
monitored. After extensive washing with PBS the electrodes were incubated in 5 ml of a 
solution of 20 flg ml-· HRP labelled goat anti-rat IgG at room temperature for 60 minutes, 
and following thorough rinsing, amperometric measurements were made as described 
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above. Currents obtained 30 seconds after the application of the 150 m V potential are 
shown in Section 2.21.2 (Table 2.6). Two (#1 and #2) electrodes were then incubated for 16 
hours in 6M guanidine pH 1.5, whilst two (#3 and #4) were incubated for 16 hours in PBS 
(controls). After washing in PBS, the electrodes were incubated in 10 ).lg ml- I long arm 
photobiotin in PBS, for 20 minutes in the dark. After extensive rinsing with PBS each 
electrode had 50 ).ll of identical solutions of goat anti-rabbit IgG in PBS placed onto it and 
the electrodes were exposed to light from a high pressure mercury vapour lamp for 15 
minutes. The electrodes were then incubated with rat IgG or rabbit IgG, and HRP labelled 
goat anti-rabbit IgG and amperometric measurements were taken as previously described, 
the resultant currents are presented in Section 2.21.2. 
2.12 Method for Characterisation of Biomolecular Patterns usinl: Atomic Force 
Microscopy and Fluorescence Microscopy. 
Neutravidin and photobiotin were immobilised on a Si02 wafer using the silanisation 
method described in Section 2.3.1. The wafer was covered with 10 ).lg ml- I goat anti-rabbit 
IgG in PBS and exposed to light, as described in Section 2.3.1, for 15 minutes through a 
mask with 3).lm interval equal mark:space ratio lines. The wafer was covered with 10 mg 
ml- I casein in PBS and exposed to light for 15 minutes in the absence of a mask. The wafer 
was then incubated in 10 J.lg ml- I TRITC labelled rabbit anti-rat IgG in PBS, for 60 minutes. 
After washing in PBS and distilled water the sample was dried in a stream of nitrogen and 
examined using fluorescent microscopy. A photomicrograph of this surface is shown in 
Section 2.22. 
The pattern of antibodies was imaged using AFM, images were obtained using a Burleigh 
Personal AFM (Burleigh, UK) with Si tips (spring constant 0.045 nM m- I , with a tip radius 
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of 10 run and an aspect ratio of approximately 4: 1, as quoted by Burleigh and verified using 
SEM (Hitachi S-900, Hitachi, Cambridge)). Imaging was carried out in air at ambient 
temperature and humidity with an imaging force maintained at approximately 5 nN. The 
resultant images are shown in Section 2.22. 
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2.13 Results and Discussion for Patternin2 of Proteins usin2 Avidin and Photobiotin. 
2.13.1 Results and discussion for patterning method using an avidin-protein conj ugate by 
depositing a protein layer on the surface. adding photobiotin followed by the addition of the 
avidinated protein 
The photomicrographs in Figures 2.14 and 2.16 (along with plots of relative fluorescent 
intensity in Figures 2.15 and 2.17) demonstrate that patterning of proteins was possible 
using this approach. However, the imrnobilisation efficiency (as evident by the intensity of 
the fluorescence and the lack of contrast between areas corresponding to mark and space on 
the photolithographic mask) was very low compared with other approaches (see Section 
2.13.3). This may be due to steric hindrance of one or more of the coupling steps (i.e. the 
majority of photobiotin is bound to the imrnobilised protein layer, in such a way that the 
biotinyl groups are unavailable for subsequent binding to avidin). The data from the 
addition of the fluorescently labelled avidin suggested that the poor efficiency was due to 
the stage where avidin bound to the imrnobilised photobiotin, as again there was relatively 
little differentiation in fluorescent intensity in areas that had been exposed to light, and 
those that had not. A further disadvantage of this technique was that for a species to be 
immobilised it must have undergone prior avidination or biotinylation. 
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10 f..lm 
Figure 2.14 Photomicrograph of silicon dioxide patterned using a BSA / photobiotin / avidin / 
biotin-immunoglobulin construct visualised by a TRITC labelled anti-immunoglobulin antibody. BSA was 
immobilised on a Si<h wafer as described in Section 2.3.1. The BSA-modified wafer was incubated in a 
solution of long arm photobiotin in PBS whilst exposed to light as described in Section 2.3.l. The wafer was 
then incubated in avidin in PBS and after washing in PBS, the wafer was incubated with biotinylated rabbit 
JgG in PBS. The wafer was then incubated in TRITC labelled goat anti-rabbit JgG in PBS, and aftcr washing 
in PBS and distilled water the sample was dried in a stream of nitrogen and examined using fluorescent 
microscopy. 
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Figure 2.15 Plot of relative fluorescent intensity against distance for cross sectional profile through the pattern 
in Figure 2.14. The relative fluorescent intensity was determined by taking the brightest point (i.e. greatest 
fluorescence) on a line across the pattern as 100. A fluorescent intensity of 0 was set as a point that would 
show no fluorescence (i.e. totally black). The fluorescent intensity of each point on the line was determined by 
interpolation between these 2 extremes. 
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10 Jlm 
Figure 2.16. Photomicrograph of silicon dioxide patterned using a BSA / photobiotin / TRITe labelled avidin 
construct. BSA and photobiotin were immobilised as described in Section 2.3.l.l. The wafer was then 
incubated in TRITe labelled avidin in PBS, and after washing in PBS and distilled water the sample was 
dried in a stream of nitrogen and examined using fluorescent microscopy. 
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Figure 2.17 Plot of relative fluorescent intensity against distance for cross sectional profile through a section of 
the pattern in Figure 2.16. The relative fluorescent intensity was determined by taking the brightest point (i.e. 
greatest fluorescence) on a line across the pattern as 100. A fluorescent intensity of 0 was set as a point that 
would show no fluorescence (i.e. totally black). The fluorescent intensity of each point on the line was 
determined by interpolation between these 2 extremes. 
81 
2.13.2 Results and Discussion for patterning a protein by depositing a protein layer on the 
surface. and add avidinated protein with photo biotin attached 
The photomicrograph in Figures 2.18 (along with plot of relative fluorescent intensity in 
Figures 2.19) demonstrate that patterning of proteins was possible using this approach. The 
immobilisation efficiency (as evident by the intensity of the fluorescence apparent when the 
wafer was viewed by eye through a fluorescence microscope, and the much longer exposure 
time necessary to obtain a photomicrograph) was low compared with other approaches (see 
2.13.3). This appeared to be at least partially due to considerable crosslinking occurring 
between the avidinated species-photobiotin complexes in solution. Due to the generally 
faster reaction kinetics in solutions, it is likely that these complexes bound preferentially to 
each other rather than to the surface protein layer. Figure 2.17 shows the elution profile 
from size-exclusion chromatography of the material pre and post exposure to light. The 
increased A280 in the earlier fractions demonstrates that the post-exposure solution 
contained very high molecular weight material which was not present in the pre-exposure 
solution, this indicates that reactions between the species in solution had occurred upon 
exposure to light. An additional disadvantage of this immobilisation method (as described 
in Section 2.13.1), is that it would only be possible to immobilise species that had 
undergone avidination prior to the start of the immobilisation process. 
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10 ~m 
Figure 2.18 Photomicrograph of silicon dioxide patterned using a BSA / photobiotin-avidin - immunoglobulin 
construct. BSA was immobilised as described in scetion 2.3.2. Avidinated rabbit JgG was pre-incubated with 
long arm photobiotin in PBS, and was then placed on the protein coated Si~ wafer and exposed to light 
through a mask with 101illl interval equal mark:space ratio lines. The wafer was then incubated in TRITe 
labelled goat anti-rabbit IgG in PBS, and after washing in PBS and distilled water the sample was dried in a 
stream of nitrogen and examined using fluorescent microscopy. 
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Figure 2.19 Plot of relative fluorescent intensity against distance for cross sectional profile through the pattern 
in Figure 2.18. The relative fluorescent intensity was determined by taking the brightest point (i .e. greatest 
fluorescence) on a line across the pattern as 100. A fluorescent intensity of 0 was set as a point that would 
show no fluorescence (i.e. totally black). The fluorescent intensity of eaeh point on the line was determined by 
interpolation between these 2 extremes. 
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Figure 2.20 Normalised A2so from fractions from chromatographic separation of a photobiotin / avidin / protein 
solution, pre and post exposure to light. 2.5 ml of 20 Ilg mI·\ avidinated rabbit IgG was incubated with 2.5 ml 
of 20 Ilg mI·\ long arm photobiotin in PBS for 20 minutes. This solution was then split into two equal 
portions, and half was exposed to light for 15 minutes from a 100 W high pressure mercury vapour lamp sited 
185 mm from the solution, whilst the other portion was kept in the dark. Both portions were then analysed 
using size exclusion cbomatograpby using a 10 x 1 cm Sepbadex G200 column, eluting using 10 mM 
phosphate buffer pH 7.4. 1 mI fractions were collected and their protein content was determined by 
measurement of absorbance at 280 run. 
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2.13.3 Results and Discussion for light activated patterning of a protein on a silicon dioxide 
surface using an avidin / photobiotin / immunoglobulin construct 
The photomicrograph in Figures 2.21 (along with plot of relative fluorescent intensity in 
Figures 2.22) demonstrate that patterning of proteins was effective using this approach. This 
immobilisation method appeared to give much better results than the alternative procedures. 
The immobilisation efficiency (as evident by the intensity of the fluorescence apparent 
when the wafer was viewed by eye through a fluorescence microscope, and the much 
shorter exposure time necessary to obtain a photomicrograph) was high compared with 
other approaches (see sections 2.13.1 and 2.13.2). The photomicrograph of the surface 
shown in Figure 2.21, and the plot (Figure 2.22) of relative fluorescent intensity against 
distance for cross sectional profile through the pattern showed that this immobilisation 
technique was capable of high resolution «lO).lm) patterning of proteins onto a surface 
with low non-specific binding. 
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Figure 2.21 Photomicrograph of silicon dioxide patterned with TRITC labelled IgG. using an 
avidin-photobiotin IgG construct as described in Section 2.3.3 . The wafer was then incubated in TRITC 
labelled goat anti-rabbit IgG in PBS, and after washing in PBS and distilled water the sample was dried in a 
stream of nitrogen and examined using fluorescent microscopy. 
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Figure 2.22 Plot of relative fluorescent intensity against distance for cross sectional profile through the pattern 
in Figure 2.21. The relative fluorescent intenSity was determined by taking the brightest point (i .e. greatest 
fluorescence) on a line across the pattern as 100. A fluorescent intensity of 0 was set as a point that would 
show no fluorescence (i .e. totally black). The fluorescent intensity of each point on the line was determined by 
interpolation between these 2 extremes. 
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2.14 Results and Discussion for Investi2ation into Achievable Resolution of Protein 
Patternin2 usin2 Avidin-Photobiotin Technique. 
A photomicrograph of a surface patterned with protein using a mask with lines 1.5)lm in 
width is shown in Figure 2.23, demonstrating that patterns can be formed with features of 
this size. The plots shown in Figure 2.24 show that baseline resolution of fluoresence 
(which is related to quantity of immobilised protein) is achieved for equal mark:space ratio 
lines as small as 1.5)lm in width. 
Although a pattern of fluorescent intensity relating to that on the mask is evident, baseline 
resolution is not achieved for lines I J,lm in width. The most likely explanation of the lack 
of resolution with I J,lm lines was that the mask was not in intimate enough contact to the 
substrate being patterned to overcome dispersion of the light through refraction etc. 
Attempts to achieve sub-micron resolution were not successful. Briefly, these experiments 
involved applying pressure to the mask to bring it in closer contact with the substrate to be 
patterned, however it was observed that by doing so the reactant solutions were forced out 
of the gap between substrate and mask, and the immobilisation process did not work (even 
when concentrations of reactants in the solutions were greatly increased). 
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Figure 2.23 Photomicrograph of SiQ, patterned with TRITC labelled IgG. using an avidin-photobiotin IgG 
construct. The photograph shows that 1.5 J.Ulllines of immobilised protein can be patterned on a Si~ surface. 
Avidin was immobilised on a Si~ wafer as described in Section 2.3 .3. The avidin-modified wafer was 
incubated with photobiotin in PBS, and was then covered with rabbit IgG in PBS and exposed to light 
through a mask with 1.5Jlffi interval equal mark:space ratio Lines. The wafer was covered with casein in PBS 
and exposed to Light in the absence of a mask. The wafer was then incubated in TRITC labelled goat 
anti-rabbit IgG in PBS, and after washing in PBS and distilled water the sample was dried in a stream of 
nitrogen and examined using fluorescent microscopy. 
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Figure 2.24 Plot of relative fluorescent intensity against distance for cross sectional profile of different width 
lines formed using the patterning of proteins as previously described. Proteins were patterned using 
avidin-photobiotin employing a photolithographic mask with equal mark:space ratio lines of different widths. 
The patterned proteins were visualised by the addition of fluorescently labelled antibodies, and resolution was 
examined by measurement of the relative fluorescent intensity across the pattern. The relative fluorescent 
intensity was determined relative to the brightest point (i.e. greatest fluorescence) assigned a value 100. A 
fluorescent intensity of 0 was set as a point that would show no fluorescence The fluorescent intensity of 
each point on the lines was determined by interpolation between these 2 extremes. 
89 
2.15 Results and Discussion for Investia:ation into Timescale of Avidin-Photobiotin 
Immobilisation Procedure. 
2.15.1. Results and discussion for monitoring effect of exposure time on patterning process 
using fluorescence microscopy. 
Upon fluorescence microscopy examination of surfaces treated as described in Section 
2.5.1, patterned IgG was clearly visible when the substrate (with immobilised avidin and 
photobiotin) had been exposed to light in the presence of casein for up to 250 seconds prior 
to exposing the substrate to light in the presence of the IgG. When the substrate had been 
pre-exposed to casein and light for 500 seconds, only a very faint pattern corresponding to 
IgG could be observed, and no pattern could be discerned for pre-exposure times longer 
than 500 seconds. This data indicates that under the conditions described in Section 2.5.1, 
some of the photobiotin could still be activated following pre-exposure to light for up to 
500 seconds. 
2.15.2. Results and discussion for monitoring effect of exposure time on patterning process 
using colourimetric enzyme assay. 
The results shown in Table 2.1 and Figure 2.25 indicate that under these experimental 
conditions (described in Section 2.5.2), the photobiotin mediated immobilisation process 
proceeds rapidly, and that it is close to completion (>90%) after 500 seconds. No further 
immobilisation occurs after 750 seconds. These results also demonstrate that the small 
amount of non-specific binding present also occurs rapidly, with approximately 60% of the 
material that is non-specifically bound being so in the first minute of exposure. 
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Time exposed to ALP ALP activity sample ALP activity sample 
(seconds) exposed to light kept in dark 
(absorbance units / g Si02) (absorbance units / g Si02) 
0 0 0 
1 l.1 0.8 
10 8.2 1.2 
25 17.1 l.5 
50 3l.4 l.8 
100 5l.6 2.2 
250 66.9 2.4 
500 71.4 2.8 
750 75.3 3.0 
1,000 74.9 2.9 
Table 2.1 Enzyme activity versus time of exposure of avidin - photobiotin coated SiO, to an ALP solution in 
the presence or absence of light. Avidin D and photobiotin were immobilised onto wafers of Si02 as 
described previously. Wafers were then flood exposed to light in the presence of 100 flg ml-I ALP in PBS for 
varying periods of time. Other "control" samples were exposed to the enzyme for the same periods of time but 
were not exposed to light. After washing in TBS, the ALP activity of all samples was assayed 
colourimetrically using pNPP as the substrate. Enzyme activity related per gram ofSi02 was calculated. 
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Figure 2.25 Plot of enzyme activity versus time of exposure of avidin - photobiotin coated SiO, to an ALP 
solution in the presence or absence oflight. Avidin D and photobiotin were immobilised onto wafers of Si02 
as described previously. Wafers were then flood exposed to light in the presence of 100 flg ml-I ALP in PBS 
for varying periods of time. Other "control" samples were exposed to the enzyme for the same periods of time 
but were not exposed to light. After washing in TBS, the ALP activity of all samples was assayed 
colourimetrically using pNPP as the substrate. Enzyme activity related per gram of SiOz was calculated. 
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2.16 Results and Discussion for Light Activated Patterning of Multiple Proteins onto 
Silicon Dioxide surfaces 
2.16.1 Results and discussion for light activated patterning of two immunoglobulins on a 
silicon dioxide surface using an avidin / photobiotin / immunoglobulin construct 
Figure 2.26 demonstrates that the avidin / photobiotin technique can be used to pattern 
multiple proteins site specifically on to a silicon dioxide surface with minimal non-specific 
binding. It should be noted that in Figure 2.26 the TRITC lines are less red than those in for 
example Figure 2.24 owing to the fact that a double exposure (TRITC & FITC filters) was 
needed to obtain the former. This colour change was not due to non-specific binding of the 
FITC probe, as it occurs in the absence of the FITC label. 
..--. 
10.." 
Figure 2.26 Photomicrograph of Silicon dioxide patterned with two fluorescently labelled antibodies. 
Avidin and photobiotin were immobilised as described in Section 2.3 .3. The wafer was then sequentially 
incubated with rabbit IgG and rat IgG whilst eX1'Osed to light through a mask with lO~m interval equal 
mark:space ratio lines. In between the 2 incubations the mask was rotated through 90°. The wafcr was then 
blcoked with casein and incubated in TRITC labelled goat anti-rabbit IgG and FITC labelled rabbit anti-rat 
IgG in PBS, and after washing in PBS and distilled water the sample was dried in a stream of nitrogen and 
examined using fluorescent microscopy. 
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2.16.2 Results and discussion for light activated patterning of five antibodies on a si licon 
dioxide surface using an avidin / photobiotin / immunoglobulin construct 
Figure 2.27 shows a series of photomicrographs demonstrating the sequential patterning of 
different antibodies on a silicon dioxide surface. These photographs demonstrate the 
micrometre scale patterning of5 functional antibodies (along with a sixth protein, casein) 
on to the surface (within an area of200 x 50 flm). This work also demonstrates the 
construction of a qualitative multianalyte immunosensor, which is capable of specifically 
detecting 5 different antigens. 
It should be noted that individual numbers are less intense in the later photomicrographs, as 
the overall amount of fluorescent light has increased and therefore the exposure time has 
decreased. The increased non-specific binding present in the later photomicrographs is due 
to the repeated drying of the substrate followed by addition of fluorescently labelled 
proteins. This was shown by repeating the experiment but not drying the sample in-between 
incubations with anti-species IgG - TRITe conjugates, where it was found that the intensity 
of the background was less than that for a sample that had been dried (note that as the 
sample had not been dried, it was not possible to take a series of sequential 
photomicrographs of pattern development). 
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Figure 2.27 A series of fluorescence photomicrographs demonstrating the sequential patterning of different 
antibodies on a silicon dioxide surface. Polyclonal rabbit antibodies raised against chicken, guinea pig, goat, 
mouse and rat were patterned using the avidin-photobiotin immobilisation method, in each case realigning the 
patterned substrate by means of a registration mark and a CCD camera attached to the microscope. See 
Section 2.6.2 for experimental procedures. 
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2.17 Results and discussion for Demonstration of Li&ht Dependent Couplin& of 
Proteins to a Gold surface 
2.17.1. Results and discussion for demonstration oflight dependent coupling of an enzyme 
to a gold surface 
The results shown in Table 2.2 and Figure 2.28 demonstrate that an enzyme ( in this case, 
GOD) can be patterned on to a gold surface using the avidin photobiotin method, whilst 
retaining its biological activity. Electrodes that had not been exposed to light in the 
presence of GOD showed negligible non-specific binding of the enzyme, whilst electrodes 
that had been incubated with GOD in the presence of light showed a significant response to 
glucose. 
Current 30 seconds after application of 650 mV potential 
fJA (± 1 SD), n=5 
Glucose Concentration Electrode exposed to light Electrode not exposed to 
(mM) light 
0 0.086 (±0.009) 0.089 (±0.010) 
100 0.358 (±0.027) 0.084 (±0.006) 
Table 2.2 Currents obtained from avidin - photobiotin coated gold electrodes which have been incubated 
with GOD in the presence or absence oflight. Experimental details are in the text (Section 2.7) 
95 
6 
5 r-
4 r-
« 
::l 
+oJ 3 r-
£: 
~ 2 L.. I-
::l 
U 
1 r- I 
\. 
0 ... 
i "" ___ 
1 ~~wW~~~-w~,I.,,,~,,,,,,,,I",~um~~,,,I, ~,mw~~~w-__ w-~w-~,~,~~-~ 
- -10 0 10 20 :n 1IO SO ro 70 8) 00 100 110 120 
Time Seconds 
100 mM Light 100 mM Dark 0 mM Light 0 mM Dark 
Figure 2.28 Chronoamperometric responses to glucose of avidin - photobiotin coated gold electrodes which 
have been incubated with GOD in the presence or absence of light. Experimental details are in the text 
(Section 2.7) 
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2.17.2 Results and discussion for demonstration of light dependent coupling of an antibody 
to a gold surface 
Data demonstrated that antibody molecules could successfully be immobilised on to gold 
surfaces using the avidin-photobiotin technique, whilst retaining their functional activity. 
The background currents (± 1 SO, n=5) for electrodes 1 and 2 (which both had rabbit 
anti-rat IgG immobilised on them) were O.079J.lA ± 0.004 and 0.083J.lA ± 0.005 
respectively. The current for electrode 1 which was subsequently incubated with rabbit IgG 
and HRP labelled anti rat IgG (± 1 SO, n=5) was 0.084J.lA ± 0.005 whilst the current for 
electrode 2 which was incubated with rat IgG and HRP labelled anti rat IgG (± I SO, n=5) 
was 0.243J.lA ± 0.021. 
The electrode (with immobilised anti rat IgG) that had been incubated with rabbit IgG 
showed negligible activity as demonstrated by the lack of response using the HRP-anti-rat 
IgG, whilst electrode that had been incubated with rat IgG showed a significant response. 
This work shows the application of the avidin - photobiotin immobilisation technique to the 
construction of a qualitative electrochemical immunosensor for the detection of rat IgG. 
This work was further developed later, as a quantitative immunosensor for FSH and LH 
(see Chapter 3). 
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2.18. Results and Discussion for Light Dependent Coupling of a Protein to a Glass 
Surface 
For the patterning of proteins on a glass substrate, areas of fluorescence were observed 
which matched the mask that had been used (Figure 2.29), however this fluorescent image 
was not as well defined as when using the irnmobilisation procedure on Si02 surfaces, and 
the same degree of resolution could not be obtained. Individual lines could not be observed 
when using a photolithographic mask with equal mark: space ratio lines lOJ-lm in width. A 
pattern of well resolved lines was clearly visible when using this mask and irnmobilisation 
procedure on Si02 substrates (Figure 2.21). The difference in resolution achieved using Si02 
and glass substrates may be due to reflection of the incident light within the glass slide 
causing activation of the photobiotin in areas normally masked from light. 
5O~m 
Figure 2.29 Photomicrograph of glass patterned with a fluorescently labelled antibody. Avidin was 
immobilised as decribed in Section 2.8. The avidin-modified slide was incubated with photobiotin in PBS, 
and was then covered with rat IgG in PBS and exposed to light through a mask with a triangular pattern. 
The wafer was covered with casein in PBS and exposed to light in the absence of a mask. The wafer was 
then incubated in TRITe labelled goat anti-rat IgG in PBS, and after washing in PBS and distilled water the 
sample was dried in a stream of nitrogen and examined using fluorescent microscopy. 
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2.19. Results and Discussion for Li2ht Dependent Couplin2 of a Protein to a Carbon 
Surface 
The results shown in Table 2.3 demonstrate that an enzyme ( in this case, GOD) can be 
patterned on to a glassy carbon surface using the avidin photobiotin method, whilst 
retaining its biological activity. Electrodes that had not been exposed to light in the 
presence of GOD showed negligible non-specific binding of the enzyme, whilst electrodes 
that had been incubated with GOD in the presence of light showed a significant response to 
glucose. The currents for both of the electrodes in the 0 mM glucose, and that in 100 mM 
glucose for the electrode that had been incubated with GOD in the dark were very similar, 
whilst the current for 100 mM glucose with the electrode that had been incubated with 
GOD in the light was significantly increased. 
Current 30 seconds after application of 650 m V 
potential JiA (± lsd), n=5 
Glucose Concentration Electrode exposed to light Electrode kept in dark 
(mM) 
0 0.092 (± 0.006) 0.102 (± 0.011) 
100 0.275 (± 0.0232) 0.094 (± 0.010) 
Table 2.3 Currents obtained from avidin - photobiotin coated glassy carbon electrodes which have been 
incubated with GOD in the presence or absence of light 30 seconds after application of 650 m V potential in 
glucose solutions. Experimental details are provided in the text (Section 2.9) 
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2.20 Results and Discussion for Investi2ation into Reducin2 Non-Specific Bindin2 on 
Gold Surfaces. 
It can be seen from Table 2.4 that the results obtained for Neutravidin and streptavidin are 
very similar, and non-specific binding tends to be lower with these preparations than with 
avidin D. The method ofirnrnobilisation of the avidin has a significant effect on the 
non-specific binding, with thiol mediated linkage (NAC & EDC, DTSSP) providing better 
results than that involving simple adsorption. A significant reduction in non-specific 
binding is seen with the use of all of the blocking agents, but the reduction is greater for 
BSA and casein than for Superblock. A low degree of non-specific binding is obtained 
when irnmobilising either Neutravidin or streptavidin to gold via a thiol, and using either 
BSA or casein as a subsequent blocking reagent 
As has already been discussed, native avidin tends to show a high degree of non-specific 
binding of substances which is usually attributed to two inherent characteristics of the 
molecule, namely the high pI and the presence of carbohydrate residues.18s.191 Streptavidin 
which has a lower carbohydrate content, and deglycosylated avidin both exhibit reduced 
non-specific binding as compared to intact avidin.185.191 The high isoelectric point (pI 10.0 -
10.5) of avidin, as well as the presence of carbohydrate (which accounts for about 10% of 
avidin's total molecular weight) on the protein contribute to non-specific binding in 
applications involving avidin. Due to its more favourable isoelectric point and lack of 
carbohydrate, streptavidin has historically been the accepted substitute for applications 
where the non-specific binding characteristics of avidin are unacceptable. More recently, 
modified forms of avidin such as Neutravidin have become available, with pI values closer 
to 7.0 and reduced carbohydrate contents leading to improved non-specific binding 
characteristics. 192.193 
100 
Normalised NSB % for blocking agent (± 1 sd), n=3 I I 
I 
Preparation of gold surface No blocking BSA Casein Superblock'" 'I 
reagent 
Bare Gold 100 (±3.7) 5 (±0.3) 6 (±Oo4) 23 (±2.7) 
Gold + adsorbed avidin D 17 (±1.0) 3 (±0.3) 4 (±0.3) 5 (±OA) 
Gold + adsorbed 14 (±0.9) 4 (±Oo4) 5 (±0.3) 7 (±0.5) 
Streptavidin 
Gold + adsorbed Neutravidin 15 (±0.7) 3 (±0.3) 6 (±Oo4) 8 (±0.6) 
Au + avidin D linked by 15 (±0.8) 6 (±0.3) 7 (±0.5) 9 (±0.5) 
NAC& EDC 
Au + Streptavidin linked by 8 (±0.3) 3 (±0.3) 3 (±0.2) 5 (±0.3) 
NAC& EDC 
Au + Neutravidin linked by 10 (± 004) 2 (±0.2) 3 (±0.3) 5 (±OA) 
NAC&EDC 
Au + avidin D linked by 13 (±1.0) 5 (±0.3) 4 (±0.2) 4 (±0.3) 
DTSSP 
Au + Streptavidin linked by 9 (±0.7) 1 (±O.O) 3 (±0.2) 3 (±0.3) 
DTSSP 
Au + Neutravidin linked by 7 (±0.5) 1 (±O.l) 2 (±O.2) 4 (±O.4) 
DTSSP 
Table 2.4 Non-specific binding to treated gold electrodes after 15 minutes exposure to JgG - ALP conjugate. 
Different avidin preparations and blocking agents were immobilised as summarised in the table. The gold 
electrodes were then washed in TBS and incubated in 10 flg mI-) rabbit IgG - ALP in TBS for 15 minutes at 
room temperature. The samples were washed extensively in TBS and ALP activity was determined 
colourimetrically using pNPP as the substrate. 
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2.21 Results and Discussion to Investia:ate Rea:eneration of Avidinated Surfaces 
2.21.1 Results and discussion to investigate regeneration of avidinated silicon dioxide 
surfaces 
As can be seen from the results in Figure 2.30 and Table 2.5, the patterned protein is 
resistant to treatment with Hel solution (PH 1.5) and 10 M urea solution (i.e. the pattern is 
still visible after treatment with these agents), although it should be noted that treatment 
with these solutions may denature the protein and render it non-functional. No change in the 
patterned protein is observed for the control treatment (incubation with PBS). Patterned 
protein is not resistant to treatment (i.e. the pattern is no longer visible after treatment) with 
NaOH solution (PH 12), but the inability to repattem the surface would indicate that a 
specific cleavage of the avidin photobiotin bond is not responsible. The high degree of 
non-specific binding observed when repatteming is attempted, suggests that this protocol 
either removes avidin and blocking proteins from the surface, or that it denatures them such 
that they no longer form an effective barrier to non-specific binding. Patterned protein is not 
resistant to treatment with 6M guanidine at low pH, and the fact that it is possible to 
repattem the surface demonstrates that it is the avidin photobiotin bond that is being broken. 
Treatment with guanidine has previously been shown to be able to break the avidin biotin 
bond.218 The ability to break the avidin - photobiotin bond with the use of guanidine, means 
that it is possible to regenerate the avidinated surface and to repattern using photobiotin, 
which would be advantageous if one was using expensive sensor elements that one wished 
to reuse. 
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2.21 Results and Discussion to Investieate Reeeneration of Avidinated Surfaces 
Pre-treatment Post-treatment Post repatterning 
a 
b 
c 
d 
e 
Figure 2.30 Fluorescent photomicrographs of attempts to regenerate avidinated SiO, surfaces. Patterns of rabbit IgG 
were generated on the surface using the avidin-photobiotin technique (detailed in Section2.11 .1) The wafer was 
incubated in TRITe labelled goat anti-rabbit IgG in PBS, and examined using fluorescent microscopy. The surface then 
underwent a number of treatments; a) Incubation in NaOH solution pH 12. b) Incubation in Hel solution pH 1.5. c) 
Incubation in 6M guanidine in Hel solution pH 1.5. d) Incubation in 10M urea. e) Incubation in PBS (all for 16 hours). 
The surfaces were washed in water, dried under nitrogen and examined using fluorescence microscopy. The treated 
Si02 was re-incubated with photobiotin and subjected to repatterning with rat IgG and BSA as described previously. 
The presence of rat IgG was visualised by the addition of rabbit anti-rat IgG - FITC conjugate, and the samples were 
examined using fluorescence microscopy. 
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Treatment Description of surfaces seen by fluorescence microscopy 
(surface incubated in Pre Treatment Post Treatmen t Post repatterning 
solution for 16 hours) 
NaOH pH 12 Rabbit IgG pattern No pattern No pattern. Bright 
background 
indicating high 
degree ofNSB 
Hel pH 1.5 Rabbit IgG pattern Rabbit IgG pattern Rabbit IgG pattern 
6M guanidine, Rabbit IgG pattern No pattern Rat IgG pattern. 
pH 1.5 Indicates regeneration 
of avidinated surface. 
10M urea Rabbit IgG pattern Rabbit IgG pattern Rabbit IgG pattern 
PBS Rabbit IgG pattern Rabbit IgG pattern Rabbit IgG pattern 
Table 2.5 Summary of results from procedures to attempt regeneration of avidinated surfaces. Patterns of 
rabbit IgG were generated on the surface using the avidin-photobiotin technique (detailed in Section 2.11.1) 
The wafer was incubated in TRITe labelled goat anti-rabbit IgG in PBS, and examined using fluorescent 
microscopy. The surface then underwent a number of treatments summarised in the table. The surfaces were 
washed in water, dried under nitrogen and examined using fluorescence microscopy. The treated Si02 was 
re-incubated with photobiotin and subjected to repatterning with rat IgG and BSA as described in Section 
2.11.1. The presence of rat IgG was visualised by the addition of rabbit anti-rat IgG - FITC conjugate, and the 
samples were examined using fluorescence microscopy. 
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2.21.2 Results and discussion to investigate regeneration of avidinated gold surfaces 
The data shown in Table 2.6 demonstrates that guanidine can be used to repattem proteins 
immobilised on gold surfaces using the avidin-photobiotin technique. The selectivity of the 
guanidine treated electrodes has changed, whilst that ofthe controls that were incubated in 
PBS has not. 
Electrode Treatment Current (J.1A) 30 seconds after the application of 150 
mV potential, for electrodes exposed to different 
antigens 
Electrode 1 Electrode 2 Electrode 3 Electrode 4 
(Rat IgG as (Rabbit IgG as (Rat IgG as Ag) (Rabbit IgG as 
Ag) Ag) Ag) 
None (Background current) 0.08 0.09 0.08 0.08 
Incubation with antigen and 0.31 0.10 0.31 0.09 
HRP - anti rat IgG 
Treatment with guanidine and 0.09 0.08 - -
repatteming 
Treatment with PBS and 
- -
0.30 0.09 
repatteming (control) 
Treatment with guanidine, 0.09 0.35 - -
repatteming , incubation with 
antigen and HRP - anti rabbit 
IgG 
Treatment with PBS, 
- -
0.32 0.11 
repatteming , incubation with 
antigen and HRP - anti rabbit 
IgG (control) 
Table 2.6 Currents obtained from ~old electrodes pre and post r~patteming antibodies using guanidine. 
Experimental details are provided in the text (Section 2.11). This data indicates that avidin -photobiotin 
modified gold surfaces can be regenerated using guanidine, thus allowing repat1eming to take place. 
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2.22 Results and Discussion for Characterisation of Biomolecular Patterns usini: 
Atomic Force Microscopy and Fluorescence Microscopy. 
Figures 2.33 and 2.35 demonstrate that protein patterns formed by use of the 
avidin-photobiotin immobilisation technique can be imaged using atomic-force microscopy. 
In Figure 2.34, the difference in the height between a peak (consisting of two IgOs 
assembled onto an avidin layer) and a trough (consisting of casein on avidin) can be 
estimated as approximately 7nm, which is less than would be expected on the basis of 
crystallographic data.219 This may be explained by the random orientation the molecules are 
likely to take, alternatively the relatively large tip force necessary to obtain these images 
which is likely to distort the molecules significantly during imaging.216•217 It should be noted 
that in Figure 2.32 (a cross-sectional profile through the fluorescent photomicrograph in 
Figure 2.31) no significance can be attributed to the arbitrary units for relative fluorescent 
intensity with respect to the height of the pattern in the z direction. 
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Figure 2.31 . 2 - dimensional fluorescence micrograph of TRITC labelled IgG bound by a patterned 
complementary antibody. The patterning procedure is detailed in the tex1 (Section 2.12). Following the protein 
immobilisation procedure, the wafer was incubated in TRITC labelled rabbit anti-rat IgG. After washing the 
sample was dried in a stream of nitrogen and examined using fluorescent microscopy. 
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Figure 2.32 Cross sectional profile through the pattern between points A and B marked in Figure 2.3l. 
Patterned proteins were visualised by the addition of fluorescently labelled antibodies, and resolution was 
examined by measurement of the relative fluorescent intensity across the pattern. The relative fluorescent 
intensity was determined by taking the brightest point (i.e. greatest fluorescence) on a line across the pattern as 
100. A fluorescent intensity of 0 was set as a point that would show no fluorescence (i.e. totally black). The 
fluorescent intensity of each point on the lines was determined by interpolation between these 2 ex1remes. 
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Figure 2.33.2 - dimensional AFM image of the same pattern as in Figure 2.31. The patterning procedure is 
detailed in the text (Section 2.12). The pattern of antibodies was imaged using AFM, images were obtained 
using a Burleigh Personal AFM with Si tips (spring constant 0.045 nM m·l , with a tip radius of 10 nm and an 
aspect ratio of approximately 4: 1, Imaging was carried out in air at ambient temperature and humidity with 
an imaging force maintained at approximately 5 nN. 
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Figure 2.34. cross sectional profile through the pattern between points A and B marked in Figure 2.33 . The 
plot was constructed from numerical data produced by the Burleigh AFM software. 
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Figur~ 2.35 3-dimensional reconstruction from AFM data of an area of a protein patterned surface. The 
patterning procedure is detailed in the text (Section 2.12). The pattern of antibodies was imaged using AFM, 
as detailed in the text (Section 2.12). 
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CHAPTER 3 
Question your desires, 
Know of your youth, 
Examine well your blood 
William Shakespeare 
A Midsummer Nights Dream 
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3 Simultaneous Determination of FSH and LH usine a Multianalyte Immunosensor 
The aim of the work described in this chapter of the thesis was to demonstrate the 
application of avidin-photobiotin technology by constructing a multianalyte immunosensor 
for the simultaneous assay for follicle stimulating hormone (FSH) and luteinising honnone 
(LH). In this respect the measurement ofFSH and LH was an attractive model system, as in 
clinical analysis, the determination of these hormones is usually requested simultaneously. 
Additionally, both FSH and LH are normally assayed by heterogeneous immunoassay, 
thereby providing techniques which could be readily adapted to use with devices fabricated 
in the course of this work. 
3.1 Follicle Stimulatine Hormone and Luteinisine Hormone 
Follicle stimulating hormone (FSH) and luteinising hormone (LH) are both glycoprotein 
hormones, with relative molecular masses of approximately 34,000 and 28,500 
respectively.220 Both hormones contain a and J3 subunits, the a subunits are identical in the 
two hormones and consist of a single polypeptide chain containing 89 amino acids and two 
carbohydrate side chains. The amino acid sequences of the a subunits are also common 
with those of the other glycoprotein hormones, thyroid stimulating hormone (TSH) and 
human chorionic gonadotrophin (hCG).221 The ~ chains ofFSH and LH contain 
polypeptide chains of 118 and 115 amino acids, respectively, but with little homology, and 
the associated carbohydrate chains also differ,m the carbohydrate content ofFSH is 
approximately 30% whilst that of LH is about 15%. The ~ side chain found in LH is very 
similar to that found in hCG.m 
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3.1.1 Physiological function ofFSH and LH. 
FSH and LH are present in both males and females, and are secreted by the anterior 
pituitary under the control of the hypothalamus.222 Secretion is subject to negative and 
positive feedback at both the hypothalamus and the pituitary by the secretory products of 
the gonads. The hypothalamic control ofFSH and LH release (Figure 3.1) is by means ofa 
decapeptide, gonadotrophin releasing hormone (ORR). 
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Figure 3.1 Schematic diagram illustrating production of gonadotrophin releasing hormone (GRH) by the 
hypothalamus which stimulates production ofFSH and LH by the pituitary, which in turn timulate the 
production of hormones by the gonadal ti sue. Androgens and inhibin exert a negative feedback influence on 
the release of the gonadotrophins (LH and FSH), whereas oestradiol and progesterone can exert either a 
positive or negative feedback influence in females, dependent upon the time in the menstrual cycle. 
Before puberty, FSH and LH production is low, but an early sign of puberty is fluctuating 
but sub-threshold secretion of both of these hormones. Once sustained secretion of 
supra-threshold hormonal levels occurs, gonadal growth in both sexes occurs. FSH and LH 
are responsible for the development of secondary sexual characteristics in both sexes, and 
for the onset of menstruation in females, these hormones are therefore referred to as 
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gonadotrophins. In females of reproductive age FSH and LH levels change during the 
course of the menstrual cycle as illustrated in Figure 3.2. 
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Figure 3.2 Typical plasma FSH and LH concentrations during the menstrual cycle.223 The average length of 
the menstrual cycle is 28 days, the first day being the onset of menstrual flow, with ovulation occurring 
around day l4. At the start of the cycle the anterior pituitary releases increased quantities ofFSH and LH in 
response to low circulating blood concentrations of oestradiol and progesterone. FSH in particular stimulates 
the development of ovarian follicle, as ovulation approaches the follicle produces high concentrations of 
oestradiol which, via positive feedback, cause a surge in FSH and LH release. This increased FSH and LH 
concentration results in rupture of the follicle, and the release of the ovum. Following ovulation oestradiol 
levels decrease, whilst progesterone levels increase reaching a maximum around day 21 of the cycle, at which 
time a second peak in oestradiol secretion occurs. The high circulating levels of progesterone and oestradiol 
inhibits the release ofFSH and LH, the levels of which fall. 
113 
The average length of the menstrual cycle is 28 days, the first day being the onset of 
menstrual flow with ovulation occurring around day 14. At the start of the cycle the anterior 
pituitary releases increased quantities ofFSH and LH in response to low circulating blood 
concentrations of the gonadal steroid hormones, oestradiol and progesterone. FSH in 
particular stimulates the development of ovarian follicle. As ovulation approaches the 
follicle produces high concentrations of oestradiol which, via positive feedback, causes a 
surge in FSH and LH release. This increased FSH and LH concentration results in a growth 
spurt and rupture of the follicle, and the release ofthe ovum. Under the influence of LH 
(and to a lesser extent FSH), the ruptured follicle develops into the corpus luteum. The 
corpus luteum is the major source of the gonadal steroids during the post-ovulatory (luteal) 
phase of the cycle, which causes development and thickening of the endometrium in 
readiness for pregnancy. 
Following ovulation oestradiol levels start to decrease, whilst progesterone levels increase 
reaching a maximum at around day 21 of the cycle, at which time a second peak in 
oestradiol secretion occurs. The high circulating levels of progesterone and oestradiol 
inhibits the release ofFSH and LH, and the corpus luteum which is reliant on LH for 
support decays. As the corpus luteum decays there is a marked decrease in oestradiol and 
progesterone secretion, and there is an associated sloughing and haemorrhage of the 
superficial layers of the endometrium and the cycle ends. If fertilisation does occur, the 
corpus luteum persists maintained by chorionic gonadotrophin (as already mentioned LH 
and heG are very similar). 
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In males FSH stimulates the growth of the seminiferous tubules and maintains 
spermatogenesis, whilst LH promotes the secretion of androgens by the interstitial (Leydig) 
cells, hence LH's alternative name, interstitial cell stimulating hormone (lCSH). 
Plasma FSH and LH levels increase with age in both sexes. In females this increase is 
associated with dwindling ovarian function, and the decreased effectiveness of negative 
feedback control by the gonadal steroid hormones. Upon the onset of the menopause 
atypical values are frequently measured, often with peak concentrations at the beginning 
and end of each cycle. Post menopausal plasma FSH and LH concentrations are increased 
and remain elevated.m .m Males do not show such an abrupt increase in levels, but older 
men tend to have a higher output of FSH.224 
3.1.2 Diagnostic utility of FSH and LH 
The determination ofLH and FSH is of use in investigating male infertility. The majority of 
male infertility cases are eugonadotrophic with normal or slightly decreased LH and FSH 
levels, the infertility being a result of oligospermia due to failure of the seminiferous 
tubules. In hypergonadotrophic (primary) hypogonadism, the primary abnormality is in the 
testes. An increased LH indicates that there is failure of function ofthe Leydig cells, 
whereas an increased FSH indicates that there is a defect in the function of the Sertoli cells 
ofthe seminiferous tubules. In hypogonadotrophic (secondary) hypogonadism the primary 
abnormality is in the hypothalamus or pituitary, LH levels are low, and usually FSH levels 
are also decreased. The measurement of the gonadotrophins is important in being able to 
distinguish between hypergonadotrophic and hypogonadotrophic hypogonadism, as in both 
cases testosterone levels are low.222,22s 
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The measurement ofFSH and LH is most frequently used as a "fertility test" in women, or 
to differentiate between primary and secondary hypogonadism. Again in primary 
hypogonadism, the gonadotrophins will be increased due to negative feedback. Primary 
hypogonadism with a raised FSH and LH and low oestrogens is indicative of primary 
failure (which may be due to a chromosomal abnormality, autoimmune disease or 
idiopathic). An elevated LH with associated increased oestrogen levels, but a decreased or 
"low normal" FSH is indicative of polycystic ovary disease. In secondary hypogonadism 
low levels ofFSH, LH and oestrogens are found, and in this case the abnormality is in the 
hypothalamus or pituitary or secondary to another endocrine disorder. 222,225 
The determination ofLH and FSH is a "first line" test in the investigation of infertility in 
both males and females. Stimulation tests, where a stimulus is applied to the system and 
the resultant change in gonadotrophin levels is monitored, can be of use in the investigation 
of infertility for both sexes.22S 
LH levels, in particular, are frequently needed for immediate decision making for assisted 
conception techniques, and there is a need for reliable assays where results can be made 
available within two to three hours of sampling.226 These tests are to determine when 
ovulation has occurred and to increase the chance of conception by monitoring the surge in 
gonadotrophin levels. 
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3.2 Review of Assay Methods Available for the Assay of FSH and LH 
3.2.1 In vivo bioassays 
A number of in vivo bioassays have been used for the determination ofLH and FSH. LH 
has been measured by monitoring the weight increase of the ventral prostate of 
hypophysectomised immature male rats after administration of the sample preparation.227 
Similarly, the weight increase of the seminal vesicles in intact or hypophysectomised 
immature rats has also been used,228,229 as the increase in weight is dependent upon the LH 
concentration in the sample. An alternative in vivo bioassay for LH was the ovarian ascorbic 
acid depletion assay. In this procedure immature female rats were pre-treated with pregnant 
mare's serum gonadotrophin and hCG. After the injection of the LH containing sample, the 
rat's ovaries were dissected and ascorbic acid, the concentration of which was related to the 
LH concentration, was determined.230 FSH has been determined by monitoring the weight 
increase of rodent ovaries, when excess LH or hCG is administered simultaneously with the 
FSH containing test material.23\,232 
3.2.2 In vitro bioassays 
LH has been assayed by monitoring the steroidogenic response of gonadal tissue. Either the 
production of progesterone by ovarian tissue 233,234 or testosterone by testicular interstitial 
cells23s.239 can be used, the progesterone or testosterone produced being assayed by 
radioimmunoassay. LH has also been determined by combining the ovarian ascorbic acid 
depletion test with histochemical techniques, the reducing activity of ovarian slices was 
assessed by staining with Prussian blue and performing microdensitometry.24o The 
measurement of oestradiol production by cultured Sertoli cells provides an assay for FSH.241 
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In vitro radioreceptor assays exist for the assay of both LH242-244 and FSH_ 245,246 
Radioreceptor assays depend on the competition for binding sites on gonadal tissue 
preparations, between the analyte in the test material and a tracer amount of radio labelled 
hormone. The bound analyte and tracer are separated from the unbound fraction by 
centrifugation. The radioactivity in the bound fraction is inversely proportional to the 
concentration of the analyte in the test material. 
3.2.3 Haemagglutination assays 
The haemagglutination assay is a semi-quantitative test that is capable of distinguishing 
samples with very elevated analyte levels, from those normally encountered. The principle 
of the assay is that red blood cells are coated with antibodies raised against the analyte. 
Upon addition ofthe sample, the analyte is bound to the antibodies and therefore to the red 
blood cells. Each analyte molecule, has multiple antigenic sites. therefore when the 
substance being measured is in high concentration, "cross-linking" of the blood cells occurs 
and an agglutination pattern is observed which can be visually differentiated from 
normals.247 The main advantages of haem agglutination assays are that they do not require 
specialist equipment, are relatively rapid to perform and are cheap. The major disadvantage 
is that they provide only very limited information, and will miss many cases which a fully 
quantitative assay would identify. However, haemagglutination assays for gonadotrophins 
have been developed, and are commercially available.248 
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3.2.4 Radioimmunoassay 
FSH and LH have been measured by radioimmunoassay (RIA). This procedure uses 
radioisotopes as tracers to monitor the distribution of free and bound antigen in the presence 
of a known quantity of antibody. RIA depends on the competition for antibody binding sites 
between unlabelled antigen (Ag) in the sample and a known amount of added labelled 
antigen (Ag*). As long as the antibody is not in excess, there is competition between the 
reactions in equations 3.1 and 3.2. The greater the amount of unlabelled antigen in the 
sample, the lower the amount oflabelled antigen (and therefore, radioactivity) that is bound 
by the antibody (Figure 3.3). Separation of bound and free tracer has been achieved by 
centrifugation,249-252 ethanol precipitation,253 filtration254 and electrophoresis.255 
Ab+Ag <::>.1bAg (3.1) 
Ab+Ag* <::>AbAg* (3.2) 
Log Antigen Concentration 
Figure 3.3 shows the semi-logarithmic dose response curve obtained in radioimmunoassay. This procedure 
uses radioisotopes as tracers to monitor the distribution of free and bound antigen in the presence of a limited 
quantity of antibody. RIA depends on the competition for antibody binding sites between unlabelled antigen 
in the sample and a known amount of added labelled antigen. The greater the amount of unlabelled antigen in 
the sample, the lower the amount oflabelled antigen (and therefore, radioactivity) that is bound by the 
antibody. 
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Early RIA methods249-252.254.255 used 131iodine as the radiolabel, which decays by p and y 
emission. The half life (ty.) of this isotope is 8.05 days and consequently it has a higher 
activity than 125 iodine, which decays with the production of y radiation and has a half life of 
60.2 days. The longer shelflife of 1251, due to it's slower rate of decay, has meant that this is 
the most frequently used radiolabel in immunoassay.256.m Occasionally, the incorporation 
of iodine (a relatively large atom) into the structure of the antigen results in steric hindrance 
of the antibody-antigen reaction/58 and in these cases 3H is frequently used as the radiolabcl 
(p emitter, ty,= 12.3 years). 
Prior to the advent of monoclonal antibodies, great problems were encountered in obtaining 
specific antibodies that did not cross react with other glycoprotein hormones.253 In most 
immunoassays for LH there was considerable cross-reactivity with hCG,m due to their 
structural similarities. This cross reactivity was exploited in early RIA methods for LH 
where antibodies against heG were used as the basis of the assay, or more commonly 
radiolabelled hCG was used for the tracer and unlabelled hCG was used for standards.24Y.254 
Numerous RIA methods have been developed for the determination of LH and FSH levels 
and are commercially available.2S7·260-262 
Radioimmunoassay is generally labour intensive and time consuming, although in recent 
years automated sample processing systems have reduced the labour required, and the time 
taken to obtain a result,263-265 however they still require operation by highly trained staff. 
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3.2.5 Immunoradiometric assay 
Immunoradiometric assay (lRMA)266 is a non-competitive technique where an excess of 
radio labelled antibody against the analyte is added to the sample. Separation of free and 
antigen-bound radiolabelled antibody is performed by the addition of a second antibody 
(immobilised on a solid phase) which is also directed against the antigen. After removal of 
the radio labelled antibody by washing, the quantity of radio labelled antibody bound to the 
solid phase is proportional to the antigen concentration in the sample (Figure 3.4). Due to 
the low background activity, IRMA techniques tend to have lower detection limits than 
their RIA counterparts. Numerous IRMA methods have been developed for the 
determination ofLH and FSH levels and are commercially available.261.262. 267-271 
Log Antigen Concentration 
Fiaure 3.4 Semi-Ioaaritbmic dose remonse curve of an irnmunoradiornetric assay. Immunoradiornetric assay 
is a non-competitive technique where an excess of radiolabelled antibody against the analyte is added to the 
sample. Separation of free and antigen-bound radiolabelled antibody is performed by the addition of a second 
antibody (iromobilised on a solid phase) which is also directed against the antigen. After removal of excess 
radiolabelled antibody by washing, the quantity of radio labelled antibody bound to the solid phase is 
proportional to the antigen concentration in the sample. 
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3.2.6 Dual Radioisotopic assay 
y Radiation from different radioisotopes display different energy spectra, therefore it is 
possible to measure 2 analytes simultaneously by differentiating radioactivity arising from 
two different labels.272 These types of assay are most appropriate for the measurement 0 f 
those analytes that are measured in the same sample such as FSH / LH, TSH / thyroxine and 
Vitamin B12 / folate.2S7 
3.2.7 Non-Isotopic immunoassays 
As has already been discussed, in recent years there has been a move away from the use of 
radioactive labels, and they have largely been replaced by amongst others luminescent,273 
fluorescent,93 and enzymatic labels.94•9s These non-isotopic labels possess a number of 
advantages such as safety, longer shelf life, shorter assay time, easier automation, 
improved detection limits and they introduce the possibility of developing disposable 
devices that can be used to perform near-patient testing. 
3.2.7.1 Enzymatic immunoassay 
Enzymes are the most widely used labels in immunoassays, the reactions can be followed 
colourimetrically, fluorimetrically, electrochemically, calorimetrically, or by using 
luminescence. Like other immunoassays, those using enzymes can be classified into two 
types, heterogeneous and homogeneous. In heterogeneous enzyme immunoassay, after the 
antibody and antigen have been incubated together, a step is required to separate the free 
antigen and antibody from the antibody-antigen complexes. The enzymic activity of one or 
both of these fractions is then assessed. The most common heterogeneous enzyme 
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immunoassay is enzyme-linked immunosorbent assay (ELISA). In this technique either the 
antigen or the antibody can be labelled with the enzyme. In the so called 'Sandwich' ELISA 
assay, an excess ofimmobilised antibody is incubated with the sample and the antigen 
binds with the immobilised antibody. After washing away the unbound sample constituents 
the immobilised antibody-antigen complex is incubated with excess enzyme-labelled 
antibody. This enzyme labelled antibody binds to a second antigenic site and excess 
enzyme-labelled antibody is washed off, therefore the remaining enzyme activity is directly 
proportional to the antigen concentration. A typical ELISA dose response curve is shown in 
Figure 3.5 
Log Antigen Concentration 
Figure 3.5 Typical semi-logarithmic dose reSJ)onse curve for a "sandwich" ELISA. In this technique an excess 
ofirnrnobilised antibody is incubated with the sample and the antigen binds with the immobilised antibody. 
After washing away the unbound sample constituents the immobilised antibody-antigen complex is incubated 
with excess enzyme-labelled antibody. This enzyme labelled antibody binds to a second antigenic site and 
excess enzyme-labelled antibody is washed off, therefore the remaining enzyme activity is directly 
proportional to the antigen concentration. 
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In homogeneous enzyme immunoassays (enzyme multiplied immunoassay technique 
(EMIT)), a separation process is not required, as the antigen-coupled enzyme activity 
changes when bound to an antibody. When the sample is added to this system, less of the 
antigen-enzyme conjugate will bind to the antibody, as it is in competition for the antibody 
binding sites with free antigen from the sample, therefore the change in enzymic activity is 
inhibited. A typical EMIT dose response curve is shown in Figure 3.6. ELISA is generally 
applicable to the measurement of almost any antigen, and can detect substances at much 
lower concentrations than can EMIT largely due to the lower inherent background signal for 
ELISA. 
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Fi&ure 3.6 mical semi-Io~arithmic dose response curve for an EMIT assay. In this technique a known 
amount of an antigen-enzyme conjugate is added to the sample in the presence of a limited amount of 
antibody, therefore there is competition for the antibody between the antigen present in the sample and the 
antigen-enzyme conjugate. If the antigen-enzyme conjugate is bound by the antibody then the enzymic 
activity is inhibited. The greater the amount of antigen in the sample, the less antigen-enzyme conjugate is 
bound and therefore there is less inhibition. The result is that the greater the antigen concentration in the 
sample the greater the enzymic activity. 
124 
In assays using colourimetric measurement of enzyme labels, the enzyme action results in a 
change in absorbance of one of the components of the reaction, similarly fluorimetric assays 
detect a change in the concentration of a fluorescent component of the reaction. 
Colourimetric94.95.274.276 and fluorimetric277.278 enzyme immunoassays have been developed 
for the determination of FSH and LH. Likewise, electrochemical enzyme immunoassays 
have been developed which measure a change in electroactive species within the reaction 
mixture as a result of enzyme activity. For example, both amperometric29 and 
potentiometric35 enzyme irnmunoassays have been developed for hCG, which as has already 
been mentioned, is similarly very similar to LH. Finally, calorimetric assays, that use a 
thermistor which detects the heat generated by enzymatic reactions,74.75 have been used for 
immunological analysis by labelling antibodies with enzymes.77•78 Luminescence detection 
of enzyme labels is discussed in section 3.2.7.3 
3.2.7.2 Fluorescence Immunoassay 
Fluorescent labels can be used for immunoassay, again classification into homogeneous and 
heterogeneous assays can be made. In homogeneous fluorimmunoassays the properties of 
the label are modified upon the antibody-antigen reaction taking place. This modification to 
the signal can be in the form of enhancement, quenching or a change in polarisation.279 In 
classical heterogeneous fluorirnmunoassays. either antigen or antibody is labelled and 
assays are performed according to the principles of heterogeneous immunoassays that have 
already been described. These assays have tended to suffer from problems such as light 
scattering. quenching and background fluorescence, which has limited their use. However, 
the use of time-resolved fluorescence techniques has provided methods which are viable 
alternatives to other detection techniques, and are now commonly used. 
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Time-resolved fluorescence techniques (e.g. dissociation enhanced lanthanide fluorimetric 
immunoassay (DELFIA))280 are based upon the long fluorescent half life of europium 
chelates. The excitation light is in the form of a flash lasting less than a microsecond, the 
background fluorescence due to endogenous material in the sample decays rapidly with a 
half life of less than 50 nanoseconds. Measurement of the fluorescence arising from the 
europium ion can be measured after hundreds of microseconds. Time-resolved fluorescence 
techniques for the determination ofFSH and LH are commercially available and widely 
used.248.260.261.281 
3.2.7.3 Luminescence immunoassay 
Luminescence is a tenn that encompasses a range of processes which produce light. 
Luminescence, in the fonns of chemiluminscence and bioluminescence are increasingly 
being used to monitor immunological reactions. Chemiluminescence is the emission of light 
as a result of a chemical reaction, bioluminescence is where the catalytic activity of a 
protein increases the efficiency of a chemiluminscent process. Luminescence has been used 
both as a label in its own right, and in reactions involving an enzymatic label. Luminescent 
reactions are very sensitive and have very low detection limits, as no external light source is 
required, all the light falling on the detector originates from the luminescent reaction. This 
means that the background signal is essentially zero, and that detection of a single photon 
produced in a luminescence reaction is possible.273 In assays where a luminescent molecule 
itself is used to label an antibody or antigen, light is generated by the provision of a 
stimulus to the luminescent molecule, for example in Figure 3.7, the addition of an 
oxidising agent to luminol results in its conversion to aminopthalate with the production of 
light. In assays where an enzyme is used as the label, there is a catalytic conversion of the 
solution phase luminescent molecule For example in Figure 3.7 horseradish peroxidase can 
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catalyse the conversion of luminol to aminopthalate. Commercial assays based on the 
measurement ofluminescence are available for both FSH and LH.257.282-2H5 
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Figure 3.7 Scheme for the chemiluminescent oxidation of luminol. 
3.2.8 Near-patient tests 
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Rapid near-patient tests for the assay ofLH have been developed, and are commercially 
available.248 These tests are designed to determine when ovulation has occurred by 
monitoring the LH surge. This information can be used to increase the chance of pregnancy 
by predicting when a woman is most likely to conceive, but perhaps the most useful 
application of rapid gonadotrophin measurements is in assisted conception. The availability 
of a simple and rapid assay makes possible successful and precise timing of ovulation 
during artificial insemination or ovum retrieval for in-vitro fertilisation (IVF) procedures in 
treatment for infertility.286 One such near-patient device is the OvukitTM (formerly known 
as the Ovutest™), which is a semi-quantitative assay system based upon 
immunochromatography (the basis of the majority of pregnancy tests). In the OvukitTM an 
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antibody specific for LH is immobilised as a line on a membrane. The sample (urine) is 
applied to one end of the membrane, and "wicks" along the length of the membrane and 
any LH in the sample is "captured" by the immobilised antibody. A similar device is the 
Unipath ClearPlan One Step ™ device, this easy to use device can provide a result in just 3 
minutes. Visualisation is by means of a conjugate which produces a coloured line visible to 
the naked eye, if the levels ofLH are above a threshold level. 287 .288 The assay is optimised so 
that a positive result is only obtained during the LH surge, and therefore indicates that 
ovulation is occurring. 
3.3 Amperometry 
The immunosensor constructed in this work was an amperometric sensor, in which an 
electdcal potential is applied to a sensor electrode, which facilitates reduction or oxidation 
of electroactive species at the electrode-solution interface. This "redox" reaction involves 
the transfer of electrons between the electrode and the electroactive species, with a current 
being produced which is proportional to the concentration of the electrochemical species at 
the electrode surface. As has already been described, amperometric transducers have been 
very widely used in biosensing, particularly systems based upon oxygen or hydrogen 
peroxide electrodes, where the current produced is directly proportional to the amount of 
oxygen or hydrogen peroxide reduced or oxidised at the electrode. This approach has high 
sensitivity and a linear concentration dependence over a given concentration range, and 
improved selectivity over interferents can be obtained by careful choice of the electrode 
potential. Many molecules (such as proteins) are not intrinsically electroactive, and 
therefore it is frequently necessary to introduce enzymic labels which can catalyse redox 
reactions and produce electroactive species. Amperometric sensing of immunological 
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reactions can be performed by using an immobilised antibody to bind the analyte at the 
electrode surface, and then adding a second enzyme labelled antibody which is also directed 
against the analyte. 
In amperometric devices the basic requirement is to be able to maintain a working electrode 
at a constant potential and measure any resultant current. This can best be achieved using a 
three electrode system, with a working electrode being maintained at a constant potential 
with respect to a reference electrode, whilst allowing current to flow between the working 
electrode and a counter electrode in solution. When the size of the current is small « flA 
cm·2), the configuration can be simplified by removing the counter electrode, and allow the 
(measured) current to return via a combined reference/counter electrode. 
The observed current is a combination of capacitive or "non-Faradaic" currents (which are 
due to the physical rearrangements of ions in the double layer) and the Faradaic current 
(which is due to redox reactions). The Faradaic current is a direct measure of the rate of the 
electrochemical reaction taking place at the electrode. In practice this will depend upon two 
dominating factors; the rate at which the material arrives at the electrode surface from the 
bulk solution (mass transport) and the rate at which electrons transfer between the electrode 
and the electroactive species (charge transfer), which is described by the Butler Volmer 
equation,289 and relates to the extent of electron transfer to the applied overpotential and the 
transfer coefficient. 
Mass transport comprises of three components; diffusion, migration and convection. 
Diffusion is the dispersion of a species within another species, tending to a homogeneous 
mixture without chemical combination (i.e. movement "down" a concentration gradient). 
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Migration is the movement of charged species in an electric field, and is therefore 
dependent upon the magnitude of the field and the charge on the ion. Convection is the 
movement ofanalyte molecules due to inducing the physical movement of the bulk solution 
(e.g. stirring). These three components of mass transport to the electrode are described (in 
one dimension) by the Nemst-Planck equation.289 If the migrational and convectional 
contributions to the mass transport flux can be eliminated then the steady state diffusion 
limited current can be determined as in equation 3.1. For the elimination of convective 
transport, all that is required is to keep the solution quiescent, whilst the addition of a 
supporting electrolyte at a concentration 100 times that of the electroactive species, 
essentially eliminates migration by dissipating the electric field over all of the ions in 
solution, thus "shielding" those ions of interest from electro-migrational forces). 
;(t) = nF AD c5C~;.I) 1,r-o (3.1 ) 
where n is the number of electrons involved in the reaction (Faraday equivalents mol· I ), A 
is the electrode area, (cm2), D is the diffusion coefficient (cm2 S·I), C is the concentration 
(mol cm·3) and F= 96,484.6 C Faraday' I • 
3.3.1 Chronoamperometrv 
Chronoamperometry is a technique where an applied potential is stepped from an initial 
value to a different value at which the potential is held for a period of time (i.e. a square 
wave). The resultant current is recorded as a function of time. A typical 
chronoamperometric response curve displays a sharp current spike (at the time at which the 
potential step occurs and consisting of both Faradaic and non-Faradaic components) which 
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decays with time. In chronoamperometry, the applied potential is sufficient to reduce the 
electrode surface concentration of the electroactive species essentially to zero.289 The effect 
of the capacitive current becomes less evident with time and the Faradaic current (which is 
a direct measure of the rate of the electrochemical reaction taking place at the electrode) 
dominates. Typical chronoamperometric input and output waveforms are shown in Figure 
3.8 
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Figure 3.8 Typical input and ouput chronoamaperometry waveforms. The input waveform comprises of an 
applied potential which is stepped from an initial value to a different value at which the potential is held for a 
period of time (i.e. a square wave). The resultant current is recorded as a function of time (output waveform). 
A typical chronoamperometric response curve displays a sharp current spike (at the time at which the 
potential step occurs and consisting of both Faradaic and non-Faradaic components) which decays with time. 
In chronoamperometry the applied potential is sufficient to reduce the electrode surface concentration of the 
electroactive species essentially to zero. The effect of the capacitive current becomes less evident with time 
and the Faradaic current (which is a direct measure of the rate of the electrochemical reaction taking place at 
the electrode) dominates. 
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3.4 Materials 
Positive S 1400-31 photoresist and Microposit developer were obtained from Shipley 
Europe, Coventry, England. Silicon wafers were obtained from Shin Etsu, Livingston, 
Scotland; NiChrome (80:20 Ni:Cr) and gold were obtained from Goodfellow Cambridge 
Ltd, Cambridge, England. 
Ferrocenemonocarboxylic acid, anti-mouse IgG -ALP conjugate, N-acetyl-l-cysteine, and 
l-ethyl-3-(3-dimethylaminopropyl)carbodiimide were obtained from Sigma, Poole, 
England. Purified FSH, purified LH, anti-FSH (clone BIO-FSHB-003), anti-LH (clone 
BIO-LH-007), HRP labelled anti-FSH (clone BIO-FSHB-002), and HRP labelled anti-LH 
(clone BIO-LH-005) were obtained from Biogenesis Ltd, Bournemouth, England. 
Neutravidin™ and casein were obtained from Pierce Warriner, Chester, England. 
Photobiotin was obtained from Vector Laboratories, Peterborough, England. A 
Bioanalytical Systems (BAS) gold electrode and a BAS RE4 Agi AgCl reference electrode 
were obtained from Biotech Instruments Ltd, Luton, England. 
Instrumentation used comprised a EG&G 273A potentiostat (EG & G, Sunninghill, 
England), Bioanalytical System CV-37 potentiostats (Biotech Instruments Ltd, Luton, 
England), a Goerz SE120 dual channel chart recorder (Belmont Instruments, Glasgow, UK), 
a lOOW HB-I0lOIAF super high pressure mercury vapour lamp (Nikon, Tokyo, Japan) and 
a photolithographic mask aligner (HTG San Jose, California, USA). 
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3.5 Method 
3.5.1 Photolithographic Lift Off patterning techniques for the fabrication of electrodes 
Positive organic resists such as Shipley S 1400-31 photoresist are composed oflong 
molecular chains with high molecular weight. Upon exposure to ultraviolet (UV) light, 
extensive chain scission takes place resulting in fragmented molecules with low molecular 
weight. A developer which dissolves the molecules at a rate dependent upon their molecular 
weight is then employed. Those regions that have been exposed to ultraviolet light, with 
molecules of relatively low molecular weight dissolve rapidly. Unexposed high molecular 
weight regions dissolve relatively slowly. Therefore, after development, the resist image has 
"windows" opened where it has been exposed to UV light. This process is shown 
schematically in Figure 3.9a-d. 
In the "lift-off' technique, metal is evaporated from a point source and is deposited both 
onto the resist and onto the substrate through the resist windows. The resist is then 
dissolved by immersion in a resist solvent, causing the overlying metallisation to lift off, 
therefore only the metal that has been deposited directly onto the substrate through the resist 
window remains. This process is shown schematically in Figure 3.ge-f. 
Areas of the deposited metal can subsequently be electrically insulated from the 
environment by patterning a second layer of photoresist on to the surface. On this occasion 
only the areas of the metallised surface that one wishes exposed to the environment are 
irradiated, after removing the resist from these areas the remaining resist is hardened in an 
oven and can then act as an electrical insulator This process is shown schematically in 
Figure 3.9g-h. 
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Figure 3.9 Fabrication of electrodes using photolithographic lift-off techniques. A substrate (typically a 
silicon wafer) is cleaned (a) and c.oated with positive photoresist (b). The surface is exposed to UV light 
though a mask (c). A developer dissolves the resist that has been exposed to ultraviolet light (d). Metal is 
evaporated from a point source and is deposited both onto the entire surface (e). The resist is then dissolved 
by immersion in a resist solvent, causing the overlying metallisation to lift off, therefore only the metal that 
has been deposited directly onto the substrate through the resist window remains (t). Areas of the deposited 
metal can be electrically insulated by patterning a second layer of photoresist on to the surface. Only the 
areas of the metallised surface that one wishes exposed to the environment are irradiated (t), after removing 
the resist from these areas the remaining resist is hardened in an oven and can then act as an electrical 
insulator (h) 
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3.5.2 Electrode fabrication 
Positive S 1400-31 photoresist was spun onto 10 cm diameter silicon wafers at 4000 rpm 
for 30 s and then baked at 90°C for 30 minutes. The resist was then illuminated by light for 
12 s from a mask aligner through a photolithographic mask containing dark field relief 
images of the electrode arrays (Figure 3.10). Exposed resist was removed by immersion in 
Microposit developer for 75 s followed by a rinse in reverse osmosis (RO) water. 
NiChrome and gold were deposited on the surface to a thickness of 10nm and 100nm 
respectively, using a modified Edwards 12E High Vacuum evaporation unit. The remaining 
photoresist was removed by immersion in acetone for 20 minutes, "lifting off' the metal 
deposited on it, and leaving the silicon wafer with the metallic electrode arrays on its 
surface. Again, S1400-31 photoresist was spun onto the surface and baked at 90"C as 
detailed above. The electrodes and bonding pads were exposed to UV light through a 
second mask. Exposed resist was removed as detailed above, and the wafer was then baked 
at 120°C for 120 minutes, to harden the remaining photoresist which acted as an electrical 
insulator. 
Agi AgCI reference electrodes were prepared by electrosorbtion of silver onto specified gold 
electrodes from a solution ofO.lM AgN03 in O.IM sulphuric acid with a silver anode (at a 
constant current of 0.4 rnA cm-2 for 6 hours), followed by chloridisation in 0.1 M HCI (0.4 
rnA cm-2 for 30 minutes). 
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Figure 3.1 0 Diagrammatic representation of the fabricated electrode array for use in the construction of a 
multianalyte immunosensor. 
The electrochemical behaviour of the fabricated electrodes was verified by comparison of 
cyclic voltammograms (-0.2 to +0.75 V, 20 mV S·I) of 0.2 mM ferrocenemonocarboxylic 
acid in 50 mM Tris 50 mM KCI, pH 7.4 with those obtained using a BAS gold working 
electrode and a BAS RE4 AglAgCI reference electrode. Reproducibility of the fabricated 
electrode arrays, was assessed by measuring the chronoamperometric response (lOs at OV, 
30 s at +650 mv)) to 0.5 mM H20 2 in 50 mM sodium phosphate buffer containing 50 mM 
KCI, pH 7.4. These studies were performed using an EG&G 273A potentiostat. 
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3.5.3 Antibody immobilisation 
Electrode arrays were incubated in 2 mM NAC in 10 mM phosphate buffer (pH 7.0) for 120 
minutes at room temperature, followed by 120 minutes incubation in 1 % (w/v) EDC in 10 
mM phosphate buffer (pH 7.0). Note that the use ofNAC provides an "open" self 
assembled monolayer (in contrast to highly organised SAMs), and this does not "block" the 
gold electrochemical surface. The electrode arrays were then incubated in 100llg ml-' 
Neutravidin in 10 mM phosphate buffer (PH 7.0) for 16 hours at 4°C. All subsequent stages 
of the immobilisation procedure were performed at room temperature. After washing in 
PBS, the electrodes were first incubated in 10 mg ml-' casein in PBS for 60 minutes and 
then in 10 J..lg ml-) long arm photobiotin in PBS, for 20 minutes in the dark. All subsequent 
stages of the immobilisation procedure were performed in the dark. After washing in PBS 
the wafer was covered with 10 J..lg ml-' monoclonal anti-FSH (clone BIO-FSHB-003), and 
selected electrodes were exposed to light from a mercury vapour lamp, using a suitable 
mask as descibed in section 2.3.1. After washing in PBS, the wafer was covered with 10 
J..lg ml-' monoclonal anti-LH «Biogenesis clone LH-007), and selected electrodes were 
exposed to light from the lamp for 15 minutes. After washing in PBS, the entire wafer was 
exposed to light from the lamp for 15 minutes in the presence of 10 mg ml-' casein in PBS, 
and again washed in PBS. 
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3.5.4 Immunoassay procedure 
The immunoassay procedure used was a "sandwich" ELISA technique, with the 
immobilised "capture" antibodies on the electrode surfaces, and the subsequent addition of 
enzyme labelled antibodies directed against second epitopic sites on the antigens (Figure 
3.11). Sensors were incubated with 250 III of sample for 60 minutes, washed thoroughly 
with PBS, and incubated in a mixture of 10 Ilg ml·1 horseradish peroxidase (HRP) labelled 
anti-FSH ((Biogenesis clone BIO-FSHB-002), and 10 Ilg ml-1HRP labelled anti-LH( 
(Biogenesis clone LH-005) in PBS, for 60 minutes at room temperature, followed by further 
washing in PBS. 
)~ 
• 
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Figure 3.11 Principle of the "sandwich" ELISA used in the determination ofLH and FSH. The specific 
capture antibody (BIO-FSHB-003 for FSH and BIO-LH-007 for LH) was immobilised onto the electrode 
surface using the avidin - photobiotin patterning technique. Upon exposure to the sample the antibody bound 
its complimentary antigen, and unbound material was washed away. A second specific antibody 
(BIO-FSHB-002 for FSH and BIO-LH-005 for LH) conjugated to HRP was added, and this bound to a second 
discrete epitope on the antigen. Therefore, the amount of HRP attached to the electrode surface was 
proportional to the concentration of the antigen in the sample. 
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Simultaneous assessment ofHRP activity at the two sensors was perfonned 
chronoamperometrically using two Bioanalytical System CV-37 potentiostats and a Goerz 
SE120 dual channel chart recorder. Activity was detennined by measuring the current 
produced at 20 s in the presence of 10 mM hydrogen peroxide, and 0.2 mM 
ferrocenemonocarboxylic acid in 50 mM phosphate buffer containing 50 mM KCI, pH 7.4, 
with a potential of + 150 m V applied to the working electrode versus the Ag/ AgCI reference 
electrode.290 The principle of using ferrocenemonocarboxylic acid as an electron mediator is 
illustrated schematically in Figure 3.12 
2Ferroceneox HRPred 
2F errocentTed HRPox 
Figure 3.12 Schematic representation of electrochemical detection ofHRP using ferrocene derivatives. As 
HRP catalyses the conversion ofH20 2 to H20 , it is oxidised in the process. HRP is reconverted into the 
reduced form by the ferrocene (bis(bS-cyclopentadienyl)iron) derivative (in this case 
ferrocenemonocarhoxyJic acid), which is itself oxidised in the process and is subsequently reduced by 
gaining electrons from the electrode, resulting in current flow. 
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The response of the immunosensors to hormone concentration in a buffered aqueous 
solution was determined by preparation of a series of standards ( 0 - 100 U 1-1) of FSH and 
LH (Biogenesis) which covered the concentration range of clinical interest. The results 
obtained (Section 3.6.2) were subsequently used as calibration curves for further studies. 
The multianalyte immunosensor was used to determine gonadotrophin concentrations in 10 
serum samples from hospital outpatients (with a representative range of values typically 
seen in clinical laboratories), and the results were compared with those obtained using an 
established DELFIA method.291 Assays using the immunosensor were performed in 
triplicate, and the results obtained are shown in Section 3.6.2. 
3.5.5 Behaviour of calibration curve over time 
Sensors which had been fabricated were tested as described previously 42 days and 60 days 
after the initial (day 0) experiments (storage was at 4°C, in a solution of PBS containing 1 % 
BSA). The response of the sensor to aqueous gonadotrophin concentration was assessed in 
triplicate at each timepoint. The responses for the FSH and LH sensors are shown in Section 
3.6.3. In order to check that the immobilised antibody was not desorbing from the surface 
upon storage, the sensors were also incubated with an anti-mouse IgG - ALP conjugate at 
each time point. Following washing in TBS and incubation in the conjugate for 60 minutes, 
the sensors were washed extensively in rBS and their ALP activity was determined 
colourimetrically using pNPP as the substrate as described in Section 2.5.2.1. The 
absorbance was measured at 404 nm, and compared with a that of a freshly prepared 
reference solution (1 :60000 dilution of stock conjugate), to take account of inter-assay 
variation. 
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3.6 Results 
3.6.1 Electrochemical Characterisation of Electrodes 
The cyclic voltammograms of 0.2 mM ferrocenemonocarboxylic acid in 50 mM Tris 50 
mM KC1, pH 7.4 (-0.2 to +0.75 ,20 mV S·I) for the fabricated electrodes and for 
commercial (BAS) electrodes are shown in Figure 3.13. The potentials at which oxidation 
and reduction peaks were evident upon cyclic voltammetry for the fabricated electrodes 
were within 5 mV of those obtained when using the BAS electrodes (Epa = 0.355V, Epe = 
0.296V), demonstrating that the fabricated electrode arrays behaved similarly to a 
combination of commercially obtained gold and AgJ AgCI electrodes. 
The intra-batch coefficient of variation for the responses of the electrode arrays to 0.5 mM 
H20 2 in 50 mM sodium phosphate buffer containing 50 mM KCI, pH 7.4 (assessed by 
measuring the chronoamperometric response (10 s at OV, 30s at +650 mV vs. Ag/AgCI, 
current measured 30 s after application of +650m V potential» was 1.86% (n=20), whilst the 
inter-batch coefficient of variation was 2.43% (n=5), thus demonstrating that the response 
(and therefore the manufacture) of the fabricated electrode arrays were both reproducible. 
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Figure 3.13 Cyclic voltammograms offerrocenemonocarboxylic acid obtained using fabricated electrode pair 
and Commercial (BAS) electrodes The electrochemical behaviour of the fabricated electrodes (manufacture 
described in 3.5.1) was verified by comparison of cyclic voltammograms (-0.2 to +0,75 Y vs. Ag/AgCI, 20 
mY S-I) of 0.2 tuM ferrocenemonocarboxylic acid in 50 tuM Tris 50 tuM KCl, pH 7.4 with those obtained 
using a BAS gold working electrode and a BAS RE4 AglAgCI reference electrode. The potentials at which 
oxidation and reduction peaks were evident upon cyclic voltammetry of ferrocene- monocarboxylic acid for 
the fabricated electrodes were within 5 mY of those obtained when using the BAS electrodes (Ep;o = 0.355Y, 
Epc = 0.296Y) 
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3.6.2 Response ofimmunosensors to aqueous and clinical samples 
The response of the sensor to FSH and LH in buffer is shown in Figures 3.14 and 3.15, the 
current (a result of the enzymic activity) is clearly linearly related to the antigen 
concentration over the range 0 to 100 U 1-1. When corrected for the specific activities of the 
hormone preparations these ranges equate to 0 to 26 ng 1-1 and 0 to 18 ng 1-1 for FSH and 
LH respectively. Figure 3.14 demonstrates that the current produced by the FSH sensor is 
proportional to the FSH concentration, and that cross reactivity with LH is negligible. The 
response to FSH is 2.11 nA lUI-I (8.018 nA I ng 1-1) whilst the response to LH is 
0.07 nA I U 1-1 (0.385 nA I ng 1-1). 
Data shown in Figure 3.15 demonstrates that the current produced by the LH sensor is 
proportional to the LH concentration, and that cross reactivity with FSH is negligible. The 
response to LH is 2.48 nA lUI-I ( 13.64 nA I ng 1-1) whilst the response to FSH is 
0.11 nA / U 1-1 (0.418 nA / ng 1-1). 
Figures 3.16 and 3.17 show comparisons of results obtained for human serum samples 
from the multianalyte sensor, with those from an established DELFIA technique. There is a 
very good correlation between methods, and close agreement between results at all 
concentrations for both FSH (r = 0.9852) and, LH (r = 0.9783). 
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Figure 3.14 Response of multianalyte sensor to FSH concentration in buffer The response of the 
immunosensors to FSH concentration in a buffered aqueous solution was determined by preparation of a 
series of standards ( 0 - 100 U 1.1) ofFSH (LH concentration = 0). Monoclonal anti-FSH and monoclonal 
anti-LH antibodies were immobilised on selected sensors using the avidin-photobiotin patterning technique. 
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Figure 3.15 Response of multianalyte sensor to LH concentration in buffer. The response of the 
immunosensors to LH concentration in a buffered aqueous solution was determined by preparation of a series 
of standards (0 - 100 U 1.1) ofLH (FSH concentration = 0). Monoclonal anti-FSH and monoclonal anti-LH 
antibodies were immobilised on selected sensors using the avidin-photobiotin patterning technique. 
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Figure 3.16 Comparison of sensor results for FSH in clinical samples (serum) with an established DELFIA 
technique. Monoclonal anti-FSH and monoclonal anti-LH antibodies were immobilised on selected sensors 
using the avidin-photobiotin patterning technique. Sensors were incubated with 250 III of sample for 60 
minutes, washed thoroughly with PBS, and incubated in a mixture of 10 Ilg mI- 1 HRP labelled anti-FSH and 
10 Ilg ml- I HRP labelled anti-LH in PBS, for 60 minutes at room temperature, followed by further washing in 
PBS. HRP activity was assayed chronoamperometrically measuring the current produced at 20 s in the 
presence of 10 mM hydrogen peroxide, and 0.2 mM ferrocenemonocarboxylic acid in 50 mM phosphate 
buffer containing 50 mM KC1, pH 7.4, with a potential of +150 mY applied to the working electrode versus 
the Ag/AgCI reference electrode. Calibration of sensor responses was versus aqueous solutions ofFSH. Error 
bars represent mean of triplicate assays ± 1 standard deviations 
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Figure 3.17 Comparison of sensor results for LH in clinical samples (serum) with an established DELFIA 
technigue. Monoclonal anti-FSH and monoclonal anti-LH antibodies were immobilised on selected sensors 
using the avidin-photobiotin patterning technique. Sensors were incubated with 250 III of sample for 60 
minutes, washed thoroughly with PBS, and incubated in a mixture of 10 Ilg mI·) HRP labelled anti-FSH and 
10 I!g mI·) HRP labelled anti-LH in PBS, for 60 minutes at room temperature, followed by further washing in 
PBS. HRP activity was assayed chronoamperometrically measuring the current produced at 20 s in the 
presence of 10 mM hydrogen peroxide, and 0.2 mM ferrocenemonocarboxylic acid in 50 mM phosphate 
buffer containing 50 mM KCI, pH 7.4, with a potential of + 150 m V applied to the working electrode versus 
the Ag/ AgCI reference electrode. Calibration of sensor responses was versus aqueous solutions of LH. Error 
bars represent mean of triplicate assays ± 1 standard deviations. 
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3.6.3 Behaviour of calibration curve over time 
The responses for sensors stored at 4°C for 0,42 and 60 days to aqueous FSH and LH are 
shown in Figures 3.18 and 3.19 respectively. It can be seen from these figures that there 
was a significant decrease in the response (in terms of current) of both sensors upon storage. 
After 42 days storage at 4°C, the FSH sensor's response was 79% of that after preparation 
(Day 0) (coefficient of variation (CV)=8.2%, n=3), whilst after 60 days the response was 
70% (CV=ll.l%, n=3) of the initial value. After 42 days storage at 4°C, the LH sensor's 
response was 69% ofthat at Day 0 (CV=9.7%, n=3), whilst after 60 days the response was 
62% (CV=6.6%, n=3) of the initial value. 
The amount of antibody immobilised on the sensor surfaces as demonstrated by testing with 
an anti-mouse IgG-ALP conjugate did not show any variation with time (Day 0 
sample:reference ratio = 2.17 (CV=7.8 , n=3), Day 42 sample:reference ratio = 2.04 
(CV=9.2 , n=3), Day 60 sample:reference ratio = 2.22 (CV=6.2 , n=3»). 
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Figure 3.18 Response of multianalyte sensor to FSH concentration in buffer over a 60 day period. The 
response of the immunosensors to FSH concentration in a buffered aqueous solution was determined by 
preparation of a series of standards ( 0 - 100 U I-I) ofFSH (LH concentration = 0). Monoclonal anti-FSH and 
monoclonal anti-LH antibodies were immobilised on selected sensors using the avidin-photobiotin patterning 
technique. Immunoassay with chronoamperometric detection was performed as de cribed in Section 3.5.4 . 
The response of the sensors was measured on the day of manufacture and after storage at 40C for 42 and 60 
days. Each point on the plot is the mean response obtained from performing the assay using three sensor. 
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Figure 3_19 Response of multianalyte sensor to LH concentration in buffer over a 60 day period. 
The response of the immunosensors to LH concentration in a buffered aqueous solution was determined by 
preparation of a series of standards (0 - 100 U I-I) ofLH (FSH concentration = 0). Monoclonal anti-FSH and 
monoclonal anti-LH antibodies were immobilised on selected sensors using the avidin-photobiotin patterning 
technique- Immunoassay with chronoamperometric detection was performed as described in Section 3.5.4 . 
The response of the sensors was measured on the day of manufacture and after storage at 40C for 42 and 60 
days. Each point on the plot is the mean response obtained from performing the assay using three sensors. 
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3.7 Discussion 
The applicability of the avidin-photobiotin immobilisation procedure to multianalyte 
immunoassays has been demonstrated using the gonadotrophins FSH and LH as a model 
system.292 This is the first report of an electrochemical multianalyte immunosensor for high 
molecular weight analytes. 
The detection limit (defined as the analyte concentration read off the standard curve, for a 
current equivalent that of the zero standard plus 3 standard deviations (n=l 0» was 2.1 U l' 
for FSH and 1.8 U 1-1 for LH. The detection limits were below the bottom of the reference 
range for both analytes and are comparable to many existing methods,261 although lower 
detection limits have been reported in some other methods.278 It is likely that further 
optimisation of the reagents and assay protocol used in the immunosensor assay would 
result in a lower detection limit. Over the working range of the assays (0 to 100 U 1-1), the 
concentration:current relationship is linear for both analytes, and the immunosensor showed 
excellent correlation with an established analytical technique upon testing clinical samples. 
The replicate (x3) analysis ofthe 10 patient samples shows acceptable imprecision (R.M.S. 
CV% = 5.2% for FSH and 6.7% for LH). 
The variation in the current recorded for a given concentration of hormone on different 
dates could be due to a number of factors. Minor variations in analytical conditions may 
have been a factor (e.g. changes in room temperature), but as there appeared to be a 
progressive decrease in current obtained for a given concentration with time, it is likely that 
there was a loss of biological activity of the antibodies and / or the enzyme label. The lack 
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of variation in the quantity of antibody on the sensor with time (as demonstrated with the 
use of anti mouse IgG-ALP conjugate) indicates that the decreased response was not due to 
desorption of the capture antibody from the sensor surface. 
The current that flowed when no antigen was present was due to a number of factors, chief 
amongst these was the current resulting from electrochemical processes unrelated to the 
immunoassay (i.e. the background current obtained when there was no enzymic activity). 
The remainder of the current when the antigen concentration was zero was due to either to 
non-specific binding or to diffusion of electroactive species between electrodes. 
As discussed in Chapter 2 there are a number of types of non-specific binding in 
solid-phase enzyme immunoassays. One of these occurs where an inappropriate antibody 
binds at a sensor site (e.g. anti-LH on a sensor for FSH), a circumstance which can come 
about for a number of reasons, such as binding through non-specific protein-protein 
interactions, hydrophobic interactions with non-polar surfaces, or electrostatic interactions 
between the protein and the surface. 124-126 This inappropriate antibody is subsequently able 
to bind it's complimentary antigen and the enzyme labelled second antibody. Sample 
components themselves can bind non-specifically to sensors, by the same processes as 
described above (e.g. LH reacting non-specifically with anti-FSH). Subsequently, if enzyme 
labelled-antibody to this sample component is added a "false" signal can be produced. The 
labelled antibodies themselves can also bind non-specifically to the sensors with the same 
effect. Antibody "cross-reactivity" can also cause spurious results, this can be minimised by 
the use, as in this study, of highly specific monoclonal antibodies. As demonstrated in 
Chapter 2, the use of deglycosylated avidin (e.g. Neutravidin or streptavidin) to precoat the 
electrodes, decreases the amount of non-specific binding, particularly that due to protein 
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interactions with the surface. This enabled the multianalyte immunosensor to be fabricated, 
with serial immobilisation of sensor antibodies. Casein was used to block unreacted 
photobiotin groups and to further decrease the effect of non-specific binding. 
It is likely that the non-specific binding observed in this study comprised of several or all of 
the above types. The binding of a labelled antibody to the sensor that is not mediated by an 
antigen, is independent of sample composition, whereas "antigen mediated" non-specific 
binding will increase with the increasing concentration of the antigen in the sample. In this 
study there was a slight increase in the non-specific signal with increasing antigen 
concentration for both sensors, possibly indicating that some LH was being bound at the 
FSH sensor and vice versa. Alternatively this increase in non-specific signal could be due to 
the diffusion of increased concentrations of electroactive species between electrodes, 
although work presented in Chapter 4 would suggest that this is unlikely. 
Simultaneous multianalyte immunoassays, where several analytes are measured by a simple 
procedure, are required in a number of clinical situations, such as the measurement of 
hormones related with thyroid function and the measurement of gonadotrophins for the 
investigation of infertility etc. Particular examples where the use of immunosensors for the 
measurement of gonadotrophins are likely to be beneficial, are as an aid to conception either 
"naturally" by determining when a woman is most likely to conceive, or for in vitro 
fertilisation procedures. In these cases the rapid measurement of gonadotrophins is 
extremely important as the rapid transient elevation of gonadotrophins (particularly LH) is 
an indication of ovulation.287.288.293 Existing multianalyte immunosensors tend to be 
qualitative assays, examples of such systems are the Triage™ system for qualitative assays 
of drugs of abuse and the Spectral Diagnostics assay for markers of myocardial 
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infarction. 120,121 These systems are based upon immunochromatography assays, which are 
observed visually and are generally unsuitable for quantitative assay. 
Although initially a sensor for measuring two analytes has been constructed, the technology 
that has been developed is compatible with the fabrication of a sensor for as many analytes 
as is required.294 The fabrication and irnmobilisation procedures used in this work would be 
suitable for larger scale production using technology commonplace in the microelectronics 
industry. Additionally, there is no waste of expensive proteins such as monoclonal 
antibodies as non-irnmobilised excess protein can easily be recovered, and be reused. 
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CHAPTER 4 
Let us not take it for granted that life 
exists more fully in what is commonly thought big 
than in what is commonly thought small. 
Virginia Woolf 
The Common Reader 
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4 Introduction 
Another objective of this work was to investigate the possibility of mini at uri sing the 
immunosensor electrodes, so as to develop microspot immunoassays as described by Ekins 
and co_workers.29s-297 High sensitivity assays based upon the microspot had previously been 
developed using fluorescence detection, but no there were no reports of the attempted 
extension of this technology to systems using electrochemical detection. Miniaturisation of 
electrodes, along with the protein patterning technique already described, would allow the 
fabrication of arrays of small sensors capable I)f simultaneously measuring numerous 
analytes, the so called "immunological compact disc". 
Section 4.1 provides a background to antibody antigen reactions at surfaces, Section 4.2 
provides a theoretical expansion of previously published work on microspot immunoassays 
with particular reference to microelectrode arrays. Practical work performed to ascertain the 
suitability of microspot electrochemical assays is presented in the remaining sections of the 
chapter. 
Practical work was performed to: 
1) Ascertain if the formation of hemispherical diffusion fields associated with 
ultramicroelectrodes caused problems in the use of multianalyte sensors. 
2) Ascertain if the diffusion of electrochemical species generated at one electrode to other 
electrodes caused problems in the use ofmultianalyte sensors, in particular those employing 
ultramicroelectrodes. 
3) Construct an enzymic biosensor using ultramicroelectrodes capable of simultaneously 
measuring two analytes. 
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4) Construct a multianalyte immunosensor using ultramicroelectrodes and capable of 
simultaneously measuring two analytes. 
4.1 Antibody anti2en reactions at surfaces 
In order to investigate the feasibility of developing an amperometric dual label microspot 
immunoassay, a degree of theoretical analysis of the principles of immunoassay is required. 
The equilibrium constant (K) is given by equation 4.1 where [Ag] = concentration of analyte 
and [Ab] = concentration of the antibody (in M· l ). 
[A bAg] 
K = [Ab][Ag] (4.1) 
All immunoassays are based upon the measurement of the proportion of available antibody 
binding sites that are bound to the antigen. It can be shown that the fractional occupancy (F) 
of antibody binding sites by antigen at equilibrium is given by equation 4.2.297 
F2 FI( 1 [Ag) [Ag] 
- [Ab] + [Ab) + 1) + [Ab] = ° (4.2) 
where [Ag] = concentration ofanalyte and [Ab] = concentration of the immobilised sensor 
antibody (both in units of the reciprocal of the equilibrium constant (11K). 
From this equation, it can be shown that as [Ab] tends to 0, 
[Ag] 
F ~ [1+Ag] (4.3) 
Equation 4.3 implies that the fractional occupancy is dependent on [Ag] and independent of 
the total amount ofimmobilised sensor antibody. The effect of this is that when very small 
amounts of immobilised sensor antibody are used, the assay becomes independent of 
sample volume. In practice this applies when analyte depletion is less than 1 %.294 Assays 
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that are independent of sample volume have a number of advantages, particularly in their 
ease of use if they are to be used in non-laboratory environments. 
4.2 micros pot immunoassay 
If it is assumed that antibody molecules exist with a uniform surface density on a support, 
then a change in surface area over which the antibody is distributed implies a change in 
antibody concentration. For example, as shown below if an antibody has an affinity 
constant (K) of 1011 M- I , the total incubation volume is I ml and the antibody surface 
density is 6000 molecules/J..lm2, a surface area of 105 J..lm2 (0.Imm2) corresponds to an 
antibody concentration ofO.1K. 
6000 molecules/J..lm2 X 105 J..lm2 = 6 xI08 molecules 
6 xl 08 molecules + 6.02 x 1023 molecules x I x 103 ::::: I x 10-12 M 
6.02 X 1023 molecules is Avagadros number (number of molecules in a mole), the factor of lOJ is to convert 
1 rn1 to llitre (volume unit used for expressing molarity). 
I X 10-12 M (number of molecules) + I x 10-11 M (reciprocal of affinity constant) = 0.1 K 
Similarly, if the area is 104 J..lm2 (0.0Imm2), and the other parameters remain unchanged 
then the antibody concentration is calculated as O.OIK 
The solution for F in equation 4.2 is given by; 
(4.4) 
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Plots showing values of F at antibody concentrations between 0.0001 K and 10K for several 
different antigen concentrations are shown in Figure 4.1. From these plots it can be seen 
that at antibody concentrations below O.OlK that for all practical purposes, the fractional 
occupancy F is dependent solely upon the antigen concentration. 
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Figure 4.1 Fractional antibody binding-site occupancy (F) related to antibody concentration for several 
different antigen concentrations. All concentrations are in unit of 11K. For antibody concentrations [Ab] less 
than approximately 0.0 11K, F is governed solely by [Ag] and is essentially unaffected by variations in [Ab]. 
The percentage of antigen bound by the antibody (i.e.depletion of antigen from solution) is 
given by Equation 4.5 (from rearrangement of Equation 4.4) and plots showing the 
percentage of antigen bound at antibody concentrations between 0.0001 K and 10K for 
several different antigen concentrations are shown in Figure 4.2. Note that for antibody 
concentrations ofless than approximately 0.0 11K, the percentage of antigen bound is less 
than 1 %. 
% Antigen bound = 
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Figure 4.2 Percentage of antigen bound to antibody related to antibody concentration for several different 
antigen concentrations. All concentrations are in unit of 11K. For antibody concentrations [Ab] less than 
approximately 0.0 11K the percentage binding of the analyte is less than 1%. 
It has previously been shown that a decrease in the sensor area and therefore antibody 
concentration (Figure 4.3a), can result in an increase in the specific/non-specific signal 
ratio, assuming that the "field of view" of the detecting instrument is restricted to the area 
on which the sensor antibody is deposited.294 However, if the amount of capture antibody is 
reduced either by decreasing the antibody coated area (Figure 4.3b), or the density of 
antibody coating (Figure 4.3c) whilst the field of view remains constant then the signal to 
noise ratio (Ssb / Snsb ) ratio falls. 
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a 
• 
b 
c 
Figure 4.3 Diagram demonstrating changes in field of view. antibody-coated area and coated antibody 
density. Shading indicates antibody-coated area (intensity of shading represents density of antibody coated 
onto surface). In (a) and (c) the antibody-coated area is equivalent to the field of view, in (b) the unshaded 
outer circle represents the field of view. In (a), both the antibody-coated area and the field of view are 
reduced which leads to increased signal/noise ratio. In (b) the antibody coated area is reduced whilst the fie ld 
of view remains constant, in this case the signal/noise ratio is decreased. In (c) the antibody coated area and 
the field of view remain constant, but the coated antibody density decreases, again this results in a decreased 
signal/noise ratio. 
The following calculations and tables demonstrate the effect of the changes in antibody 
coated area, antibody density and field of view upon the specificl non-specific signal ratio . 
The number of molecules specifically bound is given by; 
F x number of antibody molecules 
The specific/non-specific signal ratio is given by 
Fractional occupancy (F)x coated antibody density (moleculeslpm2) x area (Jlm2) 
non-specifically bound labelled antibody density (moleculeslJlm2) x area (JJm2) 
The fractional occupancy (F) is obtained from equation 4.4. 
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(4.6) 
For example if one assumes that as before, an antibody has an affinity constant (K) of 10" 
M-', the total incubation volume is 1 ml and the antibody surface density is 6000 molecules 
/ f..lm2 , but one also assumes that the analyte concentration is O.OlK (6 x 107 molecules / ml) 
and that the labelled second antibody binds non-specifically to the surface at 1 molecule / 
For an area of 1 x 106 f..lm2, F = 4.99 X 10-3 (from equation 4.4). 
4.99 x 10-3 X 6 x 109 molecules = 2.994 x 107 molecules contributing to the specific signal. 
Non-specific binding of the labelled second antibody is 1 molecule / f..lm\ therefore there 
are 1 x 106 molecules contributing to the non-specific signal. 
Therefore the specific / non-specific signal ratio = 2.994 x 10
7 
= 29 94 1 x 106 • 
Similarly for an area of 1 x 105 f..lm2, F =9.02 x 10-3, resulting in a specific/non-specific 
signal ratio of 54.1, and for an area of 1 x lOs f..lm2, F =9.80 x 10-3, resulting In a 
specific/non-specific signal ratio of 58.8 
If the reduction in the antibody-coated area were not accompanied by a corresponding 
reduction in the detecting instrument's field of view, there would not be a decrease in the 
background produced by non-specifically bound labelled antibody, and the specific / 
non-specific signal ratio would be adversely affected. This is demonstrated by calculated 
examples shown in Table 4.1. In this table it can be seen that if the field of view is 
equivalent to the area of antibody deposition, that as the size of this area decreases, the 
specific I non-specific signal ratio increases. If the area of antibody deposition is increased 
so that it is larger than the field of view, the specific I non-specific signal ratio remains 
unchanged, but if the area of antibody deposistion is decreased so that it is smaller than the 
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field of view, the specific / non-specific signal ratio decreases. The implication of this is 
that if one is working with instrumentation whose field of view can not be decreased below 
a certain area, it may be beneficial to ensure that the antibody-coated surface covers this 
entire area, the larger area's advantage of a proportionally smaller signal contribution by 
non-specifcally bound molecules outweighing the improved fractional occupancy of smaller 
areas. 
SpecificlNon-specific si2nal ratio 
Area of antibody deposition 1 x 106 1 X 105 1 X 104 
~m2 
Field of view Area ~m2 
1 x 106 29.94 5.41 0.59 
1 x 105 54.1 54.1 5.88 
1 x 104 58.8 58.8 58.8 
Table 4.1 Examples of specific / non-specific siKnal ratios for differently antibody deposition and field of 
view areas. 
In table 4.2 it can be seen that for a given field of view (assumed equivalent to the area of 
antibody deposition), that as the antibody surface density decreases, so does the specific / 
non-specific signal ratio. It should also be noted that as the antibody surface density 
decreases the advantages of using a smaller field of view are greatly diminished. 
Specific/Non-specific signal ratio 
Field of View ~m2( equivalent 1 x 106 1 X 105 1 X 104 
to area of antibody deposition) 
Antibody surface density 
molecules/~m2 
6,000 29.94 54.1 58.8 
600 5.41 5.88 5.93 
60 0.59 0.59 0.59 
Table 4.2 Examples of specific / non-specific siKnal ratios for different antibody deposition and antjbody 
surface densities. 
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4.2.1. Influence of working electrode area as proportion of total area on the specific 
Inon-specific signal ratio. 
When measuring analytes in solution amperometrically, the sensor's "field of view" is not 
restricted to the area on which the sensor antibody is immobilised. The non-specific signal 
can have a number of constituents in addition to the non-specific binding of the second 
antibody-enzyme conjugate to the sensing area itself. Signal generating molecules that are 
bound to the surrounding area also need to be considered, and mass transport of 
electroactive species between electrodes can occur. 
If one was to consider a case where the field of view encompasses the total surface and 
where diffusion was instantaneous, then the effect (for a 2 electrode system) of an 
electrode's size (expressed as a fraction of the entire surface) upon the specific signal 
(Ssb)/non-specific signal (Snsb) ratio is given by equation 4.7. The specificlnon signal ratio is 
dependent upon the electrode area (Ae), the area of other electrodes within the system (Ao), 
the total area (At), the density of signal producing molecules specifically bound to electrode 
(Des) and the density of signal producing molecules non-specifically bound to the electrode 
(Den), other electrodes in the system (Don) and to areas that are not electrodes (Dnn). 
Ssb = (Ae.Des) (4 7) 
Snsb (A e.Den+{Ao.Don}+(A,-Ae-Ao}.Dnn} . 
For equation 4.7 to apply for a system for any number (n) of electrodes the term Ao.Don is 
replaced with the term ];(Ao.Do",h."./ . Similarly the term (ArAe-Ao) is replaced by 
(ArAe-.E0oJr.II'/)' resulting in equation 4.8. 
Ssb (Ae.Des) 
Snsb = (Ae.Den+l:(Ao.Donh .. n-l +(A,-Ae-l:(Ao) l..n-l ).Dnn} (4.8) 
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The effect of Equation 4.8 is that as the electrode size (expressed as a fraction of total area) 
decreases there is a corresponding reduction in the specific/non-specific signal ratio. This is 
shown graphically in Figure 4.4, for a number of simulated examples. 
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Figure 4.4 Theoretical plot of specific/non-specific signal ratio versus electrode size for several systems with 
differing degrees ofnon-mecific binding in a 2 electrode system. For curve 'A' non-specific binding to both 
electrodes and non electrode area is 1 % of specific binding to electrode, for curve 'B' non-specific binding to 
both electrodes and non electrode area is 2% and 1 % respectively, for curve 'C' binding to electrode 1, 
electrode 2 and non electrode area is 2%, 1% and 1 % respectively and for curve 'D' binding to electrode 1, 
electrode 2 and non electrode area is 2%, 3% and 1 % respectively 
If a stationary electrode is immersed in an unstirred electrolytic solution and a potential is 
applied, provided that electroactive substances that can undergo oxidation or reduction are 
present in the electrolytic solution, charge transfer will occur at the electrodelliquid 
interface. Reduction involves electron transfer from the electrode to the electroactive 
substance, whilst in oxidation electrons are transferred from the electroactive substance to 
the electrode. As this occurs, concentrations of substances at the electrode surface start to 
change, and diffusive mass transport commences. 
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Dependent upon the size of the electrode and the volume of the solution three limiting cases 
of diffusion can be described.298 The first case is an electrode in a thin-layer cell where the 
cell volume/ electrode surface area ratio is very low. In this case mass transport within the 
cell is negligible, and there is no diffusion gradient. In the second case, that of a 
macroelectrode (not in a thin layer cell), the cell volume/electrode surface area ratio is much 
larger and one observes planar diffusion. In the final case when one reduces the size of the 
electrode so that it has an extremely small surface area (diameter < 20 Jim), the conditions 
change and the diffusion process becomes dependent upon the size and geometry of the 
electrode. For disk ultramicroelectrodes the spatial diffusion field that develops is 
hemispherical. These different types of diffusion are illustrated in Figure 4.5. 
Thin Layer Cell 
No diffusion 
Microelectrode 
Hemispherical 
Diffusion 
Lateral Diffusion 
Predominant 
Macroelectrode 
Planar 
Diffusion 
Lateral Diffusion 
Insignificant 
Figure 4.5 Transverse sections of a thin layer cell. micloelectrode and a macroelectrode demonstrating 
differences in diffusion. In the thin layer cell the available transport paths are short and no diffusion gradient 
develops. In the rnicroelectrode a spatial diffusion field develops (in the case of a disk electrode a 
hemispherical field). For the rnacroelectrode, planar diffusion occurs.298 
As mentioned in Chapter 3, mass transport of electro active species consists of three 
components, diffusion, migration and convection. Mass transport can be limited to just the 
diffusion term if the solution is quiescent (eliminating convection) and has a relatively high 
concentration of supporting electrolyte (eliminating migration). 
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As one decreases the size of an electrode, to the point of it becoming an 
ultramicroelectrode, then time-dependent changes in mass transport become evident. These 
changes involve the transformation of one-dimensional planar diffusion fields into spatial 
fields, with a radial diffusive component (parallel to the electrode surface) being added to 
the usual axial diffusion. In mathematical terms diffusion is described by Fick' sLaws, 
which vary according to electrode geometry.298 The equation for planar diffusion at a 
macro electrode is shown in Equation 4.9, whilst that for hemispherical diffusion at a disk 
electrode is shown in Equation 4.10. 
2 ~~ = D~x~ (4.9) 
The increased diffusion rate of species to ultramicroelectrodes leads to a number of 
analytical advantages such as very high current densities (in spite of small currents), rapidly 
achieving a time independent stationary state, and a large drop in ohmic resistance due to 
the resistance ofthe solution.298-3OO However, in constructing arrays ofultramicroelectrodes 
for multianalyte analysis, the hemispherical diffusion field can be problematical. The 
contribution to the observed current due to signal producing molecules that are 
non-specifically bound to areas other than the electrode (terms Don and Dnn in equations 4.7 
and 4.8) are greatly increased, resulting in a poorer specific/non-specific signal ratio. This 
in tum will lead to poorer sensitivity and reduced discrimination. 
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The fonnation of the hemispherical diffusion field effectively means that the field of view 
of the detecting instrument is not limited to the area on which the sensor antibody is 
deposited and the specific / non-specific signal ratio (from equation 4.6) would be 
adversely affected, as shown in Table 4.1. 
In Table 4.1 it can be seen that if the field of view is equivalent to the area of antibody 
deposition, that as the size of this area decreases, the specific / non-specific signal ratio 
increases. Ifthe area of antibody deposition is increased so that it is larger than the field of 
view, the specific / non-specific signal ratio remains unchanged, but if the area of antibody 
deposition is decreased so that it is smaller than the field of view, the specific / non-specific 
signal ratio decreases. As stated earlier, the implication of this is that if one is working with 
instrumentation whose field of view can not be decreased below a certain area (such as 
hemispherical diffusion at ultramicroelectrodes), it may be beneficial to ensure that the 
antibody-coated surface covers this entire area, the larger area's advantage of a 
proportionally smaller signal contribution by non-specifically bound molecules 
outweighing the improved fractional occupancy of smaller areas. 
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4.3 Materials 
Positive S1400-31 photoresist and Microposit developer were obtained from Shipley 
Europe, Coventry, England. Glucose oxidase (EC 1.1.3.4,20 U mg· I ), sodium glutamate, 
ferrocenemonocarboxylic acid, N-acetyl-I-cysteine, and 1-ethyl-3-(3-dimethylaminopropyl) 
- carbodiimide were obtained from Sigma, Poole, England. 
Glutamate oxidase (EC 1.4.3.11.5, 16 U mg- I ) was kindly provided by Yamasa Shoyu, 
Chiba, Japan. 
Silicon wafers were obtained from Shin Etsu, Livingston, Scotland. NiChrome (80:20 
Ni:Cr) and gold were obtained from Goodfellow Cambridge Ltd, Cambridge, England. 
Neutravidin™ and casein were obtained from Pierce Warriner, Chester, England. 
Photobiotin was obtained from Vector Laboratories, Peterborough, England. 
A Bioanalytical Systems (BAS) RE4 Agi AgCI reference electrode was obtained from 
Biotech Instruments Ltd, Luton, England. 
Instrumentation used comprised a EG&G 273A potentiostat (EG & G, Sunninghill, 
England), Bioanalytical System CV-37 potentiostats (Biotech Instruments Ltd, Luton, 
England), a Goerz SE120 dual channel chart recorder (Belmont Instruments, Glasgow, UK), 
a lOOW HB-IOIOIAF super high pressure mercury vapour lamp (Nikon, Tokyo, Japan) and 
a photolithographic mask aligner (HTG San Jose, California, USA). 
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4.4. Methods 
4.4.1 Method for fabrication of electrodes and electrode arrays using photolithographic 
lift-off techniques. 
Positive S 1400-31 photoresist was spun onto 10 cm diameter silicon wafers at 4000 rpm for 
30 s and then baked at 90°C for 30 minutes. The resist was then illuminated by light for 12 s 
from a mask aligner through a photolithographic mask containing relief images of the 
electrode arrays (Figures 4.6 to 4.8). Exposed resist was removed by immersion in 
Microposit developer for 75 s followed by a rinse in reverse osmosis (RO) water. 
NiChrome and gold were deposited on the surface to a thickness of 10nm and 100nm 
respectively, using a modified Edwards 12E High Vacuum evaporation unit. The remaining 
photoresist was removed by immersion in acetone for 20 minutes, lifting off the metal 
deposited on it, leaving the silicon wafer with the metallic electrode arrays on its surface. 
S1400-31 photoresist was spun onto the surface again, and baked at 90°C as detailed above. 
For the electrodes shown in Figures 4.6 and 4.7, all areas of the surface apart from the 
connecting tracks were exposed to light through a second mask (this was so that the 
connecting track did not form part of the electrode, and to allow investigations into the 
effect of specifically and non-specifically bound enzymes to the area surrounding the 
electrode). For the electrodes shown in Figures 4.8, electrodes and bonding pads (but not 
connecting tracks) were exposed to light through a second mask. Exposed resist was 
removed as detailed above, and the wafer was then baked at 120°C for 120 minutes, to 
harden the remaining photoresist that acted as an electrical insulator. 
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Figure 4.6 Diagrammatic representatiop of a photolithographically fabricated gold electrode with an electrode 
2 mm in diameter and surrounded by a gold non-electrode surface. Details of the fabrication procedure are 
provided in the text (Section 4.4.1) 
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Figure 4.7 Diagrammatic representation of an photolitho\UaphicaJly fabricated gold electrode with an 
electrode 10 urn in diameter and surrounded by a gold non-electrode surface. Details of the fabrication 
procedure are provided in the text (Section 4.4.1) 
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Figure 4.8 Diagrammatic representation of a photolithographically fabri cated electrode array with electrodes 
either 1 mm or 10 11m in diameter. Details of the fabrication procedure are provided in the text (Section 4.4.1 ) 
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4.4.2. Avidin-photobiotin immobilisation procedure. 
Electrodes (fabricated as shown in Figures 4.6 to 4.8) were incubated in 2 mM NAC in 10 
mM phosphate buffer (PH 7.0) for 120 minutes at room temperature, followed by 120 
minutes incubation in 1 % (w/v) EDC in 10 mM phosphate buffer (pH 7.0). The electrodes 
were then incubated in 100J,lg ml-] Neutravidin in 10 mM phosphate buffer (pH 7.0) for 16 
hours at 4°C. All subsequent stages of the immobilisation procedure were performed at 
room temperature. After washing in phosphate buffered saline, pH 7.4 (PBS). the electrodes 
were first incubated in 10 mg ml-] casein in PBS for 60 minutes and then in 10 J,lg ml-
' 
long 
arm photobiotin in PBS, for 20 minutes in the dark. 
4.4.3. Amperometric response of electrodes. 
Amperometric enzyme based assays were perfonned using the gold electrode as a working 
electrode, with an Agi AgCI electrode as the reference and a bare platinum flag as a counter 
electrode. Chronoamperometry was perfonned in a working solution containing 10 mM 
sodium phosphate, 140 mM NaCI, 25 mM KCI, pH 7.0. Dependent upon the experiment. 
glucose and / or glutamate could be added to this working solution to provide 
predetennined concentrations. Initially, the working electrode was poised at a potential of 
OV for 10 seconds, after which the potential was "stepped" to 65 Om V for 120 seconds at 
which time the current was recorded. 
4.4.4 Investigation into effect ofhemis.pherical diffusion field upon response of 
ultramicroelectrodes. 
4.4.4.1 Enzyme immobilisation procedure 
Avidin and photobiotin were immobilised on electrodes (as shown in Figures 4.6 and 4.7) 
as described in Section 4.4.2. After washing in PBS the wafer was covered with 10 J,lg mI-
' 
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glucose oxidase (GOD) and the desired areas (as shown in Table 4.3) were exposed to light 
as described in Section 2.3.1. After washing in PBS, the entire wafer was exposed to light 
for 15 minutes in the presence of 10 mg ml- I casein in PBS, and again washed in PBS. 
Areas of electrodes (as shown in Table 43) were then exposed to deep UV radiation (Ie < 
200 nm, irradiance = 200 m W cm-2) in order to inactivate any GOD that had been 
non-specifically bound. The areas containing specifically and non-specifically bound GOD 
are shown in Table 4.4. After the enzyme immobilisation procedure was complete a plastic 
ring was attached to the substrate to allow solutions to be placed in the cell. The prepared 
electrodes were stored in PBS until use. 
Electrode Area exposed to light in presence Area exposed to OUV following I I I 
of GOD during patterning process patterning process. I 
I 
A None Entire surface ! I 
I 
~ 
B None Entire surface apart from electrode I 
I 
~ 
C None Electrode only i 
D None None I I 
I 
E Electrode only 
~ 
Entire surface apart from electrode i 
-4 
F Electrode only None I ! ! 
G Entire surface apart from electrode Electrode only I I 
I 
H Entire surface apart from electrode None 
I 
I 
i 
I Entire surface None 
I 
Table 4.3 Areas of sensor surfaces exposed to Bib' in presence of GOP durina panemjna process and those 
areas exposed to PUV radiation followin& the panernjn& process. Exposure to light during the patterning 
process resulted in specific immobilisation of GOP, whilst in areas irradiated with DUV light the GOD was 
rendered non-functional. 
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-; 
Area with non-specifically bound GOD ! 
None Electrode Other than All ! 
electrode 
-------, 
Area with None A B C D 
specifically 
--.-----~-.-; 
bound GOD 
Electrode - E 
-
F 
Other than - - G H 
electrode 
All - - - I 
Table 4.4 Areas of sensor surfaces containin~ specifically and non-specifically bound GOD. Note that it was 
not possible to have an area with specifically bound GOD in the absence of non-specifically bound GOD. 
4.4.4.2. Amperometric Analysis 
Chronoamperometry was perfonned as described in Section 4.4.3 using solutions 
containing 100 mM glucose. Amperometric analysis was perfonned using 2mm and 10 Ilm 
I 
I 
--1 
I 
I 
I 
I 
1 
I 
"-1 
diameter electrodes (Figures 4.6 & 4.7) with a +650 mV potential (versus AglAgCI) applied 
to the electrode alone, and with a potential of +650 m V also applied to the surrounding gold 
area from a second independent potentiostat. Results are shown in Section 4.5.1. 
4.4.5 Investigation into analytical "cross-talk" caused by mass transport of electrochemical 
species generated at one electrode to other electrodes in an array. 
4.4.5.1 Enzyme immobilisation procedure 
Avidin and photobiotin were immobilised on electrodes (as shown in Figure 4.8) as 
described in Section 4.4.2. After washing in PBS the wafer was covered with 10 Ilg ml-
' 
GOD and the generator electrode (electrode I in Figure 4.8) was exposed to light and then 
blocked with casein as described in Section 4.4.4.1. Areas other than the generator 
electrode were exposed to DUV radiation, fitted with a plastic ring and stored as described 
in Section 4.4.4.1. 
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4.4.5.2 Amperometric analysis 
Chronoamperometry was perfonned as described in Section 4.4.3. A series of experiments 
were perfonned, applying a potential of +650 m V versus the Ag/ AgCl reference electrode 
to each of the electrodes in turn. Upon obtaining a stable baseline reading, glucose was 
added to give a final concentration of 100 mM. The current was recorded 120 seconds after 
the addition of the glucose. This series of experiments were then repeated, applying a 
potential of650mV to the generator electrode as well as the monitoring electrode. Plots of 
current versus distance of measuring electrode from generator electrode are shown in 
Section 4.5.2. 
4.4.6 Construction of multianalyte enzymic biosensor using ultramicroelectrodes. 
The analytes were chosen were glucose and glutamate as oxidase enzymes (whose action 
resulted in the fonnation of H20 2) were available for these 2 substances. 
glucose oxidase 
Glucose + O2 + H20 ~ Gluconolactone + H20 2 
glutamate oxidase 
Glutamate + O2 ~ 2-0xoglutarate + NHJ + H20 2 
4.4.6.1 Electrode fabrication. 
Electrodes were photolithographically fabricated as described in Section 4.4.1. The 
fabricated electrodes were 10 J..Lm in diameter and located 150 J..Lm apart. Tracks 3 J..Lm wide 
(which were electrically insulated by the use of photoresist) connected the electrodes to 
bonding pads, where connections were made to the potentiostats. 
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4.4.6.2 Enzyme immobilisation procedure. 
Avidin and photobiotin were immobilised on electrodes as described in Section 4.4.2. After 
washing in PBS the wafer was covered with 10 ~g ml- I glutamate oxidase (GLOD) for 15 
minutes and one of the electrodes was exposed to light as described in Section 4.4.4.1. After 
washing in PBS the wafer was covered with 10 ~g ml- I GOD and the other electrode was 
exposed to light 15 minutes The surface was then blocked with casein as described in 
Section 4.4.4.1. Areas of the surface other than the electrodes were exposed to DUV 
radiation, fitted with a plastic ring and stored llS described in Section 4.4.4.1. 
4.4.6.3 Amperometric analysis. 
Chronoamperometry was perfonned as described in Section 4.4.3. with solutions containing 
varying concentrations of glucose or glutamate. Results are shown in Section 4.5.3. 
4.4.7 Construction of multiana}yte immunosensor using ultramicroelectrodes. 
4.4.7.1 Electrode Fabrication 
Electrodes were photolithographically fabricated as described in Section 4.4.1. The 
fabricated electrodes were 1 0 ~m in diameter and were fabricated in pairs situated I mm 
apart (centre to centre), individual electrodes were as shown in Figure 4.7. Tracks 3 Jlm 
wide(which were electrically insulated by the use of photoresist) connected the electrodes to 
bonding pads where attachments were made to the potentiostats. 
4.4.7.2 Antibody immobilisation 
Avidin and photobiotin were immobilised on electrodes as described in Section 4.4.2. After 
washing in PBS the wafer was covered with 10 Jlg ml-
' 
goat anti-rabbit IgG for 15 minutes 
and one of the electrodes was exposed to light as described in Section 4.4.4.1. After 
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washing in PBS the wafer was covered with 10 Ilg ml-1 goat anti-rat IgG and the other 
electrode was exposed to light 15 minutes The surface was then blocked with casein as 
described in Section 4.4.4.1. Areas of the surface other than the electrodes were exposed to 
DUV radiation, fitted with a plastic ring and stored as described in Section 4.4.4.1. 
Antibodies were also immobilised to electrodes in the way described above, but instead of 
just the electrodes being exposed to light during the patterning process, the area ofpattemcd 
gold surrounding the electrodes (Figure 4.7) was also exposed, thus increasing the area of 
specifically bound antibody. 
4.4.7.3 Immunoassay procedure. 
Electrodes were incubated in solutions of PBS or PBS containing 10 Ilg ml-1 rat IgG and I 
or 10 Ilg ml-· rabbit IgG for 60 minutes at room temperature. Following washing with PBS, 
electrodes were incubated in 10 Ilg ml-· goat anti-rat IgG-HRP conjugate and 10 Ilg ml- 1 
goat anti-rabbit IgG-HRP conjugate for 60 minutes at room temperature 
Simultaneous assessment of HRP activity was performed chronoamperometrically using 
two Bioanalytical System CV-37 potentiostats and a Goerz SEl20 dual channel chart 
recorder. Activity was determined by measuring the current produced at 120 s in the 
presence of 10 mM hydrogen peroxide, and 0.2 mM ferrocenemonocarboxylic acid in 50 
mM phosphate buffer containing 50 mM KCI, pH 7.4, with a potential of + 150 mY applied 
to the working electrode versus the AglAgCI reference electrode.290 
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4.5 Results and Discussion 
4.5.1 Investigation into effect of hemispherical diffusion field upon response of 
ultramicroelectrodes. 
The results shown in Table 4.5 demonstrate that the observed current for 2 mm diameter 
electrodes was predominantly a result of electroactive species being generated at the 
electrode surface. The currents observed when GOD has been specifically immobilised on 
the electrode were significantly higher than those where GOD had been specifically 
immobilised on the surrounding gold but not on the electrode itself, and for those where 
only non-specific binding was present. The currents observed where GOD had been 
specifically immobilised on the surrounding gold but not on the electrode itself, were 
slightly higher than those where only non-specific binding was present, indicating that some 
diffusion to the electrode of H20 2 generated in the surrounding area was occurring. These 
results also indicate that the effect of non-specifically bound GOD on observed currents is 
small. 
The results shown in Table 4.6 demonstrate that for 10 ~m diameter electrodes non-specific 
binding of GOD to the gold surface surrounding the electrode can produce a very 
significant current at the working electrode. This is as the H20 2 produced in this 
surrounding area diffuses to the working electrode, and this non-specific signal is similar in 
magnitude to that obtained when GOD is specifically immobilised at the working electrode. 
These results indicate that when using ultramicroelectrode arrays for multianalyte assays 
the effect of non-specific binding (in particular to the surrounding surface) can be critical. 
The results in Tables 4.5 and 4.7 indicate that if in the presence of glucose, a potential of 
+650 m V vs. Agi AgCI was applied to the area of gold surrounding the 2 mm diameter 
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electrode as well as to the electrode itself, only a small decrease in current from the working 
electrode was observed compared with when the potential was applied to the electrode 
alone. This was as the diffusion at the 2 mm diameter electrode is predominantly planar 
with only a relatively small lateral component, which is further demonstrated by the 
relatively small current observed when there is no functional GOD deposited on the 
electrode itself, but functional GOD is present on the surrounding gold surface. 
The results in Tables 4.6 and 4.8 indicate that ifin the presence of glucose, a potential of 
+650 m V vs. Ag/ Agel was applied to the area of gold surrounding the 10 Ilm diameter 
electrode as well as to the electrode itself, the resultant current [Tom the working electrode 
was, in most cases, indistinguishable from the signal when no glucose was present. This 
was because the surrounding gold was acting as a macroelectrode and eliminated the 
hemispherical diffusion field surrounding the ultramicroelectrode. The only exception was 
that where GOD was specifically immobilised on the electrode, and any non-specifically 
bound GOD in the surrounding area was rendered non-functional by DUV irradiation. In 
this case a hemispherical diffusion of glucose to the electrode can occur. 
These results suggest that for multianalyte sensors employing ultramicroelectrodes one 
should specifically immobilise the biological element over the surface surrounding the 
electrode as well as on the electrode itself. This is so that the specific signal is being 
generated over the entire "field of view" (i.e. the hemispherical diffusion field), thus 
improving the specific/nonspecific signal ratio as discussed earlier in this chapter by 
increasing Ssb in Equations 4.7 and 4.8. An alternative is to render any molecules that are 
non-specifically bound to the area surrounding the electrode non-functional by techniques 
such as DUV irradiation, and thus decreasing 5mb in Equations 4.7 and 4.8. 
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Current nA I i 
Area with non-specifically bound GOD I 
None Electrode Other than All ! 
electrode I 
-; 
Area with None 63 76 78 84 
specifically Electrode - 358 - 346 : bound 
! GOD Other than electrode - - 118 122 
All 347 1 - - - j 
Table 4.5 Currents obtamed from 2 mm diameter electrodes in the presence of ~lucose when no potential was 
applied to the surrounding gold surface. Chronoamperometry was performed as described in Section 4.4.4.2. 
Current pA 
I 
Area with non-specifically bound GOD 1 
----1 
None Electrode Other than All I 
electrode 
i 
Area with None 23 47 102 99 J 
specifically Electrode 
-
243 - 265 i bound 
GOD Other than electrode - - 233 238 i 
All 
- - -
258 i 
Table 4.6 Currents obtamed from 10 urn dIameter electrodes m the presence of alucose when no potential was 
applied to the surrounding gold surface. Chronoamperometry was performed as described in Section 4.4.4.2. 
Current nA 
Area with non-specifically bound GOD 
None Electrode Other than All 
electrode 
Area with None 54 69 57 67 
specifically Electrode - 338 - 341 bound 
GOD Other than electrode - - 71 77 
All - - - 329 
I 
i 
Table 4.7 Currents obtamed from the 2 mm dIameter electrodes 1D the presence of alucose when a potential of 
+650 mV was IWplied to the surroundin~ ~old surface as well as to the workim: electrode. 
Chronoamperometry was performed as described in Section 4.4.4.2. 
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.~ 
, 
Current pA 
.~ 
Area with non-specifically bound GOD 
----- ._._----< 
None Electrode Other than All 
electrode ; 
Area with None 19 23 18 22 ! 
! 
specifically 1 
bound 
Electrode - 198 - 23 
GOD Other than electrode - - 30 22 
All - - - 31 
Table 4.8 Currents obtamed from the 10 "m dIameter electrodes in the presence of /:Iucose when a potential 
of +650 mV was applied to the surrounding gold surface as well as to the working electrode. 
Chronoamperometry was performed as described in Section 4.4.4.2. 
4.5.2 Investigation into analytical "cross-talk" caused by mass transport of electrochemical 
species generated at one electrode to other electrodes in an array. 
The data presented in Figures 4.9 and 4.10 indicates that unless electrodes are in very close 
proximity the contribution of electroactive species generated at one electrode to the 
observed response at another is minimal. It should be noted that distances in these Figures 
are expressed from the centre of one electrode to the centre of another. The contribution of 
electroactive species generated at one electrode to the observed response at another is more 
pronounced for the 1 0 ~m electrodes than for the 1 mm electrodes, which reflects the 
increased importance of lateral diffusion for ultramicroelectrodes. That lateral diffusion is 
less significant for larger electrodes, is also shown by the greater proportional change in 
current for ultramicroelectrodes, when the generator as well as the measuring electrode is 
held at a potential of +650 m V vs. Ag/ AgCI. 
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Figure 4.9 Current (background subtracted) as a function of electrode distance from the generator electrode 
for I mm diameter electrodes. Experimental details are provided in the text (Section 4.4.5) 
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Figure 4.10 Current (background subtracted) as a function of electrode di tance from the generator el ctrode 
for \0 J,!.m diameter electrodes. Experimental details are provided in the text (Section 4.4.5) 
Equations 4.7 and 4.8 show that the contribution to the non-specific signal (Sn b)' is 
dependent upon the relative area and number of other electrodes within an array. The effects 
are cumulative and care should be taken in the design of mUltianalyte electrode array t 
locate electrodes so that lateral diffusion of electrochemical species between them i 
negligible, particularly when using ultramicroelectrodes, where lateral diffu ion 
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predominates. The hemispherical diffusion field associated with ultrarnicroelectrodes is a 
limiting factor for how closely electrodes can be placed together in a multianalyte system. 
4.5.3 Construction ofmultianalyte enzymic biosensor using ultramicroelectrodes. 
The results shown in Figures 4.11 and 4.12 demonstrate that a combination of the 
avidin-photobiotin immobilisation technique and DUV irradiation of non-electrode areas 
can be used to construct a multianalyte biosensor using ultramicroelectrodes. The 
avidin-photobiotin immobilisation procedure specifically immobilised enzymes on the 
electrodes, and any molecules that had non-specifically bound to non-electrode surfaces 
were inactivated by the use ofDUV irradiation. 
There was minimal response of the glucose sensor to the prescence of glutamate in solution 
and vice versa. Based on the size of electrodes and distances them used in this work it 
would be possible to construct a sensor Imm2 capable of measuring at least 25 discrete 
analytes. If the distances between the electrodes were reduced this would allow significantly 
more sensor elements to be fitted into the same area, for example data shown in Figure 4.11 
shows minimal"cross-talk" between electrodes 50 J.lm apart. If electrodes were located 50 
J.lm apart, then theoretically one could fit over 350 sensors in a Imm2 area, each sensor 
responding to a different analyte. 
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Figure 4. 11 Response of the glucose oxidase electrode to solutions containing glucose and glutamate. GOD 
and GLaD were specifically immobilised on discrete 10 Ilm diameter ultramicroelectrodes using the 
avidin-photobiotin method. An amperometric enzyme based assay was performed using the modified gold 
surface as a working electrode, with an Ag/AgCI electrode as the reference. Chronoamperometry was 
performed as described in the text. 
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Figure 4 .12 Response of the glutamate oxidase electrode to solutions containing glucose and glutamate. GOD 
and GLaD were specifically immobilised on discrete 10 Ilm diameter ultramicroelectrodes using the 
avidin-photobiotin method. An amperometric enzyme based assay was performed using the modified gold 
surface as a working electrode, with an AglAgCI electrode as the reference. Chronoamperometry was 
performed as described in the text. 
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4.5.4 Construction ofmultianalyte immunosensor using ultramicroelectrodes. 
The results in Table 4.9 show that when antibodies were specifically immobilised on the 
ultramicroelectrode alone, no significant difference in current could be observed when 
antigen was or was not present. This reflects insufficient signal generating molecules (i.e. 
conjugate) present in the small area of the electrode surface to produce a current 
differentiable from that of the background. 
The results in Table 4.10 show that when antibodies were specifically immobilised on the 
area surrounding the electrode as well as the ultramicroelectrode itself, significant 
differences in current could be observed when antigen was or was not present. The 
difference between this case and that when antibody was immobilised on the electrode 
alone, is due to a greatly increased amount of conjugate being bound, with a related increase 
in signal generation. 
Current pA 
Sample Electrode with anti-rat IgG Electrode with anti-rabbit 
immobilised IgG immobilised 
PBS 25 22 
10 J.lg ml·t rat IgG 31 25 
10 J.lg ml-t rabbit IgG 26 28 
10 Jlg ml-t rat IgG + 29 28 
10 Jlg ml- t rabbit IgG 
Table 4.9 Currents obtained in presence ofantiaens for ultramicroelectrode immunoassay when antibody was 
immobilised only on electrode. Experimental details are provided in the text (Section 4.4.7) 
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Current pA 
Sample Electrode with anti-rat IgG Electrode with anti-rabbit 
immobilised IgG immobilised 
PBS 23 24 
10 Jlg ml- I rat IgG 107 31 
10 Jlg ml- I rabbit IgG 28 94 
10 Jlg ml- I rat IgG + 124 115 
10 Jlg ml- I rabbit IgG 
Table 4_10 Currents obtained in presence of antieens for ultramicroelectrode immunoassay when antibody 
was irnmobilised on surrounding area as well as on electrode_ Experimental details are provided in the text 
(Section 4-4.7) 
I 
I 
I 
I 
I 
I 
I 
I 
The qualitative immunosensor fabricated in this section of work demonstrates the feasibility 
of constructing multianalyte amperometric immunosensors using ultramicroelectrodes. The 
work presented in this chapter shows that when using ultramicroelectrodes in multianalyte 
assays, it is necessary take into account the field of view of the system (defined by the area 
of hemispherical diffusion).The field of view effects can be limited by destroying the 
activity of any biological molecules non-specifically bound to the surrounding area (e.g. by 
DUV irradiation). This provides increased sensitivity and specificity by decreasing the 
non-specific signal (Snsb in Equations 4.7 and 4.8). Alternatively one can increase the 
specific signal (Ssb in Equations 4.7 and 4.8) by extending the area of specifically 
immobilised molecules to that of the area surrounding the electrode. 
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CHAPTERS 
And in such indexes, although small pricks 
To their subsequent volumes, there is seen 
The baby Figure of the giant mass 
of things to come at large 
William Shakespeare 
Troilus and Cressida 
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5 Further applications of avidin-photobiotin immobilisation procedure 
This chapter examines the extension of the avidin-photobiotin immobilisation technique to 
applications other than protein based biosensors. Initially, work was performed to 
demonstrate the patterning of DNA on silicon dioxide, following on from this, the 
avidin-photo biotin patterning procedure was used to immobilise oligonucleotides as the 
basis of an assay to detect a genetic polymorphism. Additionally, since the publication of 
the avidin-photobiotin immobilisation technique,197 it (or variants thereof) has been 
employed by a number of other workers, and this work, along with some future prospects, 
are briefly reviewed in this chapter. 
5.1 Pattern ina: of nucleic acids 
Patterning of different nucleic acids or oligonucleotides on to sensor surfaces could be 
useful in the construction ofbiosensors for the detection of a number of genetic diseases or 
polymorphisms. An example where this application may prove useful is in the assessment 
of thrombotic risk. There are several polymorphisms, associated with an increased 
thrombotic risk, of particular interest are those for Factor VLcidcn, Factor IILciden and 
methylene- tetrahydrofolate reductase (MTHFR). 
Factor V is one of the components of the coagulation cascade (Figure 5.1) and acts as a 
cofactor for Factor X. Factor V is converted to its active form by the action of thrombin, 
and subsequently inactivated by the action of activated protein C (APC). It has been noted 
that in some people who are prone to thrombosis, that their Factor V is resistant to cleavage 
by APC.301 It has subsequently been demonstrated that the abnormality is caused by the 
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replacement of arginine by glutamine at residue 506,302 which is a major cleavage site for 
APe, and thus the mutation is associated with a prolonged plasma half-life of activated 
Factor V. The possession ofthis variant commonly referred to as Factor VLeiden, is associated 
with an increased risk of thrombosis and is an important risk factor in populations of 
European descent, where it has an incidence of approximately 7%.302 In heterozygotes the 
risk of thrombosis is increased approximately 7-fold, whereas homo zygotes have about 80 
times more chance of having a thrombotic episode as compared to someone with the normal 
Factor V gene.302 
Similarly a mutation with the Factor II (prothrombin) gene is associated with increased risk 
ofthrombosis.303 Like Factor V, Factor II is a component of the coagulation cascade (Figure 
5.1), and the variant protein is frequently referred to as Factor IILeiden This mutation is 
present in about 1 % of the European population and is associated with elevated 
prothrombin levels. It is thought that these elevated levels disturb the balance of the 
coagulation system and result in a tendency for inappropriate clot formation to occur. 303 
Homocysteine is a sulphur containing amino acid, that although itself not a building block 
for proteins, lies at an important metabolic branch point in the metabolism of methionine 
and cysteine as shown in Figure 5.2.304 A mutation in MTHFR (the enzyme responsible for 
converting homocysteine back to methionine) is thought to be a frequent and significant 
cause for mild hyperhomocysteinaemia.30s A number of large patient-control studies have 
shown that even mild hyperhomocysteinamia is a risk factor for thrombosis.306,307 
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Figure 5.1 Simplified version of the coagulation cascade. Arrows in green are those catalysing conversion of 
clotting factors and promoting procoagulant activity. Arrows in red are inhibitory, converting an activated 
factor to an inactive form and thus promoting anticoagulant activity. 
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Figure 5.2 Biochemical pathways of the conversion of homocysteine to methione and cysteine. 
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What is particularly important about the above mentioned mutations predisposing to 
thrombosis, is that the risk increases cumulatively according to the number of the mutations 
that an individual has. For example, if an individual is heterozygotic for Factor V Leiden then 
the risk of thrombosis is increased approximately 7-fold; if the individual is also 
heterozygotic for Factor IILeiden , then the thrombotic risk is increased approximately 30-fold; 
and if the individual also has the MTHFR variant, then they are about 100 times more likely 
to have a thrombotic event.308 This cumulative risk make it relevant to measure these 
analytes in a multianalyte system. 
5.1.1 DNA amplification 
In order to obtain sufficient quantities of DNA from tissue samples for genetic analysis, it is 
usually necessary to use a DNA amplification procedure, the most commonly used is the 
polymerase chain reaction (peR). peR relies on multiple amplifications between two 
oligonucleotide primers complementary to the anti-parallel DNA strands using a 
directionally specific DNA polymerase.309,31o The principle of the polymerase chain reaction 
is shown in Figure 5.3. 
peR utilises the ability of an oligonucleotide "primer" to target a specific nucleotide 
sequence on denatured DNA and form an initiation site for DNA polymerase to synthesize a 
copy of the template. Primers are selected to be complementary to opposite strands of the 
DNA, and so that the sequence to be detected is present within the section between them. 
The action of the polymerase results in the formation of two additional DNA strands 
containing the primers at the 5' end. After denaturation, 4 strands of DNA are available for 
annealing of primers and subsequent polymerisation. The three steps of the reaction; 
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a 
b 
c 
d 
e 
= Original DNA in sample 
= Oligonucleotide primer 
= Extended chain formed from mononucleotides 
Figure 5.3 Principle of the polymerase chain reaction method of amplifying DNA. a), Sample DNA is 
denatured so that the complementary strands separate. b) An oligonucleotide primer anneals to the denatured 
DNA and c) nucleotides are incorporated into a new DNA chain by the action the action of Taq polymerase 
(elongation). d) A new cycle begins with denaturation of sample and newly synthesised DNA, and primers 
annealing to the DNA strands followed bye) elongation. The process is repeated for further cycles, with a 
potential doubling of DNA each time. 
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denaturation, annealing and polymerisation (elongation) are generally performed at three 
different temperatures (denaturation - 94°C, annealing - 55°C and elongation - nOC). The 
exact temperatures and time that each temperature is maintained are dictated by factors such 
as sample type and the length of DNA to be amplified. These steps are repeated with a 
potential doubling of the amount of DNA with each cycle. 
Reactants in a typical PCR are the sample DNA, each deoxynucleotide triphosphate (A, T, 
C, G), oligonucleotide primers and the DNA polymerase. The DNA polymerase used in 
PCR is derived from the thennophilic bacteria Thermus aquaticus, and thus allows the 
enzyme to remain active at the required elevated temperatures (the enzyme usually being 
refened to as Taq polymerase). Theoretically, the reaction is capable of amplifying DNA 
by a factor of 2n where n equals the number of cycles, so 20 cycles could result in a 
million-fold amplification. In practice, as the efficiency of the reaction is less than 100 %, 
20 cycles would typically result in an amplification by a factor of about 250,000. 
5.1.2 Principle of assay for detection of Factor Vlcjdcn genotype 
Oligonucleotide primers were immobilised using the avidin-photobiotin technique and 
in-situ polymerase chain reaction amplification and detection of DNA was undertaken. 
The principle of the assay is shown in Figure 5.4. Wells of a PCR microtitre plate had one 
of two oligonucleotide primers attached using the avidin-photobiotin immobilisation 
technique. Primer 1 which was complementary to the nonnal Factor V genotype was 
imrnobilised in 50% of the wells whilst Primer 2 whichwa complementary to the Factor 
V Leiden genotype was immobilised in the others. Extracted human DNA was added to the 
wells (each sample being added to 2 wells, one containing primer 1 and the other containing 
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primer 2) along with the other reactants (as described in Section 5.1), and the plate was 
placed in a thermal cycler. 
The DNA was denatured and bound to the immobilised specific Factor V genoytype 
primer(s) with which it had complementary sequences. The sample DNA also bound to the 
biotinylated primer that is common to DNA for both genotypes (Figure S.4a). Taq 
polymerase acted to elongate the primer chain by incorporation of nucleotides using the 
sample DNA as template (Figure S.4b). With a new cycle, primers bound to the newly 
synthesised DNA chains (as well as to original DNA) and amplification continued (Figure 
S.4c) until biotinylated primers were attached to all of the immobilised primers via newly 
synthesised DNA chains (Figure S.4d). Streptavidin-HRP conjugate was added which 
attached to biotin (Figure S.4e). Substrate and chromaphore were added and colour 
development indicated the presence of a sample DNA sequence complementary to that of 
the immobilised primer. 
The combination of results from wells containing the 2 different primers gave the Factor V 
genotype. If colour develo~ment was seen in only wells with primer 1 immobilised, then 
the individual had the normal Factor V. Colour development in both wells indicated that the 
individual was heterozygotic whereas colour development in only wells with primer 2 
immobilised indicated a homozygotic Factor Vleiden. 
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a 
__ = Sample DNA 
_ = Immobilised primer 9 or 10 
.L- = Biotinylated common primer 
b _ = New DNA chains 
~ = Streptavidin-HR.P conjugate 
c / b 
r [ r r r [ 
d [[ [1[[[ 
e I 
Figure 5.4 Principle of the assay for identification of Factor V genotype. a) Sample DNA bind to the 
immobilised specific Factor V genoytype primer if its sequences are complementary. Sample DNA also bind 
the biotinylated primer that is common to DNA for both genotypes. b) Elongation of primers occurs using 
sample DNA as template. c) With a new cycle primers bind to the newly synthesi ed DNA chains (as well a 
to original DNA) and amplification continues until d) biotinylated primers are attached to all of the 
immobilised primers via newly synthesised DNA chains. e). Streptavidin-HRP conjugate is added which 
attaches to biotin and allows colour development to occur thu demonstrating presence of genotype. 
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5.2 Materials 
Photobiotin and biotinylated DNA were obtained from Vector Laboratories, Peterborough, 
England. Sodium cyanoborohydride, streptavidin-FITC, Taq polymerase, dNTPs and 
Streptavidin-horseradish peroxidase were obtained from Sigma, Fancy Road, Poole, Dorset, 
England. Neutravidin and casein were obtained from Pierce Warriner, Chester, England. 
Oligonucelotide primers were obtained from Oswel DNA Service, Southampton, England. 
1,3-trimethoxysilylpropyl- ethylene diamine, ethanol, sodium dihydrogen phosphate, 
disodium hydrogen phosphate, sodium chloride, glutaraldehyde, magnesium chloride and 
hydrogen peroxide were obtained from BDH, Poole, Dorset, England. TMB substrate was 
obtained from Shield Diagnostics, Dundee, Scotland 
Extracted human DNA was kindly provided by Dr. David Stirling of Edinburgh Royal 
Infirmary. 
Silicon wafers were obtained from Shin Etsu, Livingston, Scotland. COOH-ThermoFast 
peR microtitre plates were obtained from Advanced Biotechnologies, Leatherhead, 
England. 
A Touchdown™ thermal cycler was provided by Life Sciences International, Basingstoke, 
England. 
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5.3 Methods 
5.3.1 Patterning of nucleic acids using avidin and photobiotin. 
Neutravidin was immobilised on a Si02 wafer using the silanisation process as described in 
Section 2.3.1. The avidin-modified wafer was incubated in 5 mi of 10 Ilg ml· l long ann 
photobiotin in PBS for 20 minutes, and was then covered with 10 Ilg mI· l biotinylated 
DNA and exposed to light as described in Section 2.3.1 through a mask with 10llm interval 
equal mark:space ratio lines. The wafer was covered with 10 mg ml· l casein in PBS and 
exposed to light for 15 minutes in the absence of a mask. The wafer was then incubated in 
10 Ilg mI') FITC labelled streptavidin in PBS, for 60 minutes. After washing in PBS and 
distilled water the sample was dried in a stream of nitrogen and examined using 
fluorescent microscopy. A photomicrograph of this surface is shown in Section 5.4.1. 
5.3.2 Utilising the avidin-photobiotin imroobilisation techniQue in the determination of 
Factor V genot)!pes 
5.3.2.1 Immobilisation of oligonucleotide primers. 
Wells ofa COOH-ThennoFast™ plate were incubated with 1% (w/v) EDC in 10 mM 
phosphate buffer (PH 7.0) for 120 minutes at room temperature. The wells were then 
incubated in 200 Ilg mI') Neutravidin in 10 mM phosphate buffer (pH 7.0) for 16 hours at 
4°C. All subsequent stages of the immobilisation process were performed at room 
temperature under dark room conditions. After washing in PBS, wells were incubated with 
10 Ilg ml· l long-arm photobiotin in PBS for 20 minutes. Solutions containing Illg ml· l of 
either primer 1 (nonnal sequence) or primer 2 (Factor VLeiden sequence) were added to the 
wells and the plate was exposed to light from a high pressure mercury vapour lamp for 15 
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minutes. After washing in 10 mM phosphate buffer containing 1M NaCl and 0.1 % Triton 
X-IOO (to remove any non-covalently bound oligonucleotides) the plate was ready for use. 
5.3.2.2 peR amplification of DNA 
Samples consisted of DNA extracted from the blood of individuals with known Factor V 
genotypes. 1 III of sample was added to 50 III ofPCR reagent (20 U ml- l Taq polymerase, 
O.3mM dNTPs, 1.5 mM MgCh, 6 J,lg ml· l biotinylated common primer in 10 mM Tris-HCI 
pH 7.6) in wells with both types ofimmobilised primer. The plate was then placed in the 
thermal cycler and PCR was performed using the following protocol: 
Initial Denaturation step: 5 Minutes at 95°C 
30 cycles of Denaturation 15 seconds at 95°C 
Annealing 15 seconds at 55°C 
Elongation 30 seconds at 72°C 
Final Elongation step 5 minutes at 72°C 
5.3.2.3 Detection ofPCRproducts 
Following the PCR amplification, the wells were washed with PBS containing 1 % BSA and 
0.1 % Triton X-lOO. A streptavidin-HRP conjugate was added to the wells and incubated at 
20°C for 30 minutes, and wells were then washed with PBS containing 1 % BSA and 0.1 % 
Triton X-lOO prior to the addition of the substrate solution (contained H20 2 and 
3,3',5,5'-tetramethylbenzidine (TMB) as the chromophore). After 5 minutes incubation at 
20°C, the addition of 1M H2S04• stopped the action of the peroxidase and changed the 
colour of the chromagen from a pale blue to an intense yellow colour (AMax = 450 nm). 
Absorbances were recorded and are shown in Section 5.4.2 for people with different known 
Factor V genotypes (verified by PCR and gel electrophoresis). 
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5.4. Results and Discussion 
5.4.1 Patterning of nucleic acids using avidin and photobiotin. 
The photomicrograph of the surface shown in Figure 5.5 demonstrates that high resolution 
«IOllm) patterning of nucleic acids onto a surface could be achieved using the 
avidin-photobiotin technique developed in this work. It should be noted that the biotinylated 
DNA does not bind to the avidinated surface, via its inherent biotin groups. This is because 
the biotin binding sites of the immobilised avidin have been saturated by pre-incubation with 
photobiotin. 
10 11m 
Figure 5.5 Photomicrograph the patterning of nucleic acids by use of the avidin-photobiotin technique. 
Avidin and photobiotin were irnmobilised on to the surface of a Si02 wafer as described in Section 2.3 .3 . 
The surface was then covered with biotinylated DNA in PBS and exposed to light through a mask with 10 
~ interval equal mark:space ratio lines. The wafer was covered with casein and exposed to light in the 
absence of a mask. The wafer was then incubated in FITC labelled streptavidin in PBS. Following washing 
the sample was dried in a stream of nitrogen and examined using fluorescent microscopy. 
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5.4.2 Utilising the avidin-photobiotin immobilisation technigue in the determination of 
Factor V genotypes 
The results shown in Table 5.1 indicates that by immobilising oligonucleotide primers with 
the avidin-photobiotin technique, and using this modified surface in conjunction with peR 
and a suitable detection method it is possible to detect genetic polymorphisms. Negligible 
absorbances are obtained when the sample DNA sequence does not match that of the 
specific immobilised primer. Where sequences are complementary between sample and 
primer, high absorbances are obtained. 
Sample A..so Normal genotype A..so Variant genotype 
~rimer primer 
Homozygous normal 2.302 0.067 
Heterozygous 1.892 1.726 
Homozygous variant 0.078 2.251 
Table 5.1 Results obtained from patients with different Factor V ienottPes. Individuals with a homozygous 
normal genotype only show a reaction with the oligonucleotide primer for the normal genotype. Individuals 
with a homozygous variant genotype only show a reaction with the oligonucleotide primer for the variant 
genotype, whilst individuals who are heterozygous show reactions with both primers. 
It may be possible to construct sensor arrays for use in genetic analysis using the 
avidin-photobiotin immobilisation technique to selectively immobilise different 
oligonucleotide primers to specific parts of the array. The substrate of the array could 
incorporate an element allowing its temperature to be cycled, and thus an integrated device 
could be fabricated that would have primers capable of recognising specific nucleotide 
sequences and the capability of obtaining the temperature control necessary for peR 
without the requirement for expensive thermal cyclers. A major problem in the construction 
of a device that incorporates the DNA amplification stage would be the elimination of 
non-specific binding. Because of the tremendous amplification achieved by peR, even the 
presence of one molecule of non-specifically bound nucleotide sequence could have a 
seriously detrimental effect. 
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5.5 Review of related work from other t;:roups since publication of the 
avidin-photobiotin immobilisation technique. 
Since the first description of using photobiotin to selectively immobilise biological 
molecules l 97 , a number of other workers have used the technique or modifications 
thereof. 311·3 17 
The avidin-photobiotin patterning method has been applied to direct sensing detection 
systems.3II ,31 2 Figure 5.6 shows a SPR microscope image ofIgG patterned on to a surface 
using the avidin-photobiotin method.311 The pattern was created using a a mask with 50 ~m 
wide equal mark:space ratio lines. 
500J..lm 
Figure 5.6 Surface plasmon resonance microscopy image ofIgG patterned on to a surface using the 
avidin-photobiotin method. The pattern was created using a a mask with 50 11m wide equal mark:space ratio 
lines.311 
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One group used avidinlphotobiotin to attach enzymes to a carbon electrode surface such 
that the enzymes were spatially separated and directly adjacent to electrode transfer sites on 
the same electrode surface.313 High resolution patterning of the enzymes was required, so 
that the distance between the enzyme-loaded llomains and the electron transfer sites was 
less than 5 Ilm, so as to maintain the fast response time and high sensitivity required for the 
measurement of neurotransmitter dynamics. Patterning of enzymes was achieved by use of 
an interference pattern generated from a UV laser. Characterisation of the surfaces was 
performed using fluorescence microscopy and AFM. This group has also shown that 
extensive biotin/avidin derivatisation of carbon electrode surfaces results in a decrease of 
the electron transfer rate of the electrode, but use of photobiotin to specifically immobilise 
proteins directly adjacent to electrode transfer sites (where photobiotin has not been 
activated, and protein immobilisation has not occurred) on the same electrode surface 
maintained fast response times and high sensitivity.3\4 The use of an interference pattern 
generated from a UV laser to activate photobiotin has recently been used to immobilise 
antibodies onto a carbon surface with with sub-micron resolution.3ls 
Other workers have created patterns of biotin on polymer (polystyrene and nitrocellulose) 
surfaces, by exposing the polymeric surface to photobiotin in the presence of light through a 
mask.316 The subsequent addition of avidin resulted in the formation of surfaces to which 
biotinylated molecules could then be bound through a biotin-avidin-biotin bridge. The 
technique was used to pattern alkaline phosphatase and horseradish peroxidase whilst 
retaining their catalytic activity. It should be noted that this method is very similar to that 
described in Sections 2.3.1 and 2.13.1, the difference being the use of a polymer instead of 
a protein modified surface as the matrix for attachment of photobiotin. 
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A variation on the photobiotin based immobilisation method, is the use of a "caged" biotin 
analogue.3J7 The biotin analogue (which contains a photoactivable nitroveratryloxy-
carbonyl (Nvoc) group) is covalently linked to a substrate surface. The Nvoc group blocks 
the avidin-biotin interaction, but upon exposure to UV light it is cleaved yielding biotin 
sites which can be used to immobilise biotinylated macromolecules via a 
biotin-avidin-biotin bridge. Patterning can be achieved by the use of a photolithographic 
mask. 
Advances have been made in other methods of patterning biological molecules, particularly 
with substrates containing micron and sub-micron scale channels.318•319 The availability of 
micro machined dispensing systems capable of dispensing pi co litre quantities of 
liquids,32o,321 provides the opportunity of physical deposition of material with high 
resolution. Sub-micron resolution patterning of immunoglobulins has been achieved using 
micro fluidic networks, using gold, glass and polystyrene as substrates.318 
5.6 Future possibilities 
The work presented in this thesis has demonstrated the development of a novel method for 
selectively immobilising biological molecules in predefined areas with micron scale 
resolution, and its use in a number of applications. There are a number of areas in which the 
work outlined in this thesis could be taken further. 
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5.6.1 Multianalyte Enzymic biosensors 
The successful fabrication of a multianalyte enzymic biosensor using ultramicroelectrodes 
was demonstrated in Chapter 4. Future work could be undertaken to construct arrays of 
electrodes measuring a large number of analytes simultaneously. In these arrays a number 
of sensor elements could measure the same analyte in parallel, which would allow more 
accurate and reproducible determinations (through averaging) and minimising the effect of 
(or even excluding) any sensor elements producing a result considered to be an outlier. The 
avidin-photobiotin immobilisation technique could also be applied to the manufacture of 
multianalyte optical biosensors. One particularly attractive feature of this application is that 
for sensors such as those employing fibre-optic technology the light necessary for 
immobilisation could be delivered by the sensors tranducing element itself, which would 
make fabrication very simple. 
5.6.2 Multianalyte Immunosensors 
The successful fabrication of a number of multianalyte immunosensors has been 
demonstrated in the course of this work. In Chapter 2 the fabrication of qualitative 
immunosensors (both optical and amperometric) for up to 5 analytes was demonstrated. In 
Chapter 3 a quantitative amperometric multianalyte immunosensor for the determination of 
gonadotrophins was constructed, and in Chapter 4 the feasibility of using very small 
electrodes in multianalyte amperometic immunosensors was shown. 
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Arrays of electrodes could be constructed, and as for enzymic sensors (Section 5.7.1) these 
could be used in controlling the quality of the results produced. Again as for enzymic 
systems the avidin-photobiotin method could be utilised in the production of optical 
immunosensors. 
5.6.3 Integrated devices for analysis of nucleic acids. 
There are numerous reports in the literature ofbiosensors designed for the analysis of 
nucleic acids.322-324 One potential application of an immobilisation technique such as the one 
developed in the course of this work, is in the fabrication of an integrated device for the 
amplification and analysis of nucleic acids. As discussed in section 5.4.4, oligonucleotide 
primers complementary to a variety of nucleic acid sequences could be immobilised onto 
elements of an array on a substrate that incorporates an element capable of controlling its 
temperature. This sensor could be placed in contact with the sample and reagents and its 
temperature cycled to perform the PCR amplification. 
A multianalyte sensor constructed in this way could be very small, and thus very rapid 
temperature changes could take place resulting in a shortening of assay time. A number of 
potential detection methods exist including fluorescence, amperometry or direct methods 
such as SPR. As was discussed in section 5.4.4. a likely major problem in the construction 
and use of such a device would be the complete elimination of non-specific binding (due to 
the ability of the PCR reaction to amplify minute amounts of nucleic acids). 
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5.6.4 Direct sensing 
The avidin-photobiotin immobilisation method could be used for multianalyte direct and 
real-time sensing ofreactions involving a change of mass at the sensor surface. Such 
reactions would include immunological reactions and detection of nucleic acid 
amplification products as discussed in section 5.6.3. The combination of direct sensing 
techniques with the avidin-photobiotin immobilisation procedure has already been 
demonstrated (Section 5.5).311,312 
5.6,5. Cell Guidance 
A further possible application of this immobilisation procedure is in the fabrication of a 
device for the directional propagation of an individual cell, (e.g. nerve cell processes) on a 
patterned substrate. In this case, the essential prerequisites are the same as for the design of 
a diagnostic device. in so much that it is desirable to position molecules as a pre-defined 
pattern on a substrate with no interference from non-specific adsorption. Patterned 
molecules may act as a chemotactic or topological template for the guidance of the cell, 
which grow preferentially in a given direction detennined by the pattern, 142 Particularly 
important applications would be in the manufacture of devices either to control endothelial 
cell growth for wound healing. or to control nerve cell growth to promote regeneration. 
In addition to the design of devices for the guidance of individual cells, it may be desirable 
to use a patterning technique to alter the behaviour of many cells. For example, by coating 
appropriate molecules onto a surface. it may be possible to differentially promote or prevent 
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cell adherence and growth on the outer surface of a miniature implantable in vivo sensor, in 
order to enhance the biocompatibility properties of the device. 
An initial investigation was performed to assess if the avidin-photobiotin immobilisation 
technique could be used for guiding cell growth. Briefly, concanavalin A and BSA were 
patterned on to a silicon dioxide wafer. Snail neurones were placed on the substrate and 
incubated in growth media for 7 days. The cells were examined under a microscope. No 
guidance of the cell processes was evident, whereas in a control where protein had been 
patterned using a photolithographic lift-off technique 142 (see section 1.9.2) guidance of cell 
processes was evident with cellular processes running parallel to each other with distances 
between them reflecting the periodicity of lines on the photolithographic mask. The 
effectiveness of both patterning techniques was validated by patterning ofbiotinylated 
Concanavalin A, followed by incubation with a streptavidin-FITC conjugate. The reason for 
the difference in cell guidance between surfaces patterned with protein by these two 
techniques is not known. The lift-off technique may provide a firmer topological guide to 
cells than does the avidin-photobiotin technique, or changes to deposited protein as a result 
of the exposure to organic solvents in the lift-off technique may be influential if cell 
guidance is chemotactic in nature. 
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5.6.6 Other applications of patterning technique 
The immobilisation procedure developed in the course of this work could also be used to 
selectively deposit molecules onto a surface in ordered arrays for applications other than 
diagnostic sensors. Using this procedure, groups of molecules (which may possess 
particular properties, for example photodynamic proteins) may be positioned precisely with 
respect to other groups of molecules, or to other structures in order to build up functional 
molecular architectures. As in the case for the design of a diagnostic device, a variety of 
different transducer materials may be used as immobilisation substrates. 
5.6.7 Photoactivable Reagents other than Aryl Azides 
There are a number of reactive groups other than aryl nitrenes which may be formed 
photochemically. Carbenes may be formed from diazo compounds and diazirines, and are 
even more highly reactive than aryl nitrenes.204 Nitrophenyl ethers can undergo 
photochemical aromatic substitution selectively at amino groups, and psoralens have been 
used to react with pyrimidine and purine groups in nucleic acids. Other photactivable 
groups include non aryl azides, a.,~-unsaturated ketones, aryl halides, nitroaryl compounds, 
purines and pyrimidines.204 A major advantage of using photactivable reagents other than 
aryl azides would be in orientation of the immobilised molecule. A particular example 
where this would be extremely useful would be the patterning of oligonucleotides. 
Although the immobilisation technique employing an aryl azide (in the photobiotin 
molecule) was successful in that DNA amplification and detection occurred, it is likely that 
a significant proportion of the immobilised oligonucleotide was unable to act as a primer 
due to steric hinderance. As aryl azides react with a very wide range of species, the 
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photobiotin may attach the oligonucleotide such that subsequent binding of nucleotides or 
the action ofTaq polymerase are inhibited. Oligonucleotides with an amino group at one 
end are easily synthesised and are commercially available. Selective immobilisation using a 
photoactivable reagent such as nitrophenyl ethers that react selectively with amino groups 
would allow optimal orientation of the nucleotide for DNA amplification and detection. 
Photoreactive compounds containing specific peptide sequences promoting cell adhesion 
have been synthesised, and have been used to prepare 2-dimensional cellular patterns.325 
5.6.8 Very High Resolution Patterning 
The resolution of the protein pattern that can be "written" using a photolithographic mask is 
limited to approximately half the wavelength of light used.326 Other workers have 
demonstrated sub-micron resolution when employing avidin-photobiotin, by use of laser 
interferometric techniques (Section 5.5}.315 Another potential approach to patterning of 
biological molecules with improved resolution is by the use of a near-field optical scanning 
microscope (NFOSM}.327.328 This instrument is capable of achieving resolution of about 20 
nm. In a NFOSM a tiny aperture, typically 10 nm in diameter, is positioned at the apex of a 
conical metal screen. This aperture is illuminated from its reverse side and is scanned over 
the sample in very close proximity to it, maintaining the sample tip gap by utilisation of the 
tunnelling current as in STM. This technique has been applied to the generation of 
submicron scale patterns in photoresists,329-331 and it is possible that it could be applied to 
the avidin-photobiotin patterning technique. 
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